Adhesive microvascular anastomoses by Bowen, Clifford Vaughan Alisby
ADHESIVE MICROVASCULAR ANASTOMOSES









LIST OF ILLUSTRATIONS 11
LIST OF TABLES 13
PREFACE 14
CHAPTER 1. Development and Application of Microvascular
Surgery 19
Introduction 20
Historical Review of Vascular Repair 20




Application of Microvascular Repair 28
Replantation and revascularisation 28
Free tissue transfer 30
The New Subspecialty 32
Microsurgical education 32
Microsurgical literature 33
Cost/benefit of Microvascular Surgery 34
Current Practice in Microvascular Surgery 36
CHAPTER 2. Microvascular anastomosis: A review of Surgical
Technique and the Healing Process 38
Introduction 39
Techniques Used for Microvascular Anastomosis 39














Other important anastomotic factors 58
The Healing of Microvascular Anastomoses 59
Patency rate of microvascular anastomoses 59
Histology of microvascular anastomoses 60
SEM of microvascular anastomoses 63
Factors Relating to Anastomotic Failure 66
CHAPTER 3. Fibrinogen Adhesive and its Use in Surgery 71
Introduction 72
The Ideal Surgical Adhesive 72
The Development of Fibrinogen Adhesive 73
Pathophysiology of Fibrinogen Adhesive 75
The healing of traumatic wounds 75
Basic principles behind fibrinogen adhesive 77
Fate of fibrinogen adhesive in the tissues 78
Commercially Available Fibrinogen Adhesive 79
Packaging and composition 80
Mode of action 80
Mixing 88
Application 89
Combination with other materials 90
Side effects and contraindications 90
Risk of disease transmission 91
Detection in the tissues 92
Cost 92
3
Surgical Application of Fibrin Sealant 93
CHAPTER 4. Preliminary Study for the Development of a
Technique for the Use of Fibrinogen Adhesive in
Microvascular Anastomoses 95
Introduction 96
Previous Experience with Adhesive Anastomoses 96
Preliminary Study 98
Introduction 98
Materials and methods 99
Results 101
Development of a new adhesive technique 101
Development of an experimental model 103
The Experimental Technique with Fibrinogen Adhesive 109
The Control Technique with Sutures 111
The Rabbit Groin Flap Experimental Model 111
CHAPTER 5. Experimental Study Comparing Fibrinogen














Gross appearance of anastomoses 142
Histology of anastomoses 146







CHAPTER 6. The Role of Adhesives and the Future of
Microvascular Surgery 184
Introduction 185
Adhesive Microvascular Anastomoses 185
Other Uses for Adhesive in Microvascular Surgery 188





I declare that the contents of this thesis, submitted to the
University of Edinburgh for the degree of Doctor of Medicine, were
composed entirely by myself. The thesis is based entirely on my
own observations and, except as indicated in the
acknowledgements, the experiments were carried out, the data









ABSTRACT OF THESIS (Regulation 3.5.10)
Microvascular Surgery is a relatively new field of surgical
reconstruction and is primarily practiced by Plastic, Orthopaedic and
Hand Surgeons. Microvascular operations tend to be creative and unique,
each being custom designed to solve a specific clinical problem. Three
basic components are common to all microvascular operations: donor site
preparation, recipient site preparation, and transplantation with
microvascular anastomoses.
This thesis examines the use of adhesives in the fabrication of
microvascular anastomoses.
Chapter 1 broadly examines the development, application and
current practice of Microvascular Surgery. A historical review of vascular
repair leads into a discussion of early and contemporary replantation and
free tissue transfer operations.
Chapter 2 focuses on the technical aspects of microvascular
anastomosis. A review of the many techniques used is followed by a
description of the microvascular healing process.
Chapter 3 reviews the use of surgical adhesives. The
characteristics of an ideal surgical adhesive are set out. Previous work
with surgical adhesives is discussed, and the composition, mode of
action, application and fate of fibrinogen adhesive is described in detail.
Chapter 4 describes a preliminary study in which a new adhesive
microvascular anastomosis was developed. Using 6 rats and 12 rabbits an
adhesive end-in-end technique was found to be easy to carry out and
appeared to produce satisfactory vascular patency. A rabbit groin flap
model was developed to test the new technique in a controlled manner.
Chapter 5 describes an experimental study to test the new
technique in 50 rabbits using 100 consecutive flaps. Each animal acted
as its own control: one flap had a sutured anastomosis and one flap an
adhesive anastomosis. Despite numerous technical differences between
adhesive and sutured anastomoses, flap survival and patency rates were
not significantly different, although adhesive anastomoses were faster and
less difficult. The healing of the two types of anastomoses was compared
and contrasted using histological sections and scanning electron
microscopy.
Chapter 6 examines the relevance of the adhesive technique to the
contemporary Microvascular Surgeon, suggests other possible uses for
fibrinogen adhesive in Microvascular Surgery, and speculates a little on
future developments in this area of reconstructive surgery.
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Microvascular Surgery is a relatively new surgical subspecialty.
It has revolutionised many areas of reconstruction, especially in the
fields of Plastic Surgery, Orthopaedic Surgery and Surgery of the
Hand. It has enabled dramatic improvements to be made in older
surgical procedures, and has brought about the introduction of new
operations that were previously not possible.
The ability to carry out successful microvascular repairs was
the catalyst that made the new field of Microvascular Surgery
possible.
The first microvascular anastomoses were made using suture
technique. This method continues to be the most widely used and
is generally considered to be the 'gold standard' to which any other
method must be compared. It is, however, not without its own
difficulties and problems, and it is for this reason that
microvascular surgeons have continued to look for newer and better
methods.
The purpose of this thesis was to review the development of
Microvascular Surgery and to examine the variety of methods that
have been employed for making microvascular anastomoses.
Particular emphasis has been placed on the role of adhesives.
There are several reasons why this project was undertaken.
Over the years that I have been involved with Microvascular
Surgery I have seen and heard of many different methods for
making microvascular anastomoses. Some surgeons always use the
same technique whereas others use varying techniques, depending
on the circumstances. A few innovative surgeons are forever
looking for newer and better methods. The majority, myself
included, will fall somewhere in between, having a preferred
technique but using other methods if the occasion demands.
Hopefully we also maintain an open mind towards the use of newer
methods as they become available.
A year or two ago, I was approached by a trade representative,
from Immuno Canada, who asked if I had any use for their product,
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a fibrinogen adhesive, marketed under the tradename Tisseel.
Apart from the possibility of starting to use it for peripheral nerve
repairs, I could not think of any particular application to the type of
operations carried out in my practice of Surgery of the Hand and
Orthopaedic Microvascular Surgery. The suggestion was made that
I might consider using Tisseel for microvascular anastomoses. At
the time I was unfamiliar with the literature concerning the use of
adhesives in surgery, and my initial reaction was one of scepticism.
In short, I thought that the idea of using a product, created from
blood coagulation factors, anywhere near a microvascular
anastomosis was absurd.
Nevertheless, I was intrigued by the idea. A review of the
medical literature revealed that quite a lot had been written about
the use of fibrinogen adhesives in surgery. Unfortunately the
majority of the papers had been published in German, and the
information they contained was not readily available to non German
speaking surgeons like myself. I did have the opportunity to
examine these references with a German speaking anaesthetist who
picked out, and reviewed with me, the small number concerned
with Microvascular Surgery.
The literature review did locate some articles, concerned
with fibrinogen adhesive, in the English language literature. These
led me on to papers concerned with the use of other adhesives in
microvascular anastomoses. The reviews by Schlag and Redl316'332,
and Matras244 were also particularly useful because they reviewed,
in English, many of the papers written in the German literature. I
cannot pretend to have read the German literature, but I have
written and referenced the text in such a manner that the German
literature can be easily located by an interested reader. In the
reference section, I have included a few German papers, which I
consider to be key articles, and the contents of which have been
clearly reviewed by either the authors, or their colleagues, in
English language papers.
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After completing the literature review, I felt that, although
there had been a moderate amount of interest in the use of
adhesives for making microvascular anastomoses, there was plenty
of room for further research because:
1. Non biological adhesives had been demonstrated to
make technically good anastomoses, but these were
unsatisfactory in the long term because of an intense
inflammation reaction to the adhesive.
2. Use of the more promising fibrinogen adhesives was
mainly documented in the German literature, which
was essentially unavailable to English speaking
surgeons.
3. The small number of studies published in English
were not convincing as they were either too small to
have statistical significance or they were carried out
in a scientifically uncontrolled manner.
The literature also suggested that my initial scepticism might
be unfounded, and that it might be possible to develop an adhesive
microvascular technique using Tisseel. I also thought that if I was
successful in developing a satisfactory technique for making an
adhesive microvascular anastomosis, its description could be used
as a medium for the publication of a review of the extensive German
literature in an English language journal.
Thus, feeling that the full potential of adhesive microvascular
anastomoses had not yet been explored, I set out to examine this
whole area. The centre point of the task was to design and carry
out an experimental study to investigate whether Tisseel could be
successfully used to make reliable fibrinogen adhesive
microvascular anastomoses. The experiment was designed to
specifically answer the following questions:
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1. Is there any statistically significant difference
between the success of anastomoses made with
fibrinogen adhesive anastomoses and those made
with conventionally sutured anastomoses?
2. What morphological changes are seen at the
anastomotic sites in anastomoses made with
fibrinogen adhesive, and how do these compare with
those at sutured anastomoses?
3. Are anastomoses made with fibrinogen adhesive
faster, less expensive and less technically difficult
than those made with conventional suture
technique?
The thesis represents the full report of my investigations. It
starts with a historical review of the development of Microvascular
Surgery and goes on to discuss the different techniques and
approaches that have been used for making microvascular
anastomoses. Fibrinogen adhesive is next discussed in detail. A
preliminary study, in which a technique for making fibrinogen
adhesive microvascular anastomoses, is then described, and this is
followed by a detailed account of a large, controlled, consecutive,
and prospective experimental study designed to test the new
technique. Finally an overall view of the role of fibrinogen adhesives
in Microvascular Surgery is presented, and this is followed by a
little speculative thought on the direction that Microvascular
Surgery might take in the future.
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CHAPTER 1
Development and Application of Microvascular Surgery
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INTRODUCTION
In the past three decades, Microvascular Surgery has
experienced an extraordinarily rapid growth and evolution. The
field has progressed from a research curiosity to a clinical reality on
a scale far beyond all expectations. Techniques are widely
applicable and practitioners are drawn from many surgical
specialties, but in particular from Plastic Surgery, Orthopaedic
Surgery and Hand Surgery.
Microvascular operations are now routinely carried out at
major hospitals around the world. Cases are done on both an
emergency and elective basis. Results indicate that a high rate of
microvascular patency is being achieved with marked and, often
spectacular, improvement in the patients' clinical condition. The
passage of time has shown that the procedures are reliable and can
be reproduced by trained surgeons working in a variety of different
locations.
Chapter 1 begins with a historical review of the development
of Microvascular Surgery with emphasis on the introduction of the
operating microscope and the development of microsutures,
microinstruments and microsurgical technique. Next the
application of Microvascular Surgery to replantation and free tissue
transfer procedures is described. The chapter finishes with a
discussion of current practice in a contemporary Microvascular
Surgery Unit.
HISTORICAL REVIEW OF VASCULAR REPAIR
It has long been known that tissue viability is dependant upon
an intact circulation of blood, with arteries transporting blood to
the tissue and veins draining blood from the tissues.
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Prior to the twentieth century, haemorrhage from a major
blood vessel in an arm or leg was controlled by cauterization,
compression or ligation. These techniques reduced the loss of lives
but often resulted in the loss of limbs due to circulatory
impairment. In those days attempts at limb salvage by surgical
repair of blood vessels were associated with a high rate of wound
infection - a frequently fatal complication.
Towards the end of the nineteenth century, largely due to the
work of Koch and Lister, aseptic surgical technique became widely
accepted. It then became possible to develop methods for the re-
establishment of flow in severed blood vessels.
Some of the very early history of blood vessel surgery has
been reviewed by Wintermantel411. Stromayr, in 1559, and
Scultetus, in 1666, described surgical instruments and operative
procedures for blood vessel surgery. In 1889, Jassinowsky, in his
doctoral thesis, summarized the essential points of suturing
arteries in animals. Abbe, in 1894, used glass tubes for vascular
grafts in dog femoral arteries and cat aortae. In 1897, Nitze
described an ivory prosthesis for vascular anastomoses. Also in
1897, Murphy reviewed the literature concerning vascular sutures
and mentioned that Lambert, in 1762, pointed out the advantages
of repairing, rather than ligating, damaged arteries. Murphy also
described a new method for arterial repair that he called
'invagination', which was the first sleeve anastomosis. In 1899,
Silberberg wrote a doctorate thesis on clinical and experimental
research into vascular sutures.
At the turn of the century, Alexis Carrel52 and other
pioneering surgeons, such as Peyr, who suggested the use of
magnesium tubes for vascular anastomoses, not only demonstrated
the feasibility of vascular anastomosis with predictable patency
rates, but also developed the techniques, some of which are still
employed today.
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Carrel was the first surgeon to apply the techniques of
vascular repair to the transplantation of blood vessels, organs and
limbs. Clinical successes in vascular surgery, however, were limited
by crude suture material, inadequate needles, poorly designed
instruments, traumatic tissue handling and continuing problems
with infection.
Further progress was not made till after the introduction of
sulphonamides in 1936 and penicillin in the 1940s. The large
numbers of vascular injuries that occurred during the Second World
War fostered considerable interest in the development of expertise
in this area93. More sophisticated instruments were designed, and
suture materials were developed to satisfy surgical demand.
The 1950s saw the operative repair of blood vessels become
routine. During this period the results of seventy-seven consecutive
acute vascular lesions occurring in Korean war wounds were
published by Jahnke and Seeley172. The authors concluded that
repair should be recommended in all cases of acute major arterial
injury in order to decrease the incidence of amputation and also to
maintain viability and function.
Repairs carried out more peripherally were still associated
with a high incidence of intravascular thrombosis. At that time, it
was not known why predictable anastomotic patency rates could
not be achieved in vessels smaller than 2-3 millimetres in
diameter. The solution to this enigma, however, was already
developing in other surgical fields.
DEVELOPMENT OF MICROVASCULAR SURGERY




The use of a microscope in surgery was pioneered by
Nylen271-272 in 1921. He used the magnifying power of a
monocular microscope as an adjunct in operations on the middle
ear, and particularly for otosclerosis. In 1922, Holmgren, Nylen's
co-worker, developed a binocular operating microscope.
At first magnification was used to improve conventional
procedures. Later it was discovered that the use of magnification
allowed new operations to be developed for the small components
within the ear.
In 1946, Perritt275 started using the microscope for routine
ophthalmic surgery. Ophthalmologists soon began to use
microscopes to improve operations for the repair and
reconstruction of the anterior chamber of the eye. The technique
was widely adopted by eye surgeons in the early 1950s.
In 1953 Carl Zeiss commenced mass production of the
modern operating microscope.
Microsurgical technique was applied to the repair of small
blood vessels in experimental animals towards the end of the
1950s. The problems of small blood vessel repair were resolved
with the adoption of this new approach, and in 1960 Jacobson and
Suarez168, using microsurgical technique, reported a 100% success
rate in the anastomosis of arteries 1.4 millimetres in diameter.
From this point on the frontiers of microvascular surgery
were pushed forward by reconstructive surgeons across the world.
The foresight and tenacity of creative pioneers such as Acland
(U.K.), Buncke (U.S.A), Chen (China), Cobbett (U.K.), O'Brien
(Australia), and Yasargil (Switzerland), led to the successful
realisation of operations hitherto only possible in dreams.
Some reconstructive surgeons focussed their attention on the
application of microsurgical technique to the repair of peripheral
nerves348, whilst others continued to develop microvascular
surgical techniques. Microneural Surgery has developed in parallel
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with Microvascular Surgery, and is now well established and widely
practiced229.
The 1960s saw rapid development in instrumentation and
technique, and surgeons began to report the results of repairing
smaller and smaller blood vessels1,110,164,361.
It soon became apparent that it was necessary to make
adaptations to the binocular microscope to better suit the needs of
the new microvascular surgeons. The need for the first assistant to
actively participate in the process of microvascular anastomosis
prompted the production of double binocular microscopes
(sometimes called diploscopes). These enabled the surgeon and
assistant, seated opposite one another, to see the same stereo
image. Other improvements to the operating microscope have
included:
1. Foot controlled, variable speed zoom focussing.
2. Foot controlled, variable speed zoom magnification.
3. X-Y axis motion with a foot controlled joystick.
4. Fibre-optic illumination.
5. A variety of balanced floor stands and ceiling mounts.
6. Tiny video cameras for closed circuit television
monitoring.
These developments have provided modern microvascular
surgeons with a choice of well suited and highly sophisticated
microscopes for their work201,202,293.
Microsutures
Traditionally sutures have been used by surgeons for the
repair and reconstruction of damaged structures. In his 1976
Presidential Address, Snyder352 said:
"Stitching is not new, for it was known the second week of
creation. If you will open the Holy Bible to the book of Genesis,
chapter 3, verse 7, you may read 'And the eyes of them both (Adam
and his transplanted rib) were opened, and they knew that they
were naked; and they sewed fig leaves together and made
themselves aprons.' "
Historically as surgical technique became finer so smaller,
and more delicate, suture materials were produced. It should not
be surprising that the early microvascular surgeons wanted to use
suture material for their microvascular anastomoses.
At first there were no satisfactory microsutures and
experiments were carried out with various kinds of absorbable and
non-absorbable suture materials235'255-378. Nylon (a generic name
referring to a family of amide polymers) was found to be the best
suture material as it was easy to use, of satisfactory tensile strength,
and was found to cause very little tissue reaction. The production
of ultrafine nylon suture material was relatively easy as the material
could be spun to almost any diameter.
Needle construction was much more of a problem.
Microneedles needed to be sharp tipped, smooth bodied,
adequately shaped for ease of handling, and smoothly swaged to the
suture material307. In the early days, small needles (often
commercial ones individually reshaped and reground49) of different
sizes, shapes and materials were tested but these were almost
invariably too big and allowed for haemorrhage from large holes left
in the vessel wall. A number of histological and scanning electron
microscopic studies have documented the kind of vessel wall
damage that is caused by microsutures77,218'294'295'306.
Another approach was the development of metallised
microsutures46'276'280. These were produced by depositing a fine
film of metal onto the surface of a 12 micron nylon suture. They
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were certainly small enough, but had the disadvantages of being too
malleable, too blunt and too rough on the surface.
Commercially available microsutures were introduced by
Ethicon with a 10-0 nylon on a BV2 needle in 1966. Further
improvements quickly came from an industry that found it
profitable to invest capital and personnel into a rapidly expanding
subspecialty. The small S & T Chirurgische Nadeln firm (S & T
after its founders W Springier and G Tritt) in West Germany proved
to be particularly skilled in the production of microsutures.
Working closely with Acland3-7, they produced needles that were
considerably sharper and smaller than those of their competitors.
This was a great step forward because needle hole size, in the
vessel wall, is an interplay of two factors: needle sharpness and
needle diameter. The new S & T needles essentially solved the
needle hole problem.
Modern microsutures are made straight, swaged onto the
nylon suture material, and then curved by machine. The clear
nylon is dyed blue, with methylene blue, or black, with logwood
dye, to make it more visible. Needle points are extremely sharp,
blades are tapered, bodies are smooth and fine, and the swages are
secure. A variety of microsutures are available, although all are
expensive because of the cost of labour for the difficult processes of
sharpening and swaging. Most surgeons now use a 9-0 or 10-0
suture on a 100 or 70 micron needle for microvascular
anastomoses, although an 11-0 suture on a 50 micron needle is
available for very delicate work.
Microsurgical instruments
Use of the high magnification provided by the operating
microscope, together with the production of ultrafine
microsutures, necessitated the development of suitably sized
instruments, specifically designed for the new microsurgical
procedures. In many instances jeweller's and ophthalmic
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instruments were adapted, but a number of completely new designs
also emerged8,277,85,282.
Standard surgical instruments are made with ring handles,
and are manipulated by wrist rotation, chuck pinch and squeeze,
using the thumb and ring finger. Microsurgical instruments tend to
be more pencil shaped, and are manipulated by finger rotation and
fine pinch between the thumb and index fingers.
Early on there was interest in externally powered devices
driven pneumatically328, hydraulically46,361 and electrically282,298.
In each case, however, it was found that these were complex to
operate, slow, lacked precision and failed to improve the quality of
anastomoses. Surgeons cast them aside in favour of the hand
powered pinch controlled instruments2.
Modern microvascular surgeons can choose their instrument
sets from a wide array of commercial products, available largely due
to the work of pioneering surgeons such as Acland, Buncke and
Tamai.
Jeweller's forceps are used for tissue handling. These
instruments come in various shapes and sizes and are classified
according to the width of the bit (contact surface of the jaws),
narrowness of the shank, and their overall configuration. Some
have been modified for other applications: for instance an
adaptation with smooth rounded jaws is used as a vessel dilator, and
the No 2 jeweller's forcep is sometimes used as a needle holder46.
Ophthalmic spring handled needle holders have proved to be
very satisfactory for Microvascular Surgery. Fine tips are preferred,
and a gentle curve serves to minimise obscuration of the surgical
field. Ratchetless needle holders are used universally because their
release is not associated with the violent movement of the
ratcheted variety. Many surgeons use the needle holder for both
passing the needle and tying the suture.
Microsurgical scissors have also been derived from
ophthalmic surgery. Spring handled, round tipped, slightly curved
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microscissors of the Westcott or Castroviejo type are commonly
used for regular dissection. The smaller Vannas types are useful for
fine dissection and suture cutting. Straight iris scissors are found
in most sets and these, or a straight spring handled microscissors,
can be invaluable in some difficult situations.
Large vascular clamps were developed for use in Peripheral
Vascular Surgery. Smaller clamps were designed by neurosurgeons
for the temporary occlusion of cerebral aneurysms. Clamps from
both these sources have been used by microvascular surgeons, but a
number of specialised microvascular clamps have also been
produced6,189. Microsurgical clamps come in different widths and
at different closing pressures. They are also available, mounted on a
bar, as double approximating clamps6,152,369. Microvascular
surgeons prefer to use fine clamps, which have a light closing
pressure, in order to minimise endothelial damage16.
Other instruments specifically needed for Microvascular
Surgery include micro-bipolar coagulation, irrigators and small
scalpels. Accessories that have been found to be useful are
measuring devices, arteriotomy instruments301, surgical
background material, mobile arm rests153, custom designed
seats283 and special operating tables37.
APPLICATION OF MICROVASCULAR REPAIR
Microvascular Surgery has been applied both to emergency
repair in the form of replantation and revascularisation, and to
elective reconstruction in the form of free tissue transfer.
Replantation and revascularisation
The first application of small blood vessel repair was in the
replantation and revascularisation of amputated parts. In 1960
Lapchinsky203 obtained a 37% long term survival rate in limb
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replantations in the dog. In 1963 Kleinert et al187-i88 described
the successful revascularisation of partially amputated and non¬
viable digits. The following year Malt and McKhann236 described
two replantations of completely amputated upper extremities, and
Horn156 successfully replanted a hand. At that time it was felt that
replantation was a reasonable option for certain patients in the
right circumstances, although the results of experimental digital
replantation were not consistently good45. In 1968 Komatsu and
Tamai195 reported the first successful microsurgical digital
replantation after they reattached the thumb of a twenty-eight year
old man who had been working with a steel cutting machine in
Nara, Japan.
As clinical experience widened, the literature became replete
with reports of replantation and revascularisation of digits and
limbs. In the years that followed indications became more refined,
technique and instrumentation improved, and more predictable
microvascular patency was achieved. More recently, several studies
have looked at the end functional results of replantation at different
amputation levels28,38,279,325,398. These have been important
papers as they have put the indications and long term goals of this
new technology into perspective.
Surgeons in the People's Republic of China have shown great
interest in Microvascular Surgery. Western surgeons have been
fascinated by the Chinese experience partly because, until recently,
political differences have prevented academic communication, and
partly because of curiosity about the relationship of this modern
technology with the practice of traditional Chinese medicine. The
literature contains a number of papers describing Chinese
microsurgical practice. These were mainly written with the
specific intention of disseminating knowledge of activity in that
country58,80,296,318,415. Chen et al61, with multiple collaborators,
have published a textbook, in English, describing Microvascular
Surgery that has been carried out in China.
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Chinese surgeons were experimenting with microvascular
anastomoses386 at the same time that reports were being published
in the Western medical literature. They started carrying out
replantations in the early 1960s. These first publications not only
described replantation in the upper extremity59-60'386-387, but also
replantation in the lower extremity159.
Free tissue transfer
The favourable results with replantation encouraged
considerable research activity in laboratories around the world.
Investigators quickly realised that many tissues could be totally
isolated on vascular pedicles, transferred to distant sites and
immediately revascularised to local arterial and venous channels
using microvascular anastomotic technique. These procedures
became known as FREE TISSUE TRANSFERS; the transferred
tissue being removed from the DONOR SITE and revascularised in
the RECIPIENT SITE.
Krizek et al199 published the first experimental free tissue
transfer in 1965. Soon after, Strauch and Murray361 reported on
their encouraging laboratory experiments. In 1966, Buncke et al47
published the results of their work with toe-to-hand transplants in
Rhesus monkeys.
At about the same time considerable interest was developing
in the arterialised (axial pattern) flaps, that were later described by
Smith351 and McGregor226, and comprehensively summarised by
Daniel and Williams82. Microvascular surgeons thought that it
should be possible to use these flaps for free tissue transfer,
provided that the vessels in their vascular pedicles were large
enough for microvascular anastomosis. In 1972, McLean and
Buncke230 carried out the first clinical free tissue transfer when
they used a free omentum transfer to cover a scalp defect. The
same year, Harii and Ohmori144 transferred a hair-bearing
cutaneous flap, based on the superficial temporal artery, to provide
30
hair for the opposite side of the scalp. In 1973, the first extremity
reconstructions, using free cutaneous flaps, were reported from
Melbourne83'278.
Since the time of these original reports there have been rapid
advances in this field. The development of myocutaneous
flaps222'223 considerably increased the number of free flap donor
sites available and also led to improved knowledge concerning the
value of muscle transplantation.
With such a large choice of donor tissues it soon became
apparent that some transplants were better than others. Some free
flap donor sites have stood the test of time and are still used a great
deal (e.g. groin83'223,278'333; radial forearm237,333'333; lateral
arm180; scapula23,98,116,120,136,249,390,391; parascapula264; dorsalis
pedis221,237,248.286,321. latissimus dorsi223,224,246,237;
gracilis143,222>289; rectus abdominus39,42,31,303,376), whilst others
(e.g. axillary23'33,112'372; deltopectoral20,21,226,143,144;
epigastric13,83,163; buttock111) have largely been superseded by
better or more versatile flaps. There are some (e.g. thigh334;
saphenous12) that, although technically satisfactory, have only found
limited application and have never been used frequently.
To mention all the advances that have been made using the
technique of free tissue transfer would fill a book in itself. In the
reconstructive specialties, useful tissues that have been transferred
include skin82,142, muscle242,222,368,238> fascia41,166,210,241,377^
tendon283, bone233'371,374,373,333, and nerve373,228. Composite free
tissue transfers, such as toes47,74, joints161,284,414, epiphyseal
plates36,63,303, myocutaneous222,223, and osteocutaneous
flaps233,333,374,373 have also proved to be useful.
As the new subspecialty developed, experience rapidly
increased. The ability to freely transfer a donor tissue provided the
ability to choose the best possible donor tissue to manage any
particular clinical problem. As new techniques were explored,
some of the patterns of reconstruction changed. For instance.
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Head and Neck Surgery has been radically altered by the ability to
reconstruct the mandible and floor of the mouth with
osteocutaneous flaps such as the second metatarsal/dorsalis pedis
flap, the osteocutaneous radial forearm flap and the osteocutaneous
groin flap. Hand surgery has also been greatly improved by the
ability to reliably carry out free flap or toe transfers as single stage
procedures. In Orthopaedic Surgery, the management of Grade III
open fractures of the tibia has been considerably enhanced by the
use of free muscle and vascularised bone transfers.
The Chinese experience with microvascular free tissue
transfers is now reasonably well known in the Western World. Less
is known about the development of Microvascular Surgery behind
the Iron Curtain. Some information is available in a recent
publication317 which presents the proceedings of an International
Symposium on "Microsurgical Tissue Transplantation" which was
held in Tubingen, Federal Republic of Germany, November 27-29,
1987.
THE NEW SUBSPECIALTY
The result of all this progress has been the emergence of a
whole new subspecialty, which has become known as
RECONSTRUCTIVE MICROVASCULAR SURGERY.
In any work, such as this, concerned with historical and
technical aspects of Microvascular Surgery, some mention should
be made of the process of dissemination of knowledge and skills
from the pioneers to contemporary microvascular surgeons.
Microsurgical education
The early developments and technical successes were hard-
won by a small number of surgeons working in laboratories across
the world. Although much of the work was done personally by
these pioneers, valuable advice and technical assistance was also
contributed by their colleagues, trainees and technical staff. The
names of these individuals are recorded as co-authors on the
relative scientific publications.
The first successful clinical microvascular cases were
recognised as a tremendous advance in reconstructive surgery.
Surgeons across the world rapidly became interested in learning
the technique. Although much was to be learned by observing
procedures in the operating room, this was clearly not the place to
struggle with the difficult task of learning the delicate skills
necessary to operate through the microscope and to successfully
complete microvascular anastomoses.
Microsurgery teaching laboratories were established in the
new centres. Trainee microsurgeons could either take short formal
courses, or visit for more extended periods of time, advancing and
perfecting their skills. Nowadays there are many laboratories124
offering courses throughout the world. Excellent laboratory
manuals are available, and these detail many of the technical skills
that need to be mastered11-50'335.
Well known centres have attracted many visitors. Some have
wanted to stay for prolonged periods of time, and it was to satisfy
this demand that Fellowship programs developed. These
programs, usually lasting six months or one year, have allowed fully
qualified reconstructive surgeons to acquire enough additional
expertise to fully utilise the wide potential of Microvascular Surgery
in their practices.
Microsurgical literature
Microvascular Surgery is now a well defined subspecialty of
reconstructive surgery, although there may be considerable
variation in interest between individual surgeons. Some devote the
majority of their time to surgery of the hand whilst others are more
concerned with reconstruction of the head and neck, the
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extremities, children or have special interest in areas such as facial
re-animation or tumour reconstruction.
A number of textbooks have been available since the early
years61-84'97'239'281'336-417. Their content reflects the many facets
of Microvascular Surgery and the wide knowledge of their authors.
The strength of Microvascular Surgery as a subspecialty is
probably best illustrated by the many local, national and
international societies which are thriving and providing a forum for
the exchange of ideas. Abstracts and papers on microvascular
subjects are published in a wide variety of scientific journals, but
are generally to be found in those journals related to reconstructive
surgery. In the English language literature the 'Journal of
Reconstructive Microsurgery* and 'Microsurgery' are devoted
exclusively to papers on topics related to the field of Microvascular
Surgery.
Cost/benefit of Microvascular Surgery
It was interesting to note that as the new subspecialty
emerged, there was considerable concern about its cost/benefit
ratio. This issue remains relevant in today's climate of health care
economics.
In 1979, McGrowther227 won the Kay-Kilner Essay
Competition with an entry entitled "The operating microscope: a
necessity or a luxury?" He stated that the new field of microsurgery
should be evaluated by answering certain questions:
1. What does the operating microscope enable us to do
that we cannot do by alternate methods?
2. If there are alternate methods, do microsurgical
techniques improve the results?
3. Do the results justify the investment of
instrumentation, operating theatre time, man hours,
and hospital inpatient time?
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He concluded that, in his experience, microsurgery was
clinically important, procedures utilised less hospital bed time than
alternate methods, and that the technique should become an
essential part of surgical training.
O'Brien274 was of the same opinion. He commented that
Zeiss microscopes, bought many years previously, were still in daily
use in his unit, and, although improved in design, modern
microscopes were not greatly changed from the early models. His
experience was that hospital bed occupancy per patient for a one
stage free tissue transfer in Melbourne, was less than for a
multistaged pedicle flap reconstruction. In addition, he said that
although operating time was greater for microsurgical operations, it
was no more than the accumulated time used for multistaged
procedures.
Serafin published figures337 to support his opinion that the
cost/benefit of Microvascular Surgery was good. In a comparison of
several statistics relating to reconstruction of the head and neck,
he demonstrated that total anaesthetic time was almost the same
regardless of the type of flap used, but that microvascular cases
needed less operations and considerably fewer days in hospital.
Final success rates compared favourably with older forms of
management.
Serafin's comparative statistics334 for coverage of defects in
the leg and foot conveyed the same message. Total expenditure
was calculated for these cases, and the figures indicated that
microvascular reconstruction was the least expensive method.
In Europe, Sykes and Bryson366 studied a combined series of
patients from England and Italy. Their conclusions were similar to
those of Serafin.
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CURRENT PRACTICE IN MICROVASCULAR SURGERY
Microvascular surgery is now widely practiced around the
world. The specialty has tended to remain located in major
surgical centres. There are many reasons for this, but, primarily, it
is because the best results can be achieved using a team approach.
In a typical centre, the microsurgical team consists of three
or four microvascular surgeons, a similar number of fellows (fully
qualified surgeons), residents (at different grades), interns, clinical
clerks and medical students. During operations, dissection of
donor and recipient sites are carried out simultaneously by two
teams. Later, revascularisation of the transferred tissue and donor
site repair are also carried out simultaneously. This team approach
minimises the operative time, and this results in a number of
advantages: maintenance of the patient's body temperature, less
fluid loss, shorter anaesthetic, less problems with surgeon fatigue,
and the use of experienced daytime operating room staff for the
whole case. Knowledgeable anaesthetists, experienced operating
room and ward nurses, and specialised hand therapists, all
contribute to a successful outcome.
The modern microvascular operating room is equipped with
an extremely versatile operating diploscope, which is usually
mounted on a counterbalanced floor stand, but may be on a fully
tracking ceiling mount. It has tiltable binocular tubes, a tiny
television camera (linked to a television monitor in the operating
room), and foot controls operating the X-Y coupling, zoom focus,
and zoom magnification.
The development of specific areas of interest amongst
individual surgeons in the group allows for increasingly
sophisticated procedures to be carried out. A contemporary group
of microvascular surgeons has the ability to apply microvascular
technique to the management of congenital anomalies, extremity
reconstruction (bone or soft tissue for trauma or tumour) head and
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neck reconstruction (bone or soft tissue for trauma or tumour),
hand problems (emergency or elective), cosmetic problems, and
areas of special interest such as functioning muscle transplantation
for upper extremity trauma and facial paralysis, or the transfer of
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INTRODUCTION
In Chapter 1 a broad descriptive picture was painted of the
development, application and contemporary practice of
Microvascular Surgery. The section on microsutures might have
suggested to the reader that suturing is the method of choice for
making microvascular anastomoses. There is no doubt that suturing
is the most common method used at the present time, but for many
reasons there has been, and still is131, considerable interest in
finding an alternative and/or better method. Some techniques have
been tested and failed, others have been more successful, but
comparatively few have survived the test of time to remain in
common use.
Chapter 2 begins by classifying and reviewing techniques that
have been used, both experimentally and clinically, for making
microvascular anastomoses. Next the biological healing process of
microvascular anastomoses is examined from the point of view of
patency, histological changes and scanning electron microscopic
appearance. The final part of the chapter briefly looks at the blood
clotting mechanism and reviews many of the factors related to
anastomotic failure.
TECHNIQUES USED FOR MICROVASCULAR ANASTOMOSIS
Historically, three factors proved to be essential for the
successful repair of blood vessels 1.0 millimetre or less in diameter:
1. Magnification with the operating microscope.
2. Delicate instruments and tissue handling.
3. A satisfactory technique for microvascular
coaptation.
Chapter 1 describes how these hurdles were crossed by
either using modifications of known technology or developing new
technology. It has always been felt that there must be a better way
of achieving microvascular coaptation, and surgeons continue to
strive for new and improved methods.
A large number of different techniques have been investigated
for making microvascular anastomoses. Broadly speaking these can
be thought of as falling into two main groups according to:
1. Method of fixation. This group includes sutures,
laser techniques, electrocoaptation, mechanical
devices and adhesives.
2. Type of anastomosis. This group includes
end-to-end, end-to-side, end-to-side branch,
end-in-end, cuffing techniques and size discrepancy.
Method of fixation
Sutures
The technique of suturing microvascular anastomoses has
been widely used since Jacobson and Suarez168 reported their
successful results in 1960. Suture technique has made great
progress211 since that time and is still the most widely used
method.
In a sutured microvascular anastomosis the surgeon should
aim to achieve a leak-free anastomosis with as few sutures as
possible. Adherence to these principles150 minimises problems
associated with medial necrosis and arterial occlusion. Sutures
should pass through the full thickness of the vessel wall as this
probably causes less media disruption than sutures which pass only
part way through the wall150. The vessel ends should be closely
approximated, and care should be taken that the tissue
encompassed by the sutures is not strangulated150. It is standard
practice to cut the ends of the vessels to be anastomosed squarely
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across, but some have favoured oblique sectioning of the vessel
ends164.
Good technique is important385 because technically poor
suturing results in narrowing of the lumen at the anastomotic site,
distortion of the vessel wall, and an increase in the likelihood of
vascular thrombosis16-253. Sutures must be placed evenly and
spaced correctly320.
There are different methods for inserting the sutures. In
order to avoid catching the back wall during suture placement,
Cobbett139 described an eccentric biangulation technique in which
the initial two stay sutures were placed 120° apart, whilst Daniel
and Terzis86 recommended using the triangulation technique
where three stay sutures were placed 120° apart. These
techniques were not always easy to use because it was difficult to
accurately place the stay sutures, particularly if there was a size
discrepancy. Nowadays, most surgeons prefer a biangulation
technique, using two stay sutures 180° apart, although some
surgeons use a successive interrupted ("ship's wheel" type) suturing
technique139. Sutures should be tied with a conventional three
throw surgeon's knot.
The distance between interrupted sutures should be
separated by about 0.3 millimetres, or eight stitches for a 0.9
millimetre150 or 1.0 millimetre vessel63. It is suggested that
sutures are placed 60 to 80 microns150 or 0.2 millimetres63 from
the edge of the divided vessel, although Harashina et al136 could not
demonstrate any difference in patency rates between anastomoses
completed with small suture bites and anastomoses completed with
large suture bites.
Studies have been carried out to compare different suturing
techniques. Shumacker341, in pre-microsurgical days, reviewed
the literature on sutured vascular anastomoses, and described an
experiment comparing the reliability of vascular repairs made with
mattress and plain sutures, inserted using either interrupted or
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continuous technique. He felt that mattress techniques would
prove to be the most useful, but was concerned about the high rate
of complications in small vessels. Microsurgical continuous suture
technique169,258 has been studied32*131.134,140. patency rates were
comparable to interrupted technique and the anastomoses were
completed quicker, but the investigators felt that the problems
associated with entrapment and breakage of the suture material on
the microvascular clamps, necessitating repetition of the
anastomosis, outweighed the advantages.
Others have been more optimistic about continuous suture
technique403. Lee et al212 proposed an open-loop technique for
inserting a continuous suture and said that they did not run into
technical problems.
Some researchers have investigated the use of different types
of suture material. Phelan et al304 compared sutures made out of
silk, nylon and dacron. They demonstrated that dacron and nylon
were superior to silk, but experienced difficulty tying the knots.
Anastomoses with 9-0 dexon microsutures were studied by
Peminello et al302, and absorbable and non absorbable 10-0 sutures
were compared by Mii et al255, Mallon et al235 and Thiede et al378.
Each of these groups concluded that the absorbable sutures were
very satisfactory, yet the use of absorbable sutures has not been
widely adopted. Pitt and Humphries306 compared sutures of 10-0
nylon on a taper pointed needle with similar sutures on a new
micro edge taper needle. They found that the new needle caused
less damage to the intima, although patency rates were similar for
the two needles.
A number of technical aids have been developed to help
surgeons achieve maximum accuracy with their suturing. A surgeon
working alone or with an unskilled assistant may find Acland's
frame clamps6 useful for holding the long ends of key stay sutures.
A surgeon working with an experienced assistant usually prefers to
have the assistant apply tension to the key stay sutures so that the
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anastomosis is optimally positioned for insertion of the next suture.
In cases where the assistant is highly skilled and the anastomosis is
not in a difficult location, a lot of time can be saved by using the two
surgeon-two needle technique256 or the two surgeon Tweener
manoeuver57.
The problem of suturing in a confined space can be facilitated
by suturing without the use of double approximating clamps266.
Harashina138 pointed out that the last one or two sutures
were the most critical because the lumen may not be clearly visible
through the gap. Usually each suture is tied immediately after
placement, but Harashina recommended that it might be
advantageous to leave the final two or three sutures untied till
suture placement was complete. Foucher105 has published a
modification of the Harashina procedure.
Laser techniques
The word 'laser' is a contraction of Light Amplification by
Stimulated Emission of Radiation.
Lasers are devices for converting light of mixed frequencies
into an intense narrow monochromatic beam of coherent light.
Typically, a gas-filled tube is illuminated by a light flash to excite its
atoms. Light emitted by these atoms is reflected backwards and
forwards along the tube and stimulates further emission.
Several different types of laser beam are used in medical
practice. The most widely used are the argon laser, the
Neodymium:YAG (yttrium-aluminium-garnet) laser, the CO2 (carbon
dioxide) laser, and the thulium-holmium-chromium:YAG (THC:YAG)
laser.
Some investigators have attempted to weld blood vessels
together using laser beams. The intense monochromatic light of a
laser beam produces heat on absorption. Blood vessels are normally
transparent to the beam, but when coated with staining substances,
they can be converted to black-body absorbers and application of a
tightly focused laser beam converts light energy into heat. A "spot
weld" is accomplished by thermally-induced coagulation necrosis at
the site of application. This technique has been found to be
extremely useful in ophthalmology and a number of investigators
have tried using it for microvascular anastomoses. The laser
equipment is arranged so that it can be applied while the surgeon
is using the operating microscope. The laser beam can be aimed
with the assistance of visible laser light such as a helium-neon
spot338.
Jain has investigated the use of the NeodymiumiYAG laser176
for the repair of injuries to small arteries173, end-to-end
microvascular anastomoses174, and end-to-side anastomoses175. He
has described the results of a large number of anastomoses in
experimental animals and in addition has carried out a number of
clinical neurosurgical cases. He reports vascular patency rates in
the region of 95% but unfortunately his studies were uncontrolled
and are subject to scientific criticism. His observations, however,
are interesting. He stated that laser end-to-side anastomosis had
advantages:
1. They were fast.
2. There were no sutures to act as foreign bodies and
cause needle passage trauma.
3. There was less variance of results due to different
skill levels or steadiness of hands because the laser
was mechanically manipulated.
4. The technique could be applied to deeper parts of
the cranial cavity as well as outer cortex.
Jain used a wavelength of 1064 nanometres because he found
that lasers with a wavelength of 1236 nanometres caused
endothelial damage and thrombosis. He reported that the
technique heated up the media of the vessel wall and, at 70-80°C
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produced changes in collagen which fused the two vessels together.
His anastomoses withstood intra-arterial pressures of <300
millimetres of mercury. His histological studies indicated that the
vascular endothelium regenerated in two or three days, and the
fused collagen became fibrotic in about a week.
Bailes et al have also investigated the use of lasers19. They
tried the Neodymium:YAG laser but quite strongly disagreed with
Jain's experimental results310. They pointed out that, in their own
histological studies, the healing process of laser assisted
microvascular anastomoses did not differ from that seen with other
techniques, and that there was no reason why it should. They
favoured the CO2 laser for vascular anastomosis and have reported
on their extensive experience with this technique18'312. Their
laser was a low power unit (70 milliwatts) and they used 0.1 second
bursts and a spot size of 0.15 millimetres to produce 'spot-welds'
between three or four stay sutures. Although patency rates were
comparable to sutured anastomoses, they observed a high rate of
aneurysm formation in the laser anastomoses. This was attributed
to loss of elastic elements at the anastomotic site, and was related
to the distance between stay sutures.
Other researchers106,288'324'330'338'383 have also investigated
the use of CO2 laser assisted microvascular anastomoses. They all
used the laser in conjunction with three or four stay sutures. Each
group reported that the technique was more rapid than suture
technique, and good patency rates were obtained. Aneurysm
formation, however, continued to be a problem although the rate
varied between studies. Vale et al394 were particularly concerned
about aneurysm formation, and wrote that they could not advocate
use of this technique because of the documented vessel wall
damage and the lack of simple intra-operative methods for verifying
the quality of laser anastomoses.
The argon laser has also been used to effect end-to-end
vascular anastomoses123'309. The argon laser has the advantage of
emitting visible wavelengths of light, but unfortunately also has the
disadvantage that its tissue effect is variable, changing with
differences in the visible pigmentation of the tissues.
Despite the optimism of some of the researchers, the use of
laser assisted microvascular anastomoses has not been generally
adopted. The reason for this is due to a number of factors:
1. The need for expensive equipment.
2. The provision of insufficient initial strength.
3. The high false aneurysm rate.
4. Difficulty in determining just the correct amount of
laser energy to apply to the vessel wall to produce a
coagulation 'weld' without a damaging amount of
mural necrosis.
5. Failure to offer major advantages over suture
technique.
Bass et al24 have recently reported the results of a
preliminary study using the THC:YAG laser. They were more
optimistic about their results, finding that they were able to make
sutureless microvascular anastomoses " .... with excellent
histological appearance, 90% short term patency rate and an
acceptable initial bursting strength".
Electrocoaptation
High frequency electric currents were introduced into
medical practice at the end of the nineteenth century. It was found
that frequencies >10,000 cycles/second produced heat rather than
muscular contraction and this rapidly led to the use of
electrocoagulation for the closure of blood vessels and
haemostasis346.
The technique has been adapted for the repair of blood
vessels. The principle behind electrocoaptive microvascular
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anastomosis is the ability to produce an adherent and localised
coagulum by the passage of high frequency electric current through
the adjacent tissues. The current is applied to the anastomotic site
with the aid of bipolar electrode forceps.
In 1963, Sigel and Acevedo345 described the use of
electrocoaptation to repair linear incisions in arteries and veins.
They also reported the results of experiments in which venous344
and arterial346 anastomoses were carried out. Large canine vessels
were used in their experiments, and they achieved greater success
with venous repairs than with arterial repairs.
Wintermantel411-412 described a series of microvascular
repairs using electrocoaptation technique. He called his technique
the Thermic Vascular Anastomosis. A hard but flexible wire was
wrapped three times around a cannula to form small wire loops
with a constant inner diameter. The diameter was slightly larger
than the external diameter of the vessel ends being joined, and the
loops were flattened with a finger nail. The loop was then slipped
over one of the vessel ends and a cuff was formed with a fine angle
tipped forceps. Next the other vessel end was pulled over a second
wire loop to form an identical, but opposing, cuff. The wire loops
were then coapted and held with microsurgical needle holders.
This was the most difficult part of the operation as the two wire
loops had to be perfectly congruent in order to permit uniform
distribution of the electrical energy. Each wire loop was then
connected to an electrical pole and heat was produced with three
short applications of a defined high frequency electrical current.
After fusion of the two cuffs, the handling ends of the wire loops
were cut off with fine scissors.
Winteimantel's results demonstrated that patent anastomoses
could be made very rapidly in vessels 0.8 -1.3 millimetres in
diameter. Variation in patency rates between different
experimental groups, however, suggested that application of just
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the right amount of electrical energy was critical if vessel wall
damage, and subsequent failure, was to be avoided.
A sutureless microvascular thermic end-in-end sleeve
anastomosis has been described by Duarte et al100. They used a
bipolar coagulator (emitting 6.5 watts output for arteries and 1.1
watts for veins) to 'spot-weld' the edge of the distal stump which
was held in bipolar forceps with a 2.0 millimetre tip. Patency rates
of 100% for arteries and 78% for veins were achieved.
The problem with the use of electrocoaptation methods is the
difficulty in knowing the correct amount of electrical current
necessary to produce just the right amount of coagulation. In the
studies described, authors have pointed out that the amount of
electrical current used was determined by trial and error using a
series of similar animal vessels. In the experimental situation this
can be done, but in the clinical situation it is much more difficult
because of the variation in vessel size. For this reason,
electrocoaptive microsurgical anastomoses will not become
clinically feasible until a better understanding of the electrical
welding mechanism is available and appropriate equipment is
developed.
Mechanical devices
Staplers and couplers have been used both experimentally
and clinically for vascular repairs. The devices investigated can be
classified into three types:
1. Individual circumferential metallic staples.
2. Everting pinned ring devices.
3. Extra-lumenal cuffs and bushings.
In 1956 Androsov14 described a stapling device that his
medical engineering group had developed in the Soviet Union.
Their anastomoses were secured by simultaneously bending
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multiple circumferentially placed individual U-shaped staples into a
B-shape (in a manner similar to the gastrointestinal stapling
devices in contemporary use). Androsov described the technique
for end-to-end arterial anastomoses and for use with interpositional
reversed vein grafts. Inokuchi162'163 later described using the
device for end-to-side anastomoses. In 1958 Vogelfanger and
Beattie396 described a modified stapler that inserted fine U-shaped
tantalum staples. Khodadad183 used Vogelfanger's stapler in a
canine experiment that compared microsurgical anastomoses made
with three different types of mechanical couplers. Later, Zingg and
Khodadadeh422 reported on further modifications of the
Vogelfanger stapling device.
The use of an everting pinned ring device for end-to-end
anastomoses of small arteries was reported by Holt and Lewis155 in
1960. At about the same time another everting pinned ring device
was being developed in Japan by Nakayama, who published a review
of previous attempts to use similar devices, and a description of his
own technique in 1962259. There have subsequently been other
reports on the Nakayama pinned ring device260,290,410 and
Nakayama also reported on a modification for venous
anastomoses261. The technique involves the use of two metal rings
which have six evenly placed holes and six pins. A ring is placed
over the cut vessel end and the edge of the vessel is everted and
hooked onto the pins. Once the other cut vessel is similarly
attached to a ring, the two rings are approximated, with the pins of
each one placed through the holes in the other, and crimped thus
bringing about intima to intima contact and fixation.
A different pinned ring device has been used in Scandinavia
and is known as the UNILINK apparatus291. This was developed
with the idea that it would be better suited than the Nakayama
rings for smaller vessels. The UNILINK apparatus uses smaller
pinned rings and instruments that have been developed for use in
conjunction with the operating microscope. Reports indicate that
anastomoses are successful and the technique is rapid and easy to
use29,33.34,270,292.313
Obora273, in an experimental study, described an interesting
pinned ring system which used hollow cogwheel-shaped metal
devices held together by magnetic power. The anastomoses were
described as being simple, rapid and reliable, but no further
reports have become available suggesting that the system might not
have been as good as it was first thought.
Other types of coupling devices have also been described.
Carter and Roth53 described a method for anastomosing
coronary arteries using polyethylene rings. The use of tantalum
cuffing rings for vascular anastomosis was described by both Goetz
et al121 and Urschel and Roth392 in 1961. Haller et al133
experimented with the use of grooved tantalum and platinum rings.
Weiss and Lam401 tried using tantalum tubes and tantalum cuffs for
bridging vascular defects.
Combinations of metal couplers and cyanoaciylic adhesives
were investigated, in the 1960's, by Carton et al54 and Gottlob and
Blumel125.
Euler et al have reported their results using a teflon cuff
secured with a mini-clip102, and using absorbable cuffs constructed
from polylactid (Ethicon)103. An absorbable coupling device using
vicryl polymer was developed by Daniel88,89,90 in conjunction with
Ethicon.
In general the mechanical devices have not yet been accepted
for widespread use. In the laboratory, they have been shown to
produce rapid and successful methods for microvascular
anastomosis but, in almost all cases, they have been technically
difficult to use. The staplers are too large for manipulation under
the operating microscope; the pinned ring devices require
considerable experience and trained assistance; the coupling
devices use excessive vessel length to achieve satisfactory eversion
50
at the anastomosis, and accurate selection of the correct size of
coupler is not easy.
Adhesives
Cyanoacrylics
The properties of cyanoacrylate adhesives have been reviewed
by a number of authors17,56,151,170,240,245,265.
Cyanoacrylate adhesives are formed by the polymerisation of
monomers, which can be represented by the chemical formula
CH2=C(CN)COOR. The addition of water, normal saline, or weak
bases initiates the reaction that leads to bond formation. Strong
bonds are rapidly formed when cyanoacrylics are applied to a
variety of different materials. Bonds are chemically stable in the
normal tissue environment. It is not necessary to apply heat,
pressure, or other technical adjuvants to complete the bond. A
variety of cyanoacrylate adhesives are available and are named
according to the specific monomer used (e.g. methyl-2-
cyanoacrylate, iso-propyl-cyanoacrylate).
Experimental vascular repairs with the cyanoacrylate
adhesives30,54,55'132'170'240'356,402 have tended to be less than
satisfactory, with intense inflammatory reactions leading to
destruction of adventitia and media and eventual anastomotic
failure, although the higher molecular weight homologues have
been shown to have less histotoxicity than methyl-2-
cyanoacrylate213,413. It has been noted that the entry of "glue" into
the lumen causes instant thrombosis. Some studies56,157,340 have
reported more favourable results - perhaps this was because they
used variations on the sleeve technique, which would decrease the
risk of monomer entering the lumen.
The cyanoacrylate adhesives have not become available for
general clinical use for a variety of reasons, but in particular because
of the intense inflammatory reaction that they generate127 and
because polymeric cyanoacrylate has been shown to cause
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fibrosarcomas in laboratory animals126'327. The use of this
substance has been forbidden by the United States Food and Drug
Administration.
Other adhesives
A number of other adhesives have been investigated for
possible use in surgery.
Bemhard et al30 used polyurethane resin for the closure of
vascular incisions.
Freeman, who was mainly interested in developing an
adhesive neural anastomosis technique, tested a wide range of
substances107-108. He looked at the use of synthetic lattices,
polyurethanes, and tapes (polyurethane, silicone, teflon, and
micropore). He concluded that further refinement and continued
investigation was warranted, but, as it turns out, none of the
synthetic adhesives have survived the test of time.
Fibrinogen adhesive
The use of fibrinogen adhesive is discussed in depth in later
chapters. The development of fibrinogen adhesives for use in
surgery is described in Chapter 3 (see page 73). A review of the
literature concerned with the use of fibrinogen adhesives for
microvascular anastomoses can be found in Chapter 4 (see page 96).
Type of anastomosis
End-to-end
The end-to-end anastomosis was the first technique to be
used in Microvascular Surgery and it is still the most widely
applicable. End-to-end anastomoses are most commonly sutured
although they can be made by all the other techniques described
above.
An end-to-end anastomosis can be put together in a number
of different ways. Ideally the two cut vessel ends are held loosely
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together in a double approximating microvascular clamp. Most
commonly the anastomosis is then made by initially securing the
front wall, then the clamp is rotated, and finally the back wall is
secured. It is not uncommon for clinical conditions to be awkward,
and the anastomosis has to be made in a deep wound or in limited
space. It may not be possible to rotate the clamp, in which case it
is necessary to use the posterior-wall-first technique147'158. Some
find this technique technically more difficult to use, although
others use it almost all the time as their technique of choice232. An
alternate method of making the anastomosis in situations where the
clamp cannot be rotated is the side-wall technique421, a method
which we have also found to be very useful for solving this problem.
End-to-side
The end-to-side anastomosis was initially used by peripheral
vascular surgeons for inserting saphenous vein bypass grafts in the
management of occlusive vascular disease.
The cerebral revascularisation procedures, developed by
Yasargil, provided the first requirement for a microsurgical end-to-
side anastomosis. In these operations, the superficial temporal
artery was anastomosed to a branch of the middle cerebral
artery418,419 but this had to be done in such a way that flow was
maintained in the middle cerebral artery.
The end-to-side anastomosis has been important for the
revascularisation of free tissue transfers. Ikuta165 emphasised its
importance as early as 1975, and more recently Godina119
recommended it as his method of choice for the arterial
anastomosis in free flap transfers.
Godina119 wrote that the end-to-side anastomosis had the
following advantages:
1. A high success rate.
2. Preservation of all existing vessels in the injured
extremity.
3. Greater freedom of operative planning.
4. Technical simplicity in terms of access to the
vessels.
The size and shape of the side arteriotomy in the recipient
vessel is important. In order to reduce loss of flow, the arteriotomy
should be large and elliptical so that the side branch (the donor
arteiy) has a funnel-shaped origin, preferably with a small angle of
union217. Technically it is not easy to make the side arteriotomy.
Pederson and Barwick301 have recently reported on the use of a
vascular punch, but this is still being modified and is not yet
available for general use. Acland initially recommended11 making
two scissor cuts each side of a "pick-up" suture. Later he developed
the Acland arteriotomy instruments and these work so well that our
group no longer finds cutting the arteriotomy to be a problem.
End-to-side branch
This technique is a modification of the end-to-side
anastomosis, in which a side branch, adequately sized for a
microsurgical anastomosis, is located at, or close to, the selected
anastomotic site in the recipient vessels. The donor vessel is
anastomosed to the side branch using a conventional end-to-end
technique. This method of anastomosis, if by chance it is available,
may be preferable to an end-to-side technique, especially if clinical
conditions are sub-optimal. I have found it quite useful for the
replantation of avulsion amputations of the thumb38, when we have
sometimes anastomosed vein grafted digital arteries to a dorso-
radial branch of the radial arteiy in the anatomical snuff box. I have
also used it for venous anastomoses of free tissue transfers in
regions where recipient veins have been very large.
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End-in-end
The end-in-end intussusception method of vascular
anastomosis was first described by Murphy in 1897", although it
was popularised by Bougie56 in 1901. It was introduced into
microsurgery by Lauritzen204'208, who described it in his Doctoral
Thesis (University of Goteborg, Sweden, 1979), and called it the
sleeve anastomosis. Lauritzen found it easier and faster than the
conventional sutured anastomosis, pointing out that it required just
two sutures. Meier, later in 1978, published a modification of
Lauritzen's technique56. More recently, Nakayama et al262
described another modification which produced reliable results in
fifteen clinical free flap transfers.
In the sleeve technique the upstream vessel is placed inside
the downstream vessel to make an overlap, or sleeve, long enough
to prevent leakage. The terms upstream and downstream refer to
the direction of flow and may be either proximal or distal
anatomically, depending on whether vessels are arterial or venous.
Since Lauritzen's 1978 paper, a number of studies have been
carried out to evaluate various aspects of the sleeve anastomosis,
and to compare it with the conventional sutured end-to-end
anastomosis66* 196,205,252,342,404,405_
The advantages of a sleeve anastomosis over an end-to-end
sutured anastomosis are that:
1. It is faster196-205-342.
2. There is less intimal dissection209.
3. Aneurysms at the anastomotic site247 have not been
reported.
4. Resistance to irradiation is thought to be
improved198.
5. Patency rates are similar to end-to-end
anastomoses209'342.
The disadvantages of a sleeve anastomosis over an end-to-end
sutured anastomosis are that:
1. Intralumenal sutures causing tethering,
misalignment and tearing364.
2. A valve type mechanism may be created at the point
of anastomosis395.
3. Low blood flow may be present for the first few post
operative days404.
4. Surgeons have had difficulty reproducing Lauritzen's
patency rates364.
Despite the enthusiasm of some authors and the excellent
results of their experimental studies, the sleeve anastomosis has
not become widely adopted. Many, myself included, have found it
difficult to reproduce the high patency rates and low complication
rates reported by Lauritzen. There is no doubt, however, that
others find the technique very satisfactory. Johnston177 informed
me that microvascular surgeons in some parts of China use the
sleeve anastomosis almost exclusively. The Chinese technique has
been described by Pan and Lee296.
Cuffing techniques
In the early days of microvascular anastomosis, it was
common practice to wrap the anastomosis after it had been
sutured. Daniel and Terzis87 recommended that the material
"
.... be extremely pliable to avoid cutting into the vessel, sufficiently
narrow to fit between the clamps, long enough to be manipulated,
and clear enough to permit visualisation of the anastomosis". They
recommended a piece of Saran Wrap or clear cellophane. Saran
Wrap was also recommended by McLean and Buncke231, who had
also been experimenting with thrombin powder, Gelfoam strips,
micropore tapes and silicone sheets.
56
Hayhurst and O'Brien150 were enthusiastic about MacLean and
Buncke's cuffing technique, noting that it allowed the surgeon to
achieve a leak free anastomosis with fewer sutures than would
otherwise be necessary. They thought this would diminish the risk
of medial necrosis and arterial occlusion. Bell et al27, on the other
hand, were less enthusiastic about cuffed microarteriorraphy for
sealing partially sutured end-to-end anastomoses. Their
experimental results indicated that cuffed anastomoses (using
venous cuffs) were inferior to conventional sutured anastomoses.
Hart148, who was interested in the problem of haematoma
formation near anastomoses of vessels containing heparinised
blood, reported favourable results after using absorbable gelatin
sponge to prevent anastomotic leakage.
Other types of cuffing techniques have also been investigated
in the search for more rapid, easier or better anastomoses. Harris
et al146 demonstrated that their autogenous arterial cuff technique
needed few sutures, was associated with less vascular trauma, could
be completed quickly, and yielded high patency rates. Merrell,
Zook and Russell251 compared four-stitch microarterial
anastomoses, reinforced with cuffs of artery, vein or polyglycolic
acid, with standard eight-stitch repairs. Nakayama et al263
experimented with a technique that used a venous cuff and two
sutures.
Sanders et al329 described an interesting anastomotic
technique, in which the end of the donor vessel was split
longitudinally and wrapped around the recipient arteriotomy to
create a sort of cuffed end-to-side anastomosis.
As experience has increased, it has been realised that it is not
necessary to prevent anastomotic leakage by wrapping sutured
anastomoses. Small leaks rapidly stop by themselves. Large leaks
can be stopped by the addition of extra sutures, and these can be
inserted as an adventitial layer only, if it is felt that the insertion of
additional full thickness sutures might be hazardous300. Neither of
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these two methods appears to be associated with a decrease in the
patency rate. For this reason, anastomotic wrapping is not
generally carried out nowadays.
Size discrepancy
The anastomosis of vessels with different diameters poses
problems, which can be solved in a number of ways.
Hurwitt et al160, working with quite large size discrepancies,
suggested making variations to end-to-end anastomoses, in which
either the large vessel diameter was reduced by suturing or the
small vessel diameter was expanded with a fish mouth incision.
For small discrepancies, one technique involves mechanically
dilating the smaller vessel, till it reaches a size comparable with the
larger vessel, and then carrying out a standard end-to-end
anastomosis. Other techniques include the use of an oblique
transection of the smaller vessel142 and, in the case of large size
discrepancies, the use of an end-to-side anastomosis.
Harashina et al141 have described a Y-shaped anastomotic
technique for handling venous size discrepancy problems in free
flap surgery.
Other important anastomotic factors
A number of specific technical factors, important for
anastomotic success, have been discovered, investigated and
reported. These have included aspects concerned with
microvascular clamps70-137, preparation of the cut vessel
ends3,11 >50,62,87, i 1.8,283,335 the avoidance of tension at the
anastomosis68,99,13°.
Other factors that have been investigated have included
methods of determining the patency4,11,50,63,67,81,87,197,283-335 of
microvascular anastomoses and studies concerning the use of
irrigating solutions10,234^ the effect of hydrostatic dilatation44,319,
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the effect of blood flow^ 14,362,367,404 and measurements of
anastomotic strength75.92,i 17,194,311,397
THE HEALING OF MICROVASCULAR ANASTOMOSES
Patency rate of microvascular anastomoses
Prior to the era of the microvascular anastomosis it was not
possible to obtain satisfactory or reliable results in the anastomosis
of small blood vessels. Urschel and Roth393 did manage to achieve
a patency rate of 73% in vessels 1.4 to 2.0 millimetres in diameter
which was "much higher than expected for vessels of this size and
can be attributed in large part to improved methods of anastomotic
technique". The improvement in patency rates that occurred with
the introduction of microsurgical technique is shown in a table in
O'Brien's textbook283.
The classical paper of Jacobson and Suarez reported a 100%
patency rate in vessels 1.4 millimetres in diameter. There was
some initial concern about accepting these results and surgeons
were uncertain whether they should commit themselves to the
expense of purchasing an operating microscope. After Green128
demonstrated that the results were reproducible, the technique
began to be adopted. Soon others48-71 >72'150'164'269'277 began to
report patency rates of over 90% in vessels 1.0 millimetre in
diameter. These kind of patency rates have subsequently been
widely reproduced, and nowadays microsurgeons expect to achieve
patency rates in this range for 1.0 millimetre diameter vessels343.
The patency rate is usually lower for smaller vessels, although
skilled surgeons expect to achieve near perfect patency rates for
vessels as small as 0.5 millimetres in diameter1-361. Fortunately, in
clinical practice it is uncommon for vessels to be this small except
in veiy young paediatric patients.
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In clinical practice the patency rate also depends on the
extent of damage to the vessels283, in free tissue transfers, the
donor tissue should be no more damaged than laboratory vessels,
but the recipient vessels may be damaged by irradiation, dissection
through scar tissue, or the effects of injury. In replantations, the
extent of damage varies with the type of amputation: guillotine,
local crush, or avulsion. The results of replantation in these
different types of amputation, and some of the techniques that have
been developed to improve microsurgical survival rates, were
reviewed in our paper on the replantation of avulsion amputations
of the thumb38.
Histology of microvascular anastomoses
A number of studies have looked at the biological process of
healing and regeneration of microvascular anastomoses.
Early studies looked at vessels larger than 1 millimetre in
diameter. Histological and histochemical findings, after saphenous
veins were grafted into femoral arteries, were reported in a canine
model220. There was an initial inflammatory response, which was
followed by a thickening and fibrosis, with a concomitant increase
in ground substance, noted in all layers of the vessel wall. If the
vein graft was isolated from ingrowing adventitial blood supply by a
nylon cuff, these changes were more severe. These findings
complimented those from an earlier study by the same group416, in
which it was demonstrated that venous by-pass grafts obtained their
nutrition from intra-lumenal plasmatic diffusion in the first 48
hours, and from adventitial capillary circulation at 72 hours.
Khodadad published three reports 182-184> 185 on a study that
compared end-to-end anastomoses with longitudinal arterial slits in
a feline model. He described the processes of intimal hyperplasia,
fibrotic replacement of the media and adventitial thickening in
both types of repair. He saw elastic fibres in the new intima, and
also noted dilatation of the artery at the level of the circumferential
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repair. He found that in some cases the arterial wall decreased to
half its normal thickness and thought that this was related to
reduction in the media.
The histological features of microvascular repairs in rabbit
femoral artery repairs were described by Baxter et al26 in a paper
that was primarily concerned with the histological pattern of
different kinds of suturing errors. Like Khodadad they found new
elastic fibres forming inside the internal elastic lamina and cellular
hyperplasia deep to the intimal layer. They also noted necrosis of
the media that had been strangulated by sutures, an observation also
made by other investigators26'43'69-215.
In 1977, the histological features of rat femoral artery
anastomoses were described by Acland and Trachtenberg9, who
were interested in the effect of surgical trauma, rather than
surgical error. They examined the vessels at various times between
1 hour and 3 weeks, and noted widespread loss of endothelium
from clampsite to clampsite, and also extensive necrosis in the
media.
The Chinese have also published their view of the pathological
changes that take place after anastomosis of small arteries64.
Blair et al34 discussed the histological features of anastomoses
fixed with mechanical couplers, and described a method of dividing
anastomoses into descriptive zones.
Brunner43 described the histological findings of fibrin-glued
microvascular anastomoses.
Feeling that these previous studies had concentrated on the
healing that occurred after suture errors or surgical trauma, Lidman
and Daniel215 carried out a study to look at the chronological
sequence of healing of an end-to-end anastomosis under optimal
conditions. This is the most comprehensive description of the
histology of healing microvascular anastomoses. Observations were
made at two days, ten days, one month, two months and seven
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months and their findings in the different layers of the vessel wall
were:
Lumen. At two days there was dilatation at the anastomotic
site and this remained throughout the follow up period.
Endothelium. At two days the endothelium was normal
between the microvascular clamps except in the immediate
anastomotic area where it was absent. There was no mural
thrombus, no platelet aggregation and the internal elastic lamina
was intact. At ten days an intense repair process was underway. On
the lumenal surface there was a single layer of endothelial cells.
There was intimal hyperplasia to a thickness that equalled about
two thirds of the thickness of the normal media. They were not
able to identity the exact nature of these myointimal cells but noted
that they had characteristics that resembled the smooth muscle
cells of the media with their elongated nuclei, although these were
arranged longitudinally rather than transversely. The appearance of
these layers did not change appreciably between the tenth day and
the end of follow up.
Media and inner adventitia. Hyaline degeneration was seen in
this layer in sections taken at both the second and tenth post
operative days. The amount of degeneration varied depending on
the location of the section and was related to the proximity of
sutures. Sections near or under sutures, demonstrated marked loss
of cell structure and absence of nuclei. Sections between sutures
demonstrated an almost normal histological appearance. Later
sections, at one, two and seven months, showed media atrophy,
which varied from minimal to complete. If minimal, smooth
muscle cells were seen to form a circular arrangement, bordered by
an inner and outer elastic lamina. If complete, the media was
replaced by intimal hyperplasia.
Adventitia. In a similar manner, the adventitia underwent
necrosis if it was trapped under a suture, but otherwise remained
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relatively normal in appearance. In necrotic areas, there was loss of
nuclei from fibroblasts, although elastin and collagen fibres were
still present.
General findings. At two days an early and mild inflammatory
response was seen, and was mainly located in the adventitia. The
cell population was about 50% polymorphonuclear leukocytes and
50% lymphocytes. Few macrophages were to be seen. By the tenth
day, there was an intense inflammatory response and a foreign body
reaction around the sutures. Sections demonstrated a tapering of
the inflammatory response at one month, with chronic
inflammatory cells becoming predominant. At two months the
inflammation had almost completely resolved.
Scanning electron microscopy of microvascular anastomoses
The scanning electron microscopic appearance of normal
vascular endothelium has been described by Wieslander408'409.
Studies looking at various aspects of microvascular anastomoses
have been reported by other investigators.
Thurston et al379 examined the effect of microvascular clamp
jaw pressure. Histologically, they found that when jaw pressure
exceeded 30g/mm2 media necrosis resulted and this led to
persisting dilatation of the clamped segments. Using scanning
electron microscopy, they demonstrated endothelial loss at the
clamp sites, regardless of the clamp pressure. The endothelial
loss, however, was repaired - in contrast to the permanent media
damage.
The effect of needle and suture size has been investigated
using scanning electron microscopy by Urbaniak et al389 and
Lourie219. As expected, they demonstrated that patency rates were
higher when finer needles were used. In addition, they noted that
extensive adventitial stripping (3.0 millimetres on each side of a cat
femoral artery anastomosis) produced stenosis. Gu et al129
reported that the site of needle holes and stitches was the main
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location of thrombocyte adhesion and aggregation in the normal
microvascular anastomosis.
Dirrenberger and Sundt95 studied endothelial regeneration
after canine carotid endarterectomies. They concluded that the
endothelium regenerated from intact endothelium adjacent to the
injury.
Servant et al339 found that endothelial regeneration
completely covered suture threads in rat aorta anastomoses by four
weeks. Other investigators137*362'382 found that reconstitution of
the neo-intima took two weeks, whereas Lidman216 found the
process to be much faster, with complete endothelialisation evident
after only one week. Gelderman and Berendsen114 also found the
process to be rapid, finding that the suture line of end-to-side
anastomoses became re-endothelialised in four days.
A number of other studies78,79'167,364,399,400 have examined
re-endothelialisation and healing of microvascular anastomoses.
The results of these investigations did not differ appreciably from
previous studies.
Lauritzen and Hansson207 looked at the re-endothelialisation
of sleeve anastomoses. They reported that the process started
before the third day and was complete by the end of the first week.
Nightingale et al268 have written the most comprehensive
description of the scanning electron microscopy of healing
microvascular anastomoses, and their findings at different times
after anastomosis were:
Zero hours. Sutures could be seen as they perforated the
endothelium of the lumen. Suture tension could be observed by
looking at the degree of suture flattening. It was rare to see a loose
suture, and usually sutures were tight enough to cause bunching of
the vessel wall, giving it a corrugated appearance. There was
tearing of the endothelium, at the site of suture perforation, and
thrombus at both the anastomotic site and at the site of needle
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holes. The thrombus was usually a thin layer of platelets, red blood
cells and thrombin. At the microvascular clamp sites, there were
sharply demarcated areas of endothelial loss, which were also
covered with a thin layer of thrombus. Between clamp sites, the
endothelium demonstrated loss of surface detail, with scattered
areas of desquamation. Some arteries showed sharply defined areas
of endothelial loss, which was thought to represent the effect of
mechanical dilatation with forceps.
One to twenty-four hours. Anastomotic sites became
completely covered with a thin layer of thrombus, which was
maximal at four hours. The thrombus consisted of platelets, red
blood cells and leukocytes, which appeared from about one hour
onwards. Fibrin was rarely present. By the end of the first day the
thrombus was gradually diminishing and bare areas were becoming
visible on the sutures. After the first hour, the microvascular clamp
sites were completely covered with a thin layer of platelets and
leukocytes. The surface between the clamp sites was nearly
completely covered with a thin layer of platelets, red blood cells
and leukocytes. Surface details, such as microvilli and cytoplasmic
projections at the junctions of endothelial cells, were not visible.
There were scattered patches of endothelial loss, and deficient
areas were filled with platelets and platelet debris.
One to seven days. During this period, there was a
progressive decline in the amount of thrombus at the anastomotic
site, but by one week there was still no evidence of re-
endothelialisation. At three days monocytes and/or small
macrophages were seen on the sutures. At one week giant cells
were common on the sutures and the lumenal surface at the
anastomotic site. At the microvascular clamp sites, a sheet of
regenerating endothelial cells became visible at about the third day.
Along the growing edge individual cells, irregular in outline and
orientation, projected outwards from the sheet. It was not clear
whether these new cells were laid down over the top of the
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thrombus or whether they undermined the thrombotic deposits.
Between the clamp sites, the thin thrombus decreased after the
first day, and after the third day increasing endothelial cover was
observed. The increased visibility of endothelial cells was thought
to result partly from loss of thrombus and partly from regeneration.
Two weeks. At this time, regeneration of endothelium was
virtually complete. Sutures were almost totally covered and
microvascular clamp injuries were no longer visible. The
endothelial cells were still irregular in outline and orientation, but
by four weeks the cells were axially aligned with well defined
margins.
FACTORS RELATING TO ANASTOMOTIC FAILURE
In any project, concerned with the success or failure of
microvascular anastomoses, it is important to consider the causes
and mechanism of failure. Unfortunately, this is a complex and not
completely understood area, and is, itself, a field of intense study at
the present time. A review of some of the factors related to
microvascular anastomotic failure is indicated but an in-depth
discussion is out of the scope of this work.
There are a number of complications that can occur after
microvascular anastomosis. The main complications include
dehiscence, aneurysm, stricture and thrombosis. Although there
has been specific interest in aneurysm formation247, it is
thrombosis that causes most clinical problems.
Every microvascular anastomosis involves an operative
procedure that produces the three components of Virchow's Triad
which are precursors of intra-lumenal thrombosis:
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1. Trauma to the vessel wall.
2. Alteration of blood flow.
3. Changes in blood constituents.
The first stage in the formation of intralumenal thrombosis is
the production of a haemostatic platelet plug. It is this platelet
plug which causes the immediate intra-operative flow failure which
the microvascular surgeon is on his guard to prevent at the time of
operation. Tissue damage on the intimal surface of the
microvascular anastomosis is a stimulus for the adherence of
platelets. Lipoproteins on the surface of the platelets (sometimes
called platelet factor 3) catalyse the intrinsic clotting mechanism
with the resultant formation of fibrin, which consolidates the
platelet plug. Finally the fibrin clot retracts, by an uncertain
mechanism that is influenced by the contractile protein complex,
thrombosthenin, which is present in platelets.
The clotting mechanism is complex (Figure 1). The objective
is to convert the plasma protein fibrinogen into an insoluble
network of fibres called fibrin. A common end pathway can be
triggered by either an intrinsic system or a faster extrinsic system.
The intrinsic system is triggered by contact with an abnormal
surface, whilst the extrinsic system is triggered by tissue factors
released from damaged tissues. The reactions form a true cascade,
for they not only trigger each other in sequence, but the process
has the ability to accelerate. Acceleration is brought about by the
presence of thrombin, which potentiates the activity of Factors V
and VIII as well as causing further platelet aggregation, thus
increasing the amount of platelet factor 3.
Once formed, the haemostatic platelet plug may either
dissolve, by the process of fibrinolysis, or organise and/or propagate
into an intra-vascular thrombosis. Fibrinolysis is important to the
success of a microvascular anastomosis, and the process occurs
rapidly after surgical manipulation. The mechanism of fibrinolysis
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Figure 1. A simplified diagram of the blood clotting mechanism.
Solid arrows represent transformations.
Interrupted arrows represent actions.
PL stands for Platelet Factor 3.
A Factor number followed by 'a' indicates the activated form of
the Factor.
Ca++ is not shown but is required for most steps.
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is unaffected by the type of microvascular anastomosis18. Platelet
plugs are most prominent at about fifteen minutes, and if complete
vascular occlusion is going to occur, it usually happens in the first
thirty minutes322.
The problems associated with loss of blood flow through a
microvascular anastomosis are complex, particularly when they
become associated with increasing ischaemic times in the
replanted or transplanted tissue, and the process of ischaemic
reperfusion injury starts to evolve. Klitzman193 has reviewed the
factors that determine the perfusion of a given region of tissue, and
classified them into geometric factors (active and passive changes
in diameter) and rheologic factors (plasma viscosity, platelets, red
blood cells, white blood cells).
The basic principles for managing anastomotic failure181 are:
1. To recognise the problem.
2. To manage the anastomosis.
3. To minimise the ischaemic injury.
The problem is almost invariably at the anastomosis, and this
should be surgically corrected, looking carefully for a reason why
the clot occurred. Some of the technical factors relating to
anastomotic failure have been investigated by Fukui and Tamai113.
Their experiments documented " .... that:
1. If there is a branch from a damaged arteiy that
constitutes a sufficient collateral route, the success rate of an
anastomosis just above the branch is significantly greater higher
than just below.
2. When recipient arteries are dissected in preparation
for anastomosis, the vessels should have high-pressure outflow to
assure a successful outcome.
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3. If both recipient and donor arteries are normal and
not damaged, anastomosis where turbulence is likely to occur will
present no problems."
In the occasional instance, when surgical correction is
impossible, pharmacological manipulation of the anastomosis with
plasminogen activators, possibly introduced through a side branch
catheter, may be beneficial. Clinically, the ischaemic injury297 can
be minimised by cooling and, temporarily (while waiting for
operating room availability) with the aid of leeches, an area in
which there has recently been much interest388. Laboratory
experiments, using drugs (such as allopurinol and ibuprofen) to
decrease free radical production, and drugs (such as superoxidase
dismutase and deferoximine) to scavenge free radicals, are




Fibrinogen Adhesive and its Use in Surgery
7 1
INTRODUCTION
In the first part of Chapter 2 many different approaches to
the technique of microvascular anastomosis were described. One of
these involved the use of adhesives. Unfortunately, the synthetic
adhesives proved to be unsatisfactory for anastomoses, not so much
for technical reasons, but rather because of their detrimental effect
on the surrounding soft tissues.
Chapter 3 begins by considering features thought to be
desirable in an ideal adhesive. Next there is a review of the
historical milestones in the development of fibrinogen adhesives for
surgery. This is followed by the main thrust of the chapter, which
is a detailed description of Tisseel, a current commercially available
fibrinogen adhesive.
THE IDEAL SURGICAL ADHESIVE
Daniel and Terzis86 have reviewed the qualities that they
consider to be desirable in an ideal adhesive substance for surgical
application. They suggest that it should:
1. Adhere and set quickly without excess heat
production.
2. Remain stable at body temperature.
3. Work in a moist environment.
4. Be noncarcinogenic and nondetrimental to healing.
5. Be sterilisable.
According to these criteria, fibrinogen adhesive would appear
to be a very satisfactory material, but in order to determine if it can
be satisfactorily used for making microvascular anastomoses, it will
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be necessary to investigate and answer a number of questions about
its use:
1. Can a fibrinogen adhesive anastomosis produce
statistically comparable patency rates to a
conventional suture technique?
2. What are the morphological changes that occur at
anastomotic sites?
3. What advantages does an fibrinogen adhesive
anastomosis have compared to a conventional
sutured anastomosis?
This chapter has been devoted to describing the
development, mode of action and application of a fibrinogen
adhesive. The following chapters describe experimental work
carried out to answer the three questions above.
THE DEVELOPMENT OF FIBRINOGEN ADHESIVE
The idea of using clotting constituents from human blood as
an adjunct to surgery dates back to the beginning of the 20th
century. Initially they were used to help obtain haemostasis, but
subsequently they have been used for many other purposes.
The historical milestones, and original references concerning
the development of fibrinogen adhesive, have been recorded by
Schlag and Redl332. In 1909 Bergel described the haemostatic
effect of fibrin powder. Later, Grey in 1915 and Harvey in 1916,
both in the United States, used either fibrin or fibrin patches to
arrest haemorrhage in the brain and other viscera. The concept
was then lost and was not rediscovered till the 1940s.
In 1940, Tarlov and Benjamin370, in the United States and
Young and Medewar420, in the Great Britain, published the results
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of experimental nerve anastomoses in which they used a fibrin
adhesive to maintain nerve stump approximation. Results did not
meet their expectations due to poor strength and stability in the
adhesive. They suggested that the lack of adhesiveness and stability
was related to an inadequate concentration of fibrinogen and the
absence of antifibrinolytic substances. It must also be remembered
that Factor XIII was unknown to them (Laki and Lorand discovered
Factor XIII in the late 1940s).
Also in the 1940s, Tidrick and Warner, were working with
thrombin as a haemostatic agent3®0 and for the fixation of skin
transplants381.
Work continued with other types of resins and adhesives
through to the 1970s.
In 1972, in the German literature, Matras et al published the
successful results of a peripheral nerve repair experiment in which
they used a cryoprecipitate of concentrated fibrinogen which
contained an enhanced content of Factor XIII. Problems
encountered were associated with fibrinolysis. Aprotinin, isolated
by Kunitz and Northrop, was incorporated to inhibit fibrinolysis and
delay the onset of fibrin degradation.
In 1975, the first successful application of fibrin adhesive for
human nerve repair was published, in the German literature, by
Matras and Kuderna.
Matras244 reported that the first recorded use of fibrinogen
adhesive for microvascular surgery was recorded in the German
literature in 1977243. Karl, Tilgner and Heiner179 reported that
soon afterwards Dinges et al94 recorded, in the German literature,
the histological healing process of experimental anastomoses using
a combination of fibrinogen adhesives and sutures. Matras244
reported that it was not long before a clinical series of satisfactory
neurosurgical arterial microvascular anastomoses was reported in
the German literature191.
PATHOPHYSIOLOGY OF FIBRINOGEN ADHESIVE
It is impossible to separate a discussion on fibrinogen
adhesive from the process of wound repair, in which endogenous
fibrin plays an important part. For this reason this section will
commence with a review of the process of wound repair.
The healing of traumatic wounds
The process of wound healing involves two main components
that are integrally related:
Contraction. This is the mechanical reduction in the
size of the wound which takes place during the first few weeks.
The process is probably mainly brought about by granulation tissue
through the action of myofibroblasts, although the contraction of
collagen fibres and the removal of fluid by drying have also been
suggested as contributory factors.
Repair. This is the replacement of lost tissue by
granulation tissue which matures to form scar.
To facilitate understanding, the process can be divided into
three phases, although this is purely artificial and there is
considerable overlap between them:
1. Traumatic inflammation. In this phase, tissue
trauma is immediately followed by coagulation and haemostasis.
The blood clotting process produces fibrin, which is also a product
of the acute inflammatory response initiated by cellular damage.
The inflammatory response starts within hours and extends to
about the fourth or fifth day. Fibrin brings about recruitment in the
injured tissue, activates macrophages and chemotactically attracts
polymorphonuclear leukocytes. These polymorphonuclear
leukocytes, which are also attracted by plasma components and
chemotactic substances released from aggregated platelets, are
quickly subject to lysis and their main task is to degrade damaged
tissue and to phagocytose cellular debris.
2. Demolition. In this phase, lysosomal enzymes,
either released from dead tissue cells or from disintegrating
polymorphonuclear leukocytes, bring about a debridement of the
wound. Monocytes migrate into the wound and change into
macrophages, becoming maximal in number between the fourth
and fifth days. Macrophages, which may fuse to form foreign-body
giant cells, have several functions. These include regulation of
coagulation and fibrinolysis; the removal of tissue debris, cells and
bacteria; and the release of growth factors which stimulate
angiogenesis and myofibroblast activity.
3. Ingrowth ofgranulation tissue. This phase also gets
underway during the first week. Macrophages invade the fibrin
clot, advance towards the centre and are followed closely by a
vascular granulation tissue consisting of capillary loops and
myofibroblasts. The insoluble fibrin clot is replaced in a process
called organisation. Macrophage growth factors stimulate the
production of granulation tissue, although platelet-derived growth
factor is also important for the attraction and activation of
myofibroblasts. Differentiation soon occurs. Arterioles and venules
form within the vascular network, and the large plump 'fibroblast
precursors' develop the characteristic features of myofibroblasts.
The latter secrete soluble collagen, which polymerises to form
fibrils, and mucopolysaccharide ground substance. Later, in this
phase, as maturation proceeds, nerve fibers and lymphatics form,
and mature collagen fibres are seen, orientated according to the
stresses applied to the wound. Advancing maturity is associated
with devascularisation, some vessels undergoing atrophy whilst
others show endarteritis obliterans. This results in the formation
of a pale avascular scar and may be associated with local tissue
distortion in a process known as cicatrisation.
Basic principles behind fibrinogen adhesive
The above review indicates that naturally occurring fibrin is
an important substance in the process of wound healing. Fibrin
acts as a sealant, preventing the loss of body fluids; it forms a
barrier against external contamination; and it provides a substrate
material for the ingrowth of reparative granulation tissue.
Naturally occurring fibrin is formed in the final common
pathway of the blood clotting mechanism (Figure 1). Fibrinogen is
converted to fibrin by the action of thrombin, which splits off two
peptide fragments called fibrinopeptides A and B (see page 83).
The remainder of the fibrinogen molecule undergoes spontaneous
polymerisation with its fellows. In this manner, the fibrin
monomer forms orderly molecular aggregates which build up to a
network of fibres that become known as a clot. Factor XIII, fibrin-
stabilising factor, creates covalent bonds between the aggregates,
thus converting the easily disrupted soluble fibrin into stable
insoluble fibrin and the clot becomes a firm gel.
Fibrin clots can be similarly created in vitro using products
obtained from donated blood through blood transfusion services.
This forms the basis for the production of fibrinogen adhesives.
Fibrinogen adhesives have three effects that have been put to
use in surgical procedures:
1. Haemostasis. Fibrinogen adhesives have been used
to obtain haemostasis in situations where there is blood loss from
wide surfaces but no specific vessels for ligation or cauterisation.
The achievement of haemostasis avoids the problem of haematoma
formation in the wound. This is an advantage because the lengthy
process of absorption and/or organisation of the haematoma is not
necessary, and because haematoma has a rather negative influence
on the quality of granulation tissue formed.
2. Adhesive. Fibrinogen adhesives have, as their name
implies, been used to hold structures together. Critics have
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repeatedly pointed out that their adhesive strength is quite limited
and will not tolerate exposure to major stress. Fibrinogen
adhesives, however, are not used to obtain adherence of major
tissue segments. Rather, they are used to maintain approximation
of adjacent tissue surfaces which are not under external stress.
They do not introduce an artificial barrier (like the synthetic
adhesives), but form a tight biological seal (keeping out haematoma
and other adjacent tissues) and, in this way, aid in smooth healing
of the 'glued' structures.
3. Fibrin network. The fibrin network is a good
substrate for the ingrowth of granulation tissue and particularly for
the attraction of fibroblasts. This effect is thought to be beneficial
for wound healing357, and has been used beneficially for the healing
of ulcers unresponsive to other forms of management331.
Fate of fibrinogen adhesive in the tissues
Fibrinogen and fibrin are removed from the tissues by the
process of fibrinolysis, which is brought about by proteolytic
enzymes.
Intra-vascularly, the fibrinolytic enzyme, plasmin, is produced
by the activation of circulating plasminogen. This can be initiated
in a number of ways. Prekallikrein is the inert precursor form of
the enzyme kallikrein, which is present in concentrated form in
the lysosomes of most tissue cells, and has also been isolated from
leukocytes and platelets. Plasminogen activators have been
identified with kallikrein. Plasmin has a wide range of activity. In
addition to degrading fibrin and fibrinogen, it also degrades other
clotting factors and a variety of plasma proteins such as
complement and some hormones. Kallikrein is released in vivo by
vasoactive stimuli such as physical stress, histamine, adrenalin,
hypoxia, ischaemia and bacterial pyrogens. It is presumed that, in
these circumstances, prekallikrein is released from the endothelial
cells of small blood vessels, although it is known that prekallikrein
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can also be released from the lysosymes of other cells both
physiologically and in circumstances where there is shock or tissue
damage. Activation of plasminogen occurs on the fibrin rather than
in the blood itself. Plasma proteins that specifically neutralise free
plasmin also exist. The concentration of plasmin in the blood
varies and, thus, there appears to be a delicate balance between the
two extremes of intravascular clotting and afibrinogenaemia.
When large deposits of fibrin exist extra-vascularly, either as
haematomata, as inflammatory exudates or after the application of a
fibrinogen adhesive, they are found to be quite stable. They are
removed during the demolition phase of wound healing. Digestion
is brought about by proteolytic lysosomal enzymes derived from
invading inflammatory cells and also by plasmin derived from the
the activation of plasminogen by kallikrein in the endothelium in
the advancing granulation capillaries. The fibrin is broken down to
fibrin degradation products and is then replaced by granulation
tissue. The rate of degradation is dependent on the fibrinolytic
activity of the surrounding tissues, and, in the case of fibrinogen
adhesives, on the amount of added antifibrinolytic substances
added. Large quantities of fibrin slow down cell migration and thus
wound healing becomes delayed.
COMMERCIALLY AVAILABLE FIBRINOGEN ADHESIVE
Fibrinogen adhesive is produced both commercially and non-
commercially.
The Osterreichisches Institut fur Haemoderivate, a subsidiary
of Immuno AG in Vienna, has developed a commercial fibrin sealant
(note that the terms fibrinogen adhesive and fibrin sealant refer to
the use of the product rather than its content and are, therefore,
mutually interchangable) and this is readily available (note that, in
the United States, Tisseel is still pending Food and Drug
Administration approval) and licensed under the trademarks
Tissucol, Tisseel and Fibrin-kleber Human Immuno.
This fibrinogen adhesive is commercially available in Canada
and licensed under the trademark Tisseel. It is marketed by
Immuno (Canada) Ltd, 5334 Yonge Street, Suite 1727, Toronto,
Ontario.
Packaging and composition
A Tisseel Kit (Figure 2) contains five separate vials containing
substances which, when mixed correctly, form a two component
adhesive, of which fibrinogen is the main active ingredient. The
contents of the vials are listed in Table 1. Of the five vials, only four
are used for a given application because two different
concentrations of thrombin are provided in each Tisseel Kit. This
allows a choice of two clotting rates.
The protein concentrate is made from pooled fresh frozen
human plasma, whereas the aprotinin and thrombin is bovine in
origin.
Each Tisseel Kit also contains an application set consisting of
a Duploject applicator, disposable syringes, two joining pieces and
four application needles.
Four types of pack are available, each containing a different
quantity of Tisseel. Tisseel Kits 0.5, 1.0, 2.0 and 5.0 each provide
either 0.5, 1.0, 2.0 or 5.0 millilitres of reconstituted Tisseel
solution and a matching amount of Thrombin solution.
The shelf life of Tisseel is twenty-four months when stored
between +2°C and +8°C. It is advised that reconstituted Tisseel
and thrombin solutions are used within four hours.
Mode of action
The fibrinogen adhesive, Tisseel, acts by converting
fibrinogen to fibrin under the influence of thrombin. It is an
imitation of the final sequence of blood clotting, although the
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Figure 2. The commercially available fibrinogen adhesive used in
the preliminary and experimental studies.
A The Tisseel Kit 0.5, illustrating the outer
packaging, the five vials used to make up the two
components and the Duploject system for
application.
B The custom designed Fibrinotherm heating and
stirring device.
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TABLE 1. Contents of the five vials contained in each Tisseel Kit.
Protein Vial.
Tisseel protein concentrate (human), freeze dried and heat
treated. (Contains a magnetic bar to facilitate reconstitution when




Factor XIII 10-50 U*
Plasminogen 40-120 pg/ml
Human albumin 20-50 mg/ml
TOTAL PROTEIN 100-160 mg/ml
Aprotinin Vial.
Aprotinin solution (bovine). 3000 KIU/ml^
Thrombin 4 Vial.
Thrombin 4 (bovine), freeze dried.
Reconstituted contains: 4 IU/ml^
Thrombin 500 Vial.
Thrombin 500 (bovine), freeze dried.
Reconstituted contains: 500 IU/ml*
Calcium Chloride Vial.
Calcium chloride solution. 40 mmol CaCl2/l
* One unit corresponds to the amount of Factor XIII contained in
1 ml of fresh normal plasma,
t 30 Kallidinogenase Inactivator Units (KIU) correspond to 1 FIP
unit.
$ One International Unit (IU) of Thrombin is defined as the activity
contained in 0.0853 mg of the First International Standard of
Human Thrombin.
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concentration of fibrinogen is very high in the product to
compensate for the absence of platelets.
A detailed plan of the sequence of events that takes place is
illustrated in Figure 3.
The first component consists of a vial containing freeze dried
and heat treated protein (mainly fibrinogen; other plasma proteins
such as fibronectin [cold insoluble protein] and albumin; and Factor
XIII) mixed with a vial containing aprotinin solution.
The second component consists of a vial containing freeze
dried thrombin (a choice of two different concentrations is
provided) mixed with a vial containing calcium chloride solution.
The preparation of Tisseel fibrinogen adhesive is
diagrammatically illustrated in Figure 4.
When the two components are mixed, thrombin converts
fibrinogen into activated fibrin monomers. This initiates clotting
and the mixture solidifies. The pharmacodynamics of the process
have been described by Redl, Schlag and Dinges314.
Fibrinogen (Figure 5) is a protein with a molecular weight of
about 340,000. The molecule consists of six polypeptide chains of
three different types: alpha, beta and gamma. The chains are all
connected through disulphide bridges. Thrombin splits the
fibrinopeptides A and B from the fibrinogen molecule leaving fibrin
monomer. Hydrogen bonding produces aggregation of the fibrin
monomers and this produces the fibrin clot.
The thrombin simultaneously activates Factor XIII to the
transaminase Factor XHIa in the presence of calcium ions.
Factor XHIa acts to immediately (3 to 5 minutes) cross-link
the fibrin gamma chain to the gamma-gamma dimer. The beta
chain does not react and alpha chains are cross-linked by peptide-
like bridges to an alpha polymer.
Factor XHIa also acts as a catalyst for the formation of fibrin
cross-linkages with collagen. The plasma protein fibronectin plays
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Figure 4. A Tisseel Kit 0.5 with its enclosed diagram illustrating
the method of preparation of the two components of the
fibrinogen adhesive using material from four of the five vials.
Note that only one of the two vials of thrombin is used,
depending on whether rapid solidification (thrombin 500) or
slow solidification (thrombin 4) is required. The adhesive




Figure 5. Diagrammatic representation of the fibrinogen molecule
demonstrating the six polypeptide chains (three different
types: alpha, beta and gamma) and the interconnecting
disulphide bridges.
The arrows indicate the locations in which thrombin
splits the fibrinopeptides A and B from the fibrinogen
molecule leaving fibrin monomer.
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an important role in this process, which results in an increase in
the clot's strength.
The addition of aprotinin to the fibrinogen adhesive retards
the inevitable process of fibrinolysis and absorption of the clot
during the process of wound healing.
Developmental improvements. As experience was gained, changes
were made with the developing fibrinogen adhesive in order to
bring about product improvement.
Fibrinogen. Initial attempts at making fibrinogen adhesives,
using autologous material, were unsatisfactory because of poor
tensile strength in the clots. Production method refinements for
the fibrinogen component, including the pooling of fresh frozen
human plasma, have resulted in an increase in the concentration of
fibrinogen. Modern product contains between 100 and 160 mg/ml
of total protein, of which about 70 to 80% consists of fibrinogen. A
further improvement has been the lyophilisation of liquid
fibrinogen without any alteration of its properties. This has
produced a product which is much easier to handle and transport.
Thrombin and calcium chloride. Initially, a bovine thrombin
in a concentration of 500 IU/ml dissolved in 12 mmol CaCl2 was
used. It was found that the clot formation was too rapid and the
solidification was less than satisfactory. Modifications have been
made to the concentrations of thrombin and CaCl2 to correct these
factors.
Antifibrinolvtics. One of the advantages of fibrinogen adhesive
is its ability to be resorbed, but this must occur in a controlled
manner. The process of fibrinolysis is not well understood and
varies from tissue to tissue. The process is determined by
plasminogen activators which are mainly localised in endothelial
cells. Highly vascularised tissues such as lung and kidney have high
fibrinolytic activity. Aprotinin is one of several substances that were
investigated for their antifibrinolytic action. It is added to the
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adhesive to retard fibrinolysis. The dose provided is 3000 KlU/ml,
although other concentrations are also available.
Factor XIII and fibronectin. There is experimental evidence
that collagen and fibronectin are cross linked with fibrin in the
presence of Factor XHIa. This may explain some of the adhesive
qualities of Tisseel. The role of fibronectin is poorly understood,
but it has been found on the surface of fibroblasts. Tisseel contains
three times as much fibronectin as normal plasma.
Mixing
The substances in the Tisseel Kit are mixed to prepare two
components (Tisseel sealant and thrombin/calcium chloride) which
are then mixed at the time of application, rather like an epoxy
cement (Figure 4).
The four vials containing protein concentrate, aprotinin,
calcium chloride and the selected concentration of thrombin
(thrombin 500 for rapid solidification or thrombin 4 for slow
solidification) are initially warmed to 37°C. This is carried out by
placing them in a custom designed heating and stirring device
known as Fibrinotherm (Figure 2). Fibrinotherm is a thermablock
with a magnetic stirrer arranged to rotate a metal bar in the
protein concentrate vial. The vials reach 37°C in ten minutes.
Colour coded syringes are then used to transfer the aprotinin
solution to the lyophilised Tisseel vial and the calcium chloride
solution to the selected thrombin vial. The vial containing Tisseel
sealant is then stirred in the magnetic stirrer until clear, a process
that normally takes about five to ten minutes.
The time taken for preparation and mixing does not delay the
surgical procedure because it is carried out in an unsterile field by
the circulating nursing staff in the operating room. Once
reconstituted, the vials containing each of the two components are




For transfer to the sterile field, the circulating nurse holds
the sterile vials and the scrubbed nurse withdraws the two
component solutions, again using colour coded syringes.
The two components of fibrinogen adhesive can be applied in
a variety of ways. They can be applied sequentially, premixed or
simultaneously mixed from a double-syringe applicator known as a
Duploject (Figure 2). The Duploject system is widely used because
it is versatile, offering the advantages of single-handed operation,
thorough mixing and thin-layer application.
The adhesive can be delivered through needles, spray heads
or catheters according to specific need for the application. It is
possible to use the spraying catheter through the biopsy canal of an
endoscope and, in addition, special micro-application techniques
are possible.
For optimal benefits, users should adhere to a number of
technical details during application:
1. Tisseel should be fully mixed, dissolved and warmed
to 37°C.
2. The recipient surface should be as dry as possible.
3. The thrombin concentration should be adjusted for
the required clotting time. Thrombin 4 IU/ml
produces slow solidification and takes about
30-60 sees. Thrombin 500 IU/ml produces rapid
solidification and takes less than one second.
4. Tisseel is best applied as a thin film.
5. Mechanical stress should be avoided for at least
three minutes after application.
Once the two components are mixed, they form a viscous
solution with strong adhesive properties. This adheres to the
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tissues and then solidifies to form a white rubbery mass which gains
strength for two hours following application.
Combination with other materials
Biomaterials, such as Dacron patches, lyophilised dura, fascia,
muscle, vascular grafts, decalcified bone and hydroxyapatite, have
been used in conjunction with Tisseel to supplement its function or
to provide additional mechanical support316. Experiments testing
the interaction of Tisseel with a variety of collagen fleeces have
been carried out by Redl and Schlag316.
Antibiotics have been used in combination with Tisseel both
experimentally and clinically. The German literature has been
summarised by Redl and Schlag316. Drug release from the fibrin
clot is probably by simple diffusion and thus depends on the
concentration gradient between the clot and the surrounding
tissues. It is unlikely that adequate local drug concentrations are
maintained for more than three days. It is advised that the total
dose of drug used should be less than the recommended maximal
daily systemic dose.
Tisseel does not have any known adverse interactions with
other substances.
Side effects and contraindications
There are no known specific side effects or contraindications
for the use of Tisseel. For obvious reasons Tisseel must not be
administered intra-vascularly. Alcohol and iodine may denature
Tisseel and these chemicals should be removed prior to the
application of the adhesive.
There are no recorded cases of hypersensitivity to Tisseel,
and in none of the numerous experimental studies that have been
undertaken with the material, has there been any evidence of an
unfavourable immunological response.
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Tisseel is manufactured from pooled plasma and the potential
problems arising from this are discussed in the following section
entitled 'Risk of disease transmission'.
Risk of disease transmission
As the Tisseel protein concentrate is made from pooled fresh
frozen human plasma there is concern that it is possible to transmit
disease with its use. Numerous safeguards are incorporated in the
production process.
Plasma donors are tested for HBs-antigenaemia, anti-HTLV
III, and alanine aminotransferase (ALT) levels each time they
donate. Positive donors are irrevocably excluded from the
plasmapheresis program. In addition Tisseel, once made, is
subjected to a product specific heat treatment, which has been
demonstrated to produce a decrease in HTLV III titre of 104 or
more infectious units per millilitre.
A randomised controlled study on the risk of hepatitis
transmission using Tisseel has been undertaken and preliminary
results are available101. None of the patients contracted hepatitis B
or non-A/non-B hepatitis. Although one can always argue that the
study group was not large enough and the follow up was not long
enough, it is a fact that there are no known cases of hepatitis which
have been caused by the surgical use of fibrinogen adhesive.
The risk of transmission of other viral diseases, and in
particular the risk of transmission of the Adult Immune Deficiency
Syndrome (AIDS) virus appears to be either extremely low or non
existent. There are no known clinical cases, despite the
widespread use of fibrinogen adhesives in the years before stringent
precautions were taken with blood products and in areas where
AIDS was endemic. It is generally believed that the mechanism of
transmission for the AIDS virus parallels that of the hepatitis virus
and thus the above mentioned study101 is reassuring. In a
randomised clinical trial, in which Tisseel was used on 333
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patients undergoing re-sternotomy or re-operation after cardiac
operations, in the United States323, there were no adverse
reactions, no transmission of hepatitis B or non-A/non-B hepatitis,
and no human immunodeficiency virus seroconversion. This is the
only study that has specifically looked at the incidence of human
immunodeficiency virus seroconversion in patients that have been
exposed to fibrinogen adhesive. It is presumed that the stringent
testing of plasma donors now in place will completely eradicate the
possibility of AIDS virus transmission through the use of Tisseel.
Detection in the tissues
At the time of application, it is easy to see clotted Tisseel in
the tissues because of its opaque white appearance. If it is
necessary to observe the unclotted solution as it is being delivered,
disulphine blue dye can be added316.
For radiographic detection it is possible to add contrast
media316. Metrizamide is probably the best available but
unfortunately it causes some depression of fibrin alpha chain cross
linking.
Histologically Tisseel is easily seen using haematoxylin and
eosin stain or trichrome stain. Differentiation between Tisseel and
endogenous fibrin requires some experience. The difference is
that Tisseel does not react as well as endogenous fibrin, perhaps
due to the thicker network of fibrin strands in Tisseel.
Immunoperoxidase techniques and Malloiy's phosphotungstic
method have both proved to be useful in animal experiments316.
Cost
At the time of writing the current cost of a 0.5 millilitre
Tisseel Kit 1.0 is $50.00 CAD. There is no capital cost outlay. The
Fibrinotherm is provided on loan by the company to Canadian
institutions using Tisseel sealant.
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This cost can be compared to the cost of microsurgical
sutures. At the present time one Davis and Geek 10-0 dermalon
microsuture on a 100 micron needle costs $21.07 CAD. and one
Ethicon 10-0 ethilon microsuture on a 100 micron needle costs
$21.20 CAD.
SURGICAL APPLICATION OF FIBRIN SEALANT




3. Improved wound healing.
Surgeons in various different specialties have used fibrin
sealant for many different purposes. Almost all the papers are
published in the German literature but Redl, Schlag and Dinges314
have summarised much of their content.
In abdominal surgery, fibrin sealant has been used for
haemostasis, particularly in cases of rupture of the liver or spleen.
It has also been used in the surgery of pancreatic fistulas, and as
reinforcement for sutured gastric and colonic anastomoses.
In thoracic surgery, fibrin sealant has been used in the
management of idiopathic pneumothorax and for making airtight
seals after partial pneumonectomy.
In cardiovascular surgery, fibrin sealant has been used for
sealing Dacron grafts and for a number of different functions during
aorto-coronary by-pass surgery, where it is particularly useful when
the patient is on extracorporeal circulation.
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In plastic surgery, fibrin sealant has been used for anchoring
skin grafts and in conjunction with morcellised cancellous bone
graft in maxillofacial reconstruction.
In neurosurgery, fibrin sealant has been used to augment
anastomoses in extra-intracranial bypass procedures. In addition, it
has been used to seal dural tears.
In orthopaedics and traumatology, fibrin sealant has been
used in conjunction with morcellised cancellous bone graft for
packing bone cavities, and in the management of epiphyseal
injuries149. It has also been used to reduce haemorrhage in
haemophiliac patients undergoing resection of pseudotumours.
Peripheral nerve repairs and nerve grafting have been quite
successfully carried out using fibrin sealant's adhesive qualities.
In ear, nose and throat surgery, fibrin sealant has been used
to reduce haemorrhage in tonsillectomies and adenoid surgery in
patients with bleeding disorders. It has also been used to fix
middle ear bioprostheses316 and to solve other technical problems
in the surgery of the middle ear, maxillary sinuses and orbital floor.
In Dermatology, success has been reported in the use of fibrin
sealant for cases of crural ulcers.
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CHAPTER 4
Preliminary Study for the Development of a Technique for the Use
of Fibrinogen Adhesive in Microvascular Anastomoses
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INTRODUCTION
The characteristics of fibrinogen adhesive, presented in
Chapter 3, suggest that it offers several advantages over other
adhesives that have been used surgically, and its disadvantages
seem to be few and relatively unimportant. In fact, put up against
the criteria set out by Daniel and Terzis, fibrinogen adhesive
performs quite well. For this reason, it was considered worthwhile
to design and study a technique for the use of fibrinogen adhesive
in making microvascular anastomoses.
Chapter 4 begins with a review of previous papers on
fibrinogen adhesive microvascular anastomoses. The rest of the
chapter is devoted to the description of a preliminary study in the
development of a fibrinogen adhesive anastomotic technique. The
first part of the preliminary study is concerned with finding a
satisfactory anastomotic technique. The second part of the
preliminary study is involved with the preparation of a suitable
model for controlled testing of the newly developed technique.
PREVIOUS EXPERIENCE WITH ADHESIVE ANASTOMOSES
In Chapter 3 it was pointed out that a "natural adhesive" or
"fibrin suture" was used as far back as the 1940's370>42°. Its use for
peripheral nerve anastomoses is quite well established347, but,
apart from an interesting study looking at the use of fibrin tubes for
venous anastomoses365, its use for vascular end-to-end anastomoses
was not proposed till 1977243. Soon afterwards, the histological
healing process of experimental anastomoses using fibrin adhesives
was described94, and it was not long before a small clinical series of
arterial anastomoses was reported - eleven out of twelve
anastomoses remaining patent191.
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Reference to the German publications, concerning the use of
fibrinogen adhesives for microvascular anastomoses, is made in
Chapter 3 (see page 74). A small number of reports are also
published in the English language literature.
Some investigators have used fibrinogen adhesive to augment
previous described techniques such as conventional sutured
anastomoses13,192'299, and a coupling technique326.
Other investigators190 attempted to use fibrinogen adhesive
to seal end-to-end anastomoses approximated with only two
sutures, but the thrombosis rate was very high.
Wintermantel tried using a fibrinogen adhesive to augment
his experimental thermic vascular anastomoses412.
End-to-side and side-to-side anastomoses using fibrinogen
adhesive were described by Gestring, Lerner and Requena115.
Karl, Tilgner, and Heiner179 used a combination of end-in-
end technique with fibrinogen adhesive in a small and uncontrolled
study of end-in-end anastomoses. Fourteen day follow up
demonstrated patency in all ten femoral arteries but in only eight
out of ten femoral veins.
Brunner43 experimented with a fibrin-glued telescoping
anastomosis, made over a Fogarty embolectomy catheter.
A more recent Japanese study363 investigated the use of
'fibrin glue' as a method for saving time during the insertion of
venous interposition grafts. They demonstrated the technique to
be speedy, and anastomotic failure occurred in only one out of forty-
five rats. They also described a successful clinical case.
The English literature only contains brief mention of a single
microvascular free tissue transfer using fibrinogen adhesive358. In
this case, a cutaneous groin flap was transferred to the neck of a
twenty-one year old man for the release of a burn contracture. A





A preliminary study was initially carried out to examine and
develop different methods for making microvascular anastomoses.
The study was aimed at two main objectives:
1. To develop a new fibrinogen adhesive anastomotic
technique that offered potential advantages and was
not simply a fibrinogen adhesive supplement to a
conventional form of anastomosis.
2. To develop an experimental model that would be
satisfactory for a controlled clinical trial of the newly
designed fibrinogen adhesive anastomoses.
It was felt that the achievement of these aims was an
important first step prior to carrying out a prospective
experimental series comparing the new fibrinogen adhesive
anastomoses to the 'gold standard' of conventionally sutured
anastomoses.
Four main goals were set in order to achieve the two aims of
the preliminary study:
1. Familiarisation with the standard rat and rabbit
femoral artery and groin flap models.
2. Development of the new fibrinogen adhesive
anastomotic technique.
3. Development of a satisfactory groin flap model.
4. Completion of a small preliminary trial of the new
technique to ensure that it was feasible, that it
appeared to offer potential advantages over




The preliminary study was designed to be strictly
developmental. Although an outline plan was made prior to its
commencement, the study was not intended to be controlled,
statistically significant, or to follow a strict protocol.
The preliminary study (Figure 6) was made up of three
components: a rat study, a rabbit study and a preliminary trial.
Rat study. Initially six white laboratory rats underwent
microvascular anastomoses to each femoral artery. Four types of
anastomoses were made:
1. Sutured anastomoses with no fibrinogen adhesive.
2. Sutured anastomoses with fibrinogen adhesive.
3. Lauritzen sleeve anastomoses with no fibrinogen
adhesive.
4. End-in-end anastomoses with fibrinogen adhesive.
A total of twelve anastomoses were made and in each case
blood flow was checked intra-operatively with a patency test and a
spurt test. Animals were sacrificed at the end of the experimental
operations.
Rabbit study. After the rat study was completed, twelve young
New Zealand White rabbits were used to further study different
methods of making an end-in-end anastomosis. This was done to
try to find the most efficient way of making an end-in-end
anastomosis so that the best possible technique could be tested in
the experimental study. Several different methods were tried out
and, eventually, one method was selected as the best.
At the same time as the rabbits were being used to develop
and test the adhesive anastomoses, they were also used to work out











Figure 6. Diagrammatic representation of the course of the
preliminary study.
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1. Best size and shape for the flaps.
2. Safest anaesthetic technique.
3. Most useful follow up studies.
Early in the study, rabbits were only subjected to
microvascular femoral artery anastomosis. Later, rabbits underwent
groin flap transfer.
In rabbits used for microvascular anastomosis development,
blood flow was checked intra-operatively with a patency test and a
spurt test in a manner similar to that used in the rat sudy. The
same flow tests were used in rabbits that underwent groin flap
transfers, although, in addition, flap colour, capillary refill and
bleeding were also assessed in these animals.
Eight rabbits were sacrificed at the end of the experimental
operations. The remaining four were used for a preliminary trial.
Preliminary trial Four animals from the rabbit study were
followed for seven days in order to assess the patency of the new
adhesive anastomoses after post operative recovery and one week of
follow up.
Results
Development of a new adhesive technique
Rat study. Amongst the 12 anastomoses carried out in the 6
rats, the sutured anastomoses acted as a control, against which the
other techniques could be compared. A standard end-to-end front
wall interrupted suture technique was used. All the sutured
anastomoses were patent at the end of the operative procedure.
The addition of fibrinogen adhesive did not appear to add any
benefit to the sutured anastomoses.
Technical problems were encountered with the Lauritzen
sleeves. The sleeve technique could not be made to work in the rat
model despite Lauritzen's reported 100% success rate in rat
femoral arteries. All the failures appeared to be due to excessive
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intra-lumenal pressure which caused the anastomoses to leak, push
the sleeve into an unsleeved position and finally result in a blow-out
of the anastomosis. All femoral artery anastomoses blew-out at the
time of operation.
When end-in-end anastomoses were modified and
supplemented with the application of fibrinogen adhesive, all
anastomoses were successfully completed.
These results confirmed my previous impression that it was
difficult to reproduce Lauritzen's work with the sleeve technique.
The results also suggested that a modified end-in-end technique,
used in conjunction with fibrinogen adhesive, might produce a
dependable new technique that could compete with a conventional
sutured anastomoses.
Rabbit study. In the rabbits, the results of Lauritzen sleeve
anastomoses and the modified end-in-end anastomoses with
fibrinogen adhesive were similar to those in the rats. The plain
sleeves did not succeed whereas the modified adhesive end-in-end
anastomoses all remained patent in the short term. As more of the
new adhesive anastomoses were carried out, technical details were
improved and the final technique was developed.
It was decided that the new adhesive technique was
satisfactory, appeared to have advantages over other techniques
available, and should be tested in a full experimental study. Exact
details of the technique are described and illustrated on page 109.
A small number of sutured anastomoses in rabbits were made
at the beginning of the study. These were all successful, but it was
noted, with interest, that the adhesive anastomoses could be
completed in about half the time of the sutured anastomoses. A
standard end-to-end front wall interrupted suture technique was
used. It was decided to use this technique for the control in the
experimental study. Exact details of the technique are described
and illustrated on page 111.
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Preliminary trial. In each of the four rabbits followed for
seven days post-operatively, flaps remained completely viable and
patency tests were positive at the time of sacrifice. This suggested
that the new fibrinogen adhesive end-in-end anastomotic technique
was durable and confirmed the impression that the technique was
worth testing.
The experimental fibrinogen adhesive end-in-end
anastomosis and the control sutured end-to-end anastomosis are
illustrated in Figure 7.
Development of an experimental model
The experimental animal
Although the pilot study results indicated that there was no
difference in patency rates, it was decided that rabbits, rather than
rats, would be used in the experimental study. The main reasons
for this were:
1. Rabbits were more pleasant to work with.
2. Rabbit femoral arteries were thought to be more
similar to those encountered in human clinical
practice.
3. Larger flaps and larger vessels were available in the
rabbits on account of the animal's bigger size, and it
was hoped that this would reduce the number of
failures and result in better evaluation of the
anastomotic technique.
4. Anaesthetic technique was thought to be associated
with less peri-operative risk in the rabbits.
5. Rabbits were more reliable than rats from the point
of view of long term survival.
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Figure 7. The two types of microvascular anastomosis. Photographs
taken through the operating microscope using xl5
magnification,
A Adhesive anastomosis (Preliminary study rabbit).
B Sutured anastomosis (Preliminary study rabbit).
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Young New Zealand White rabbits were used as they were
available, clean, robust, healthy, and similar in size. The vascular
anatomy of the region of the inguinal ligament and proximal thigh
has been well described22'40. There is some variation in the
location and pattern of arterial branches and venous tributaries.
These are normally unimportant, although in a few cases they did
produce technical difficulty with the anastomoses (see page 170).
Peri-operative management
Rabbit general anaesthetic technique was well known to the
animal health technicians in the laboratory. They were less familiar
with techniques for lengthy anaesthesia, and advice was obtained
from the laboratory veterinarian. The twelve rabbits used in the
preliminary study enabled the laboratory staff to perfect their
anaesthetic technique. The four rabbits kept for seven post¬
operative days provided experience in the management of these
animals post-operatively.
General anaesthetic was used with an intramuscular injection
of Rompun (xylozene) 3 mg/kg and Ketamine 40 mg/kg for
induction. Maintenance of anaesthesia was achieved with a mixture
of 2.0 - 3.5% halothane and oxygen at 3 litres per minute delivered
through a Bains facemask. The percentage of halothane varied a
little both from animal to animal and also from time to time during
the operative procedure.
Intravenous fluids were used intra-operatively for some of the
initial operations but were soon discontinued as the operations
were not as lengthy as first expected, and operative fluid loss was
minimal.
The operating room arrangement is illustrated in Figure 8.
Post-operatively the rabbits were recovered overnight in
warm padded intensive care cages. The following day they were
returned to their regular holding cages. It was necessary to tape
light bandages circumferentially around the animals' abdomen in
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Figure 8. Photograph illustrating the operating room arrangement.
The rabbit (R24) is supine on the operating table and is
receiving anaesthetic through a Bains facemask. The
operating microscope is to the right of the picture and the
surgical instruments are on a side table.
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order to prevent the flaps from dragging along cage floors.
Dressings were inspected daily and changed as frequently as
necessary till the wounds were completely healed.
The rabbits had no problem returning to their normal diets in
the immediate post-operative period.
Post-operative infections were not seen and, thus, it was felt
that the administration of antibiotics would not be necessary for
wound healing.
Similarly, the animals did not appear to be in discomfort
post-operatively and so neither analgesics nor sedation were used.
Development of the experimental flap
Having used the femoral arteries for the development of the
anastomotic technique, it was a logical progression to consider the
use of the groin flap for the experimental model.
The anatomy of the rabbit groin is not unlike that of the
human. The femoral artery originates as a continuation of the
external iliac artery beneath the inguinal ligament and passes
through the anterior and medial aspect of the thigh on its route to
the popliteal fossa. In the femoral triangle it gives off a number of
branches including the epigastric artery, which supplies the skin of
the abdominal wall and supports the groin flap. Venous drainage
follows the arterial supply.
Rounded flaps were favoured over rectangular flaps in order
to avoid pointed corners at the margins. In the size of animals
used, it was found that elliptical flaps measuring 5cm x 7cm
seemed to be the best size to enable bilateral and symmetrical flaps
to be raised. These flaps were adequately sized for a free tissue
transfer model.
The main problem with this model was that the venous
anastomoses could not be considered representative of human
vascular repairs due to their very thin walls. There was concern
that these flimsy vessels might skew the results of the
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experimental study by lowering the patency rates, reflecting a
problem with the model rather than the anastomotic techniques.
To avoid this source of error, and to make the results easier to
interpret, it was decided to use the groin flap model with only an
arterial anastomosis, leaving the veins intact. All other structures
were divided and thus the flaps could be considered as being either
modified island flaps or modified free flaps, their form lying part¬
way between the two types of flap.
Follow up evaluation
During the preliminary study, thought was also given to the
best method for evaluation of the anastomoses post-operatively.
There was no doubt that flaps were useful as they provided a
method of day-to-day monitoring. The shaved skin of the white
rabbits was quite easy to subjectively evaluate for blood flow as it
clearly became pink in colour after the arterial clamps were
removed. Most of the flaps contained one or two nipples and these
were found to be particularly useful as their colour was easy to
assess, and they also visibly increased their turgor with the re-
establishment of blood flow.
At sacrifice it was initially planned to assess anastomotic
patency using a standard patency test4*11(150 (bearing in mind its
possible inaccuracies267), arteriography (with either renografin or
barium) and to make and study intra-lumenal latex casts178*383.
Concern was raised, however, that this might lead to difficulties
with the processing and interpretation of histological studies of the
vessel wall. For this reason, it was decided to substitute the
arteriography and intra-lumenal latex cast techniques with
scanning electron microscopy of the intra-lumenal surface of the
anastomoses. Several of the anastomoses in the preliminary study
were removed and used to establish satisfactory processing
techniques in the histology and scanning electron microscopy
laboratories. Exact technical details are described on page 128.
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THE EXPERIMENTAL TECHNIQUE WITH FIBRINOGEN ADHESIVE
The experimental fibrinogen adhesive anastomotic technique
is diagrammatically illustrated in Figure 9.
Using the magnification of a Zeiss operating microscope, the
femoral vessel was clamped and divided in a microvascular double
approximating clamp. The cut ends of the femoral vessel were
then approximated without tension and cleaned of peri-adventitial
tissue. Care was taken to ensure that there was adequate vessel
length for the anastomosis and that there were no branches near
the cut vessel ends in a location that would interfere with the
smooth formation of an end-in-end anastomosis.
Two stay sutures of 10-0 dermalon (Davis and Geek) with
100 micron needles were inserted 180° apart, at 3 o'clock and
9 o'clock, in such a manner as to produce an end-in-end
anastomosis with one vessel passing into the other for a distance of
one to two diameters. The proximal end of the artery (up-stream
vessel) was inserted into the distal end (down-stream vessel). The
stay sutures were placed full thickness through the outer vessel
wall, but only partially (into the media but not the adventitial into
the inner vessel wall. The stay sutures were tightened and knotted.
To prevent loss of overlap in the back wall, due to retraction of the
outer (down-stream) vessel wall, a retracting suture was
temporarily placed full thickness through the free edge of the back
wall centrally (at 6 o'clock). The outer surface of the anastomosis
was then sealed with a film of adhesive (made up from a Tisseel
Kit 0.5, using Thrombin 500), applied using the Duploject system.
The completed anastomosis was left for three minutes, to allow the
adhesive to fully set, before the retracting suture was removed and
the microvascular clamps were released. The final anastomosis is
illustrated in Figure 7.
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Figure 9. Diagrammatic representation of the technique used to
make the adhesive end-in-end microvascular anastomosis. In
each diagram, the upstream (inner) vessel is on the right and
the downstream (outer) vessel is on the left.
A Insertion of the first stay suture at the 3 o'clock
position. Note that the suture passed partially
through the inner vessel wall and completely
through the outer vessel wall.
B Insertion of the second stay suture at the 9 o'clock
position.
C The temporary retracting suture was placed at the
6 o'clock position, but only into the outer vessel.
D After the inner vessel was placed into the outer
vessel, the outer surface of the anastomosis was
sealed with a film of fibrinogen adhesive applied
using the Duploject system.
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THE CONTROL TECHNIQUE WITH SUTURES
The control sutured end-to-end anastomotic technique is
diagrammatically illustrated in Figure 10.
In a manner similar to the experimental side, using the
magnification of a Zeiss operating microscope, the femoral vessel
was clamped and divided in a microvascular double approximating
clamp. The cut ends of the femoral vessel were then approximated
without tension and cleaned of peri-adventitial tissue. Care was
taken to ensure that there was adequate vessel length for the
anastomosis and that there were no branches near the cut vessel
ends, in a location that would interfere the suture anastomosis.
Interrupted 10-0 dermalon sutures on a 100 micron needle
were inserted and tied using a standard front wall technique. Two
sutures were initially placed 180° apart at 3 o'clock and 9 o'clock.
Next a central suture was inserted at 12 o'clock. The gaps between
were then sutured, usually with one suture per gap. The double
approximator clamp was then rotated to present the back wall. A
central suture was placed at the 6 o'clock position and, similar to
the front wall, the gaps between the 6 o'clock and the lateral
3 o'clock and 9 o'clock sutures were sutured closed. Eight to ten
sutures were usually needed for each femoral vessel. Finally, flow
was re-established with release of the microvascular clamps in a
manner identical to the experimental side. The final anastomosis is
illustrated in Figure 7.
THE RABBIT GROIN FLAP EXPERIMENTAL MODEL
Rabbits were placed supine on the operating table with their




Figure 10. Diagrammatic representation of the technique used to
make the sutured end-to-end microvascular anastomosis.
A Insertion of the first stay suture at the 3 o'clock
position.
B Insertion of the second stay suture at the 9 o'clock
position.
C Insertion of the central suture at the 12 o'clock
position.
D Sutures were inserted to close the gaps between
the 3 o'clock and 12 o'clock and the 12 o'clock
and 6 o'clock sutures. After the front wall was
completed, the microvascular clamp was rotated
and steps C anc D were repeated for the back wall.
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A bilateral groin flap model was designed with one side
experimental and the other side control. The model is illustrated
in Figure 11.
Using an elliptical template, 5cm x 7cm flaps were drawn out
on the abdomen, symmetrically and with reference to the mid line
and the mid points of the inguinal ligaments as illustrated in
Figure 12. Flaps were marked into six segments in order to
facilitate wound closure, and to aid in the identification of potential
zones of failure. One segment was blacked in to aid orientation
during wound closure so as to prevent malrotation and torsion of
the vascular pedicle. Surgical antisepsis was achieved with
Betadine solution and then all but the operative field was covered
with sterile drapes.
Initially the lower part of the flap was raised and the femoral
vessels located distally. These were then mobilized from the
inguinal ligament proximally to a point beyond the origin of the
epigastric vessels distally. Care was taken to avoid any excess tissue
handling in the region of the epigastric pedicle. The femoral
vessels were ligated and divided distal to their epigastric branches.
The femoral vein was then separated from the femoral artery for
1.0 to 1.5 centimetres between the inguinal ligament and the
inferior epigastric vessels. Branches were cauterised with bipolar
cautery.
Next the remainder of the flap was raised from the lower
abdominal wall, starting proximally and taking care to remain deep
to the inferior epigastric vascular pedicle. The groin flap was now
an island flap based on the femoral vessels and epigastic pedicle.
The flap is diagrammatically illustrated in Figure 13.
A double approximating microvascular clamp was next
applied proximal to the inferior epigastric pedicle, and the
clamped femoral artery was divided. The microvascular
anastomosis was then made, the clamp released, and flow re¬





Figure 11. Diagrammatic representation of the experimental
animal. The groin flap on the experimental side was
revascularised using a fibrinogen adhesive anastomosis, whilst




Figure 12. The experimental and control flaps. Prior to starting
the operation, a plastic template was used to draw the
experimental and control flaps on the rabbit's abdomen, using
the pubic symphysis and anterior superior iliac spines for
bony landmarks. The grid was used as an aid in wound
closure and for harvesting skin biopsies. The blacked in
segment helped to prevent flap rotation at the time of wound
closure (R42).
Note the nipples in the flaps. These were useful in









Figure 13. Diagrammatic representation of the rabbit groin flap
experimental model. The flap was supported by the axially
orientated epigastic vessels and was revascularised with a
femoral artery anastomosis.
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pedicle. After a few minutes a patency test was carried out to
ensure that there was flow across the anastomosis. The flap was
then sutured into its original location, using 3-0 silk sutures. The




Experimental Study Comparing Fibrinogen Adhesive Technique
with Conventional Sutured Anastomosis Technique
1 1 8
INTRODUCTION
Although there have been a small number of previous
publications concerned with the use of fibrinogen adhesive for
making microvascular anastomoses, the experiments and clinical
cases described have been uncontrolled, and the numbers have not
been large enough to consider that a satisfactory trial has yet been
undertaken.
Chapter 5 describes a large and controlled experimental
study aimed at comparing the new fibrinogen adhesive technique,
described in Chapter 4, with a conventional suture technique, the
gold standard of microvascular anastomosis. The chapter is set out
in the conventional manner associated with the publication of
scientific papers: an introduction (in this case listing the basic
concepts behind the experimental design), materials and methods,
results, discussion and conclusions.
BASIC CONCEPTS
A number of basic concepts were considered to be important
to the experimental study, and these were incorporated into its
design:
1. Once started, the series had to be continued as a
consecutive and prospective study.
2. The experiment had to be tightly controlled. In the
chosen design each animal was similar in strain, size
and sex, and each acted as its own control.
3. The number of anastomoses studied had to be
sufficiently large to provide statistically significant
results.
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4. The number of parameters examined and measured
for each anastomoses had to be as large and varied as
possible in order to fully evaluate the outcome for
each anastomosis.
5. Potential problems had to be anticipated and
precautions taken to minimise bias in the results.
MATERIALS AND METHODS
General plan
The overall plan of the experiment is illustrated in Figure 14.
Young adult female New Zealand White rabbits, weighing
approximately 2.5 - 3.0 kg, were used for the experimental model.
Each animal underwent bilateral microvascular flap transfers,
on the experimental side with a fibrinogen adhesive end-in-end
anastomosis and on the control side with a sutured end-to-end
anastomosis. This produced a controlled, consecutive, prospective
series of one hundred flaps in fifty rabbits. Individual animals were
easily identified by sequential numbers tattooed on the inner aspect
of their ears.
Animals were divided into three follow up groups according
to the length of follow-up:
Specific identification for the rabbits in each group is
documented in Table 2.
At the end of the follow up period, the rabbits were given an











































Figure 14. Diagrammatic representation of the experimental study
illustrating details of the experimental plan, the tests carried
out at the time of sacrifice and the type of laboratory
investigations used to examine the flaps and anastomoses.
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TABLE 2. Specific rabbit identification numbers for each of the
three experimental groups.
1 day follow up
R4 R5 R6 R7 R16
R17 R30 R31 R32 R33
7 day follow up
R8 R9 RIO Rll R12
R13 R14 R15 R28 R29
21 day follow up
R18 R19 R20 R21 R22
R23 R24 R25 R26 R27
R34 R35 R36 R37 R38
R39 R40 R41 R42 R43
R44 R45 R46 R47 R48
R49 R50 R51 R52 R53
Substitutions for intra-operative failure
R14 with 114
R39 with 139 and 139 with 239
R46 with 146
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skin biopsies taken, the anastomoses were re-explored and patency
tests repeated. This done, the rabbits were sacrificed and the
anastomoses were harvested and prepared for histological
examination and scanning electron microscopy studies.
A number of potential sources of error were anticipated prior
to commencement of the study. These were handled as follows:
1. In order to eliminate potential errors arising from
variation in surgical expertise, all operations were carried out by a
single, experienced microvascular surgeon (myself).
2. In order to eliminate any bias of side or order, a
convention was established for deciding which flap (left or right:
first or second) would have a sutured anastomosis and which would
have a fibrinogen adhesive anastomosis. The left flap was always
done first and the type of anastomosis was determined by referring
to a computer generated table of random numbers (Table 3). An
even number indicated that the left (first) flap would have a
fibrinogen adhesive anastomosis, whereas an odd number indicated
that the left (first) flap would have a sutured anastomosis. The
specific matching of experimental animals to random numbers is
shown in Table 4.
3. In order to minimise my own 'learning curve' error,
the consecutive series was not started till I felt satisfied that my
technical ability to carry out the new fibrinogen adhesive
anastomosis equalled my ability to complete a conventional suture
anastomosis (hence the false start and the matching of the first
rabbit - R5 - with the random number 1470).
Anaesthetic
The anaesthetic technique used was identical to that
described in Chapter 4 for the rabbit groin flap experimental model
(see page 105).
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TABLE 3. Table of random numbers used to determine whether
the arterial anastomosis for the left (first) flap would be made
using suture technique or the fibrinogen adhesive technique.
14 99 461 513
814 842 850 922
934 1041 1176 1370
1470 1560 1608 1769
1789 1848 1904 1906
1924 1992 2040 2051
2136 2257 2388 2410
2724 2878 2897 3246
3279 3333 3484 3494
3547 3570 3635 3736
3901 3926 3928 4269
4322 4347 4402 4500
4545 4752 4934 5027
5076 5118 5170 5216
5346 5508 5537 5559
5670 5894 5914 6050
6094 6321 6462 6474
6479 6605 6675 6806
7059 7072 7178 7223
7310 7416 7424 7452
7455 7559 7718 7995
8138 8139 8191 8320
8404 8431 8478 8723
8869 8932 8940 8961
9016 9383 9697 9811
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TABLE 4. The manner in which the consecutive and prospective
series of experimental rabbits were matched to the computer
























































The operative technique used was identical to that described
in Chapter 4 for the rabbit groin flap experimental model
(see page 111), the experimental fibrinogen adhesive anastomoses
(see page 109) and the control sutured anastomoses (see
page 111). Pre-operative markings, drawn around the plastic
template, ensured that flap size and location was always the same,
and segmental grids were drawn on as a technical aid (Figure 12).
Both experimental and control sides were operated on
immediately consecutively as a single operative procedure. A clock
was started at the beginning of the operation, and the times of key
events, such as skin incision, start and finish of microvascular
anastomoses, and skin closure were recorded. Specific technical
details concerning each procedure were also noted. The collection
of this information, together with the maintenance of post¬
operative progress notes, ensured that complete and individual
records were available for each animal, operation, flap, and
anastomosis.
Intra-operative flap viability was checked by assessing the
cutaneous capillary refill and the degree of bleeding, after release of
the microvascular clamps. In addition, a venous outflow patency
test was used as a test of blood flow.
Sutured anastomoses that were thought to be unsatisfactory at
the time of operation were resected and replaced. It was not
possible to do this with fibrinogen adhesive anastomoses because of
constraints which were thought to be specific to the model and not
relevant to human clinical practice (see page 172). For this reason,
on the small number of occasions when fibrinogen adhesive
anastomoses were thought to be unsatisfactory at the time of
operation, operations were abandoned and the animal was replaced.
In this manner, all animals admitted to the study were good
working models containing functioning experimental and control
anastomoses. This protocol ensured that the models started out on
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an equal basis and was felt to be acceptable because it represented
the clinical principle that unsatisfactory anastomoses must be
either revised or replaced. In order to ensure that this protocol
did not bias results in favour of the adhesive anastomoses, a record
of intra-operative technical failures was kept, and is reported in the
results section (see page 134).
Post-operative management
The post-operative management was identical to that
described in Chapter 4 for the rabbit groin flap experimental model
(see page 105).
Intravenous fluid was not given post-operatively, and rabbits
returned to their normal diet immediately after recovering from
their anaesthetic.
The flaps were inspected daily and dressings were changed
according to clinical need until the wounds were healed, at which
time dressings were discontinued. Close attention was paid to
wound healing and appropriate nursing and/or surgical measures
were taken in the small number of cases where this proved to be
necessary.
Antibiotics were not used routinely but in cases where there
were clinical problems with wound healing (partial or complete flap
necrosis), tribrissen 24% was administered subcutaneously in a
single dose of 30 mg/kg/day till the problem was resolved.
Analysis of results
Technical data, gathered at the time of each operation,
included the animal's weight, external diameter of femoral arteries,
total operating time for each flap, and time taken to complete each
anastomosis (experimental and control). Notes were made of
technical differences (both positive and negative) between the two
techniques. Intra-operative complications were recorded. Intra¬
operative flow tests were carried out both at the distal side of the
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arterial anastomosis and through the draining femoral vein. In
addition, at the end of each operation, flap bleeding was noted, and
flap colour and capillary refill recorded.
Daily clinical observations of flap viability and fur growth were
recorded in the clinical chart of each individual animal.
On the day of sacrifice (either 1 day, 7 days or 21 days) each
animal was again given a general anaesthetic using the same
technique used for the original operative procedures. Flaps where
photographed (Figure 15), and objective studies of flap survival and
anastomotic patency were then undertaken.
Skin biopsies were taken from both the distal (cranio lateral)
and proximal (caudo medial) end of each flap. Biopsies were cut
full thickness through skin and subcutaneous tissues and measured
approximately 2.0 mm x 2.0 mm. They were immediately placed in
a solution of gluteraldehyde 5% in 0.2M s-collidine buffer. Skin
biopsy sites were checked for bleeding, and this was photographed
(Figure 16).
Experimental and control flaps were then dissected from the
abdominal wall and the epigastric vascular pedicles carefully
removed from surrounding scar tissue. With the flaps now isolated
as islands on their intact vascular pedicles (Figure 16), circulation
was again checked by looking at the bleeding from skin biopsy sites
and capillary refill. A venous outflow patency test was next carried
out and this was followed by a spurt test produced by transecting
the epigastric arteries distal to the anastomoses. Animals were
then sacrificed with an overdose of sodium pentothal.
The anastomotic sites were rapidly fixed with a solution of
gluteraldehyde 5% in 0.2M s-collidine buffer, and removed en bloc.
Using the operating microscope, the artery was dissected from the
adjacent vein and surrounding scar tissue. Arteries were then
divided longitudinally, from proximal to distal, and split into two
halves. A small suture was placed in the proximal end of each to
mark the direction of flow. The lumenal surface of each half artery
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Figure 15. Photographs demonstrating the appearance of flaps at
the time of sacrifice.
A Flaps at 1 day (R30).
B Flaps at 7 days (R29).
C Flaps at 21 days (R24).
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Figure 16. Photographs of flaps at the time of sacrifice.
A Shaved flaps at 7 days demonstrating skin biopsy
sites (R8).
B The flaps have been isolated as islands on their
vascular pedicles. The venous outflow patency test
and spurt test were about to be carried out (R28).
130
was gently flushed with normal saline solution to remove any freshly
formed blood clot, but care was taken not to wash away any mural
thrombus formation. Specimens were then placed into a solution of
5% glutaraldehyde in 0.2M s-collidine buffer.
All specimens (skin biopsies and arterial sections) were
stored at 4°C until processed in the histology laboratory.
Processing consisted of:
1. Samples were washed with 0.2 M s-collidine buffer
pH 7.3 (using 3-4 changes of Buffer over a minimum
of three days).
2. The material was then postfixed with 1% osmium
tetroxide in freshly prepared sodium bicarbonate
buffer for one hour at room temperature.
3. The samples were rinsed quickly with distilled
water and then,
4. dehydrated in a graded series of ethanol 50%, 70%,
95%, 100%, 100% for one hour each.
5. This was followed by substitution to amyl acetate,
placing the samples first in a mixture of one part
amyl acetate to three parts ethenol for 30 minutes,
then in a mixture of one part amyl acetate to one
part ethenol for 30 minutes, then into pure amyl
acetate.
Arterial sections, to be processed for scanning electron
microscopy, were stored at room temperature in amyl acetate until
they could be critical point dried, mounted on studs and gold
coated for viewing in a Philips SEM 505 scanning electron
microscope.
The other half of each fixed artery sample was imbedded in
methyl methacrylate and then cut to 1.0 to 1.5 microns. These
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were then stained with haemotoxylin and eosin and toluidine blue
for light microscopic examination.
Skin biopsy specimens were also imbedded in methyl
methacrylate, cut to 1.0 to 1.5 microns, and stained with
haemotoxylin and eosin and toluidine blue for light microscopic
examination.
Details of composition of solutions used in the histology
laboratory are listed in Table 5.
RESULTS
General results
The experiment used fifty-four young adult female New
Zealand White rabbits weighing between 1.25 and 3.75 kg (mean
weight 2.06 kg). The four extra rabbits were used to replace cases
where fibrinogen adhesive anastomoses failed intra-operatively
(R14 replaced by 114; R46 replaced by 146; R39 replaced by 139,
which was again replaced by 239).
Four rabbits (all in the 21 day group) did not complete their
follow up period due to non-microsurgical post-operative
complications. Three had severe wound infections (R18; R45;
239), and one suffered an unexpected cage death (R49). There
were no other post operative problems.
Femoral artery diameter
There was some variation in femoral artery diameter amongst
the different animals. On the sutured side, femoral artery diameter
varied from 1.0 to 1.8 mm (mean diameter 1.2 mm), whilst on the
adhesive side, femoral artery diameter varied from 1.0 to 1.8 mm
(mean diameter 1.2 mm). Statistically, these differences in femoral
artery diameter were not significant (paired t value 0.544, DF 48,
NS).
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• 2.5% NaHCC>3 adjust pH to 7.2 - 7.4 just before using with
IN HC1.
s-collidine buffer (0.2M)
• 2.67 ml pure s-collidine (2-4-6 trimethyl pyridine).
• 50 ml distilled water.
• approximately 9 ml IN HC1.
Adjust pH to 7.2 - 7.4 withlN HC1 and dilute to 100 ml with
distilled water (this makes a stock buffer that is stable for storage
under refrigeration).
Fixatives:
5% gluteraldehvde in 0.2M s-collidine buffer
•20 ml of 25% solution of gluteraldehyde, bring volume up to
100ml with stock 0.2M s-collidine buffer.
1% osmium tetroxide in sodium bicarbonate buffer
• one part stock 4% osmium tetroxide in water (1 gm OsC>4 in
25 ml water).
• one part distilled water.
• two parts 2.5% sodium bicarbonate buffer.
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Intra-operative technical failures
Four of the sutured anastomoses were not considered to be
acceptable at the time of operation. These were resected and
replaced. Three of these (R43; R50; R51) went on to a successful
outcome, whilst the fourth (R49) appeared to be successful,
although this could not be confirmed completely as the animal
died, unexpectedly, in the cage before the completion of follow up.
Three of the fibrinogen adhesive anastomoses were not
considered to be acceptable at the time of operation. These models
were replaced with new animals. Two of these (114; 146) went on
to a successful outcome, whilst the third (239) became infected,
and was sacrificed before the completion of follow up.
Anastomotic speed
The time taken to complete a sutured anastomosis varied
from 15 to 37 mins (mean time 21.1 mins), whereas the time
taken to complete an adhesive anastomosis varied from 11 to 22
mins (mean time 14.7 mins).
Statistically, the time taken to complete fibrinogen adhesive
anastomoses was significantly less than for sutured anastomoses
(paired t value 8.864, DF 46, p<0.0005).
Total operating time for flaps with a sutured anastomosis
varied from 36 to 60 mins (mean 46.9 mins), whereas total
operating time for flaps with a fibrinogen adhesive anastomosis
varied from 32 to 51 mins (mean 41.4 mins).
Statistically, total operating time for flaps with fibrinogen
adhesive anastomoses was significantly less than for flaps with
sutured anastomoses (paired t value 4.979, DF 46, p<0.0005).
Flap survival
Individual results of the 1 day follow up group are listed in
Table 6. On the sutured anastomoses side, 10/10 flaps survived
134
TABLE 6. Individual results of the 1 day follow up group.









Unilateral problems - suture anastomosis:
R17 partially thrombosed anastomosis - flap survival
Unilateral problems - fibrinogen adhesive anastomosis:
R5 completely thrombosed anastomosis - partial flap
necrosis (primarily venous flow failure)
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TABLE 7. Individual results of the 7 day follow up group.
No problem either side:
R8 R9 RIO Rll
R12 R13 R15 R28
R29
Unilateral problems - fibrinogen adhesive anastomosis:
R14 intra-operative failure - successful revision with 114
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TABLE 8. Individual results of the 21 day follow up group.
(Underlining indicates failure to complete follow-up)
No problem either side:
R19 R20 R22 R23
R24 R26 R27 R35
R36 R37 R38 R40





Unilateral problems - suture anastomosis:
R43 intra-operative failure - successful revision
R50 intra-operative failure - successful revision
R51 intra-operative failure - successful revision
R49 intra-operative failure - successful revision - cage death
R47 partially thrombosed anastomosis - flap survival
Unilateral problems - fibrinogen adhesive anastomosis:
R46 intra-operative failure - successful revision with 146
R39 intra-operative failure - revision with 239 - infected
R41 anastomosis partially unsleeved - flap survival
R25 partially thrombosed anastomosis - flap survival
R21 completely thrombosed anastomosis - partial flap
necrosis
R34 completely thrombosed anastomosis - complete flap
necrosis
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completely, whereas on the fibrinogen adhesive anastomoses side
1/10 flaps (R5) underwent partial necrosis.
Individual results of the 7 day follow up group are listed in
Table 7. On the sutured anastomoses side, 10/10 flaps survived
completely, and 10/10 flaps on the fibrinogen adhesive side also
survived completely.
Individual results of the 21 day follow up group are listed in
Table 8. Amongst the surviving animals in this group, 26/26 flaps
on the sutured anastomoses side survived completely, whereas on
the fibrinogen adhesive anastomoses side 1/26 flaps (R21)
underwent partial necrosis and 1/26 flaps (R34) underwent
complete necrosis.
Flap survival rates, after arterial anastomosis by each of the
two techniques, did not show a dramatic statistical difference
(paired t value 1.772, DF 45, p<0.05). The figures left the slight
discrepancy between the two techniques open to interpretation.
Certain technical factors about the experimental model were
thought to slightly favour results in the suture anastomosis group.
These factors are reviewed in the discussion section (see
page 170), and the flap survival rate data should probably be
interpreted as indicating that the two techniques did not differ.
Patency
In the 1 day follow up group, 9/10 sutured anastomoses were
completely patent, and 9/10 fibrinogen adhesive anastomoses were
completely patent.
In the 7 day follow up group, 10/10 sutured anastomoses
were completely patent, and 10/10 fibrinogen adhesive
anastomoses were completely patent.
In the 21 day follow up group, 25/26 sutured anastomoses
were completely patent, whereas 23/26 fibrinogen adhesive
anastomoses were completely patent.
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Statistically, there was no significant difference between the
patency rates of the two techniques (paired t value 1.354, DF 45,
NS).
Technical findings
During the course of the experiment, as experience was
gained with the adhesive anastomosis, a number of technical
factors, that were important to the success of the adhesive
anastomosis, became apparent.
Application of the microvascular clamps
It was important that the double approximating clamp was
not applied too close to the cut vessel ends. If clamps were too
close, when they were removed they lifted the glue away from the
entrance to the sleeve, and this caused high pressure blood to leak
out with the possibility of blowing the anastomosis apart.
Construction of the end-in-end anastomosis
The length of overlap in the sleeve was important. This was
realised in the preliminary study and its importance became quite
clear in the experimental study. A one diameter length of overlap
was just satisfactory, but two diameters seemed safer.
End-in-end anastomoses should not be formed close to either
branches or cauterised/clipped branch stumps. These posed little
or no problem to sutured anastomoses, but for end-in-end
anastomoses they could cause a number of things to go wrong:
1. A branch stump could be drawn into the anastomosis
as the sleeve was being formed. This could produce a separation of
the inner and outer walls and allow adhesive to flow into the lumen.
2. A branch stump could prevent the sleeve from being
overlapped sufficiently, by getting caught up at the opening. This
produced a short sleeve and, in consequence, it could either
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increase the risk of the anastomosis being blown apart or increase
the risk of allowing adhesive to flow into the lumen.
3. A branch stump could cause a poor interface
between the adhesive and the outer margin of the sleeve,
increasing the risk of an anastomotic blow out.
It was important to place the three stay sutures as evenly as
possible, in order to be able to apply balanced tension to the
anastomosis during application of the adhesive. Tension applied
through the 180° apart stay sutures corrected any tendency for the
inner vessel to fold and increase the risk of adhesive flow into the
lumen. At the same time that tension was applied to these two stay
sutures, they could also be used to lift the anastomosis away from
the surgical background material, thus improving adhesive coverage
of the back wall. The back wall stay suture was important for
ensuring that the back wall of the sleeve was well overlapped prior
to the application of adhesive.
Application of the adhesive
A number of technical observations were made concerning
the preparation and application of the fibrinogen adhesive:
1. It was essential to be meticulous in preparing the
adhesive. This was not a difficult process but failure to pay
attention to details in the manufacturers instructions could cause
problems. It was particularly important to avoid the presence of
bubbles in Duploject syringes. Bubbles resulted in uneven mixing
and this could produce adhesive-free zones on the anastomotic wall
with subsequent anastomotic leakage or even blow-out.
2. It was important to ensure that the back wall was
adequately covered with adhesive. The technique to do this
involved careful manipulation of the stay sutures while the adhesive
was applied. Initially the surgeon dried the anastomosis whilst the
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assistant prepared the Duploject syringe. Once ready to apply the
adhesive, the surgeon, using fine forceps, held a side suture with
one hand and the back wall suture with the other hand. The
assistant held the other side suture in her non dominant hand and
the Duploject in her dominant hand. The surgeon then rotated the
vessel so that the back wall was visible, and the assistant started to
slowly apply the adhesive. During the application, the surgeon
rotated the vessel so that the assistant could continue to evenly
apply the adhesive until the anastomosis was completely, uniformly
and circumferentially covered. With a little practice this could be
smoothly achieved in a single straightforward movement. It was
essential to check the back wall of the anastomosis prior to
application of the adhesive, as on a few occasions the inner vessel
had, unnoticed, become unsleeved.
3. It was important to ensure that the anastomosis was
uniformly covered with adhesive, both circumferentially and
longitudinally for about two to three diameters proximally and
distally. The outer surface of the anastomosis had to be as dry as
possible to obtain an optimal interface with the fibrinogen adhesive.
It was necessary to drop the adhesive from a height of one to two
centimetres in order to produce a homogeneous mix. This
technique also minimised the risk of potential problems arising
from contact between either the anastomosis or the adhesive seal
and the metal cannula of the Duploject. It was necessary to leave
anastomoses a full three minutes, for cross linking to occur
between the fibrin gamma chain and the gamma-gamma dimer,
prior to releasing the microvascular clamps. Where possible,
clamps should be placed distant to the anastomosis to avoid them
becoming covered in adhesive and attached to the anastomosis. In
the small operative field in this experimental model, this problem
could not always be avoided, but if the adhesive was gently teased
away from the clamp prior to removal, difficulties could be avoided.
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It was essential to always remove the downstream clamp before the
upstream clamp.
4. If an anastomosis had not obtained circumferential
coverage with adhesive, or if the thickness of the adhesive layer was
insufficient, leaks could occur when the clamps were released. In
this situation a second application of adhesive to the weak area,
prior to clamp release, successfully rectified the problem. If a leak
occurred as the clamps were being removed, the application of
gentle pressure, re-application of the clamp, and a further
application of adhesive rectified the problem.
Subjective findings
An important subjective observation was that the adhesive
technique was technically much easier to carry out than suturing,
and also demanded less expertise and concentration from the
surgeon.
Skin biopsies
The histological appearance of the skin biopsies exactly
matched the clinical observations of flap appearance. Figure 17
illustrates the histological appearance of typical biopsies taken from
areas where the skin was either clinically viable or not clinically
viable. The main difference in the two sections is the global
evidence of cell death in the biopsy from the non viable flap. There
was no spectral variability of cell death. All specimens were either
viable or non viable. Viability was always predictable from clinical
observations, and the histological appearance of the skin biopsies
did not provide any additional information.
Gross appearance of anastomoses
Figure 18 demonstrates typical features of the gross




Figure 17. Photomicrographs of skin biopsy histological sections.
A Live skin (x31) demonstrating hair follicles and
viable cells (R15).
B Dead skin (x31) demonstrating the absence of hair
follicles and global cell death (R14).
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Figure 18. Gross appearance of anastomoses at the time of
sacrifice, shown to illustrate the sectioning of the
anastomoses. Note the marking sutures, placed upstream to
the anastomoses, to record the direction of flow.
Photographs were taken through the operating microscope at
xlO magnification.
A Fibrinogen adhesive anastomosis at day 7 (R13).
B Sutured anastomosis at day 7 (R12).
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Most of the anastomoses were patent, and in those arteries,
once the freshly formed clot had been gently washed away, it was
possible to identify and observe the anastomotic region. In the
small number of partly and completely thrombosed anastomoses,
the lumen was filled with a plug of blotchy dark red/greyish
thrombus, and it was difficult to see exactly where the anastomosis
was located, particularly in the twenty-one day specimens. There
were not enough failures to comment on similarities and
differences between the two types of anastomosis, but they did not
appear to differ greatly.
Sutured anastomoses
One day group. Patent anastomoses were easy to locate, and
the lumen contained minimal quantities of pinkish fibrinous
material adherent to the vessel wall at and around the anastomotic
site. The cut vessel ends were still sharply demarcated, but were
held together by the sutures, which were easily visible, and usually
appeared to be evenly spaced. Outside the vessel wall a small
amount of haematoma was frequently seen.
Seven day group. Patent anastomoses were still easy to locate.
There was little or no intraluminal debris. Sutures were still
visible, but the cut vessel ends appeared to be blending together
with some tissue adhesion. Little or no extra-mural haematoma was
visible, and scar was beginning to form.
Twenty-one day group. It was much harder to find the exact
location of the anastomoses, although this could usually be located
from the position of extra-mural parts of the sutures. The lumen
was clear of debris, and sutures were difficult to see on the lumenal
surface. The cut vessel ends were firmly adherent with scar, which
was also abundant outside the anastomoses.
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Fibrinogen adhesive anastomoses
One day group. Patent anastomoses were easy to locate, and
the lumen contained a small amount of pinkish, fibrinous material
adherent to the vessel wall at and around the inner margin of the
sleeve. This intra-lumenal material did not appear to differ from
that seen in the sutured anastomoses. The sleeves were easily
visible, and, although there was some adhesion between the inner
and outer walls, they were not firmly adherent. Anastomoses
seemed to be held together by the stay sutures and the white
fibrinous material (presumably the fibrinogen adhesive) outside the
anastomoses. There was no evidence that any stay suture had been
placed into the lumen. Some haematoma was usually present
around the outside of the anastomosis.
Seven day group. Patent anastomoses were still easy to locate.
There was little or no intra-lumenal debris. The inner and outer
layers of the sleeves were still clearly visible, although they were
becoming more adherent. The inner margin of the sleeves was still
quite well demarcated. Stay sutures could still be located and there
was no evidence of intra-lumenal insertion of any stay sutures.
Fibrinogen adhesive was no longer visible outside the anastomosis,
where scar was beginning to form.
Twenty-one day group. It was much harder to find the exact
location of the anastomoses, although they could still be located
because of the extra-mural parts of the stay sutures. The lumen was
clear of debris, and the inner margin of the sleeves was usually only
visible by a smooth transverse irregularity in the lumenal surface.
The two walls of the sleeves were usually firmly adherent with scar,
which was also abundant outside the anastomoses.
Histology of anastomoses
Histological sections of both experimental adhesive and
control sutured anastomoses are illustrated in Figure 19 (1 day),
Figure 20 (7 day) and Figure 21 (21 day).
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Figure 19. Photomicrographs of the two types of anastomosis at
1 day.
A Sutured anastomosis (x31).
B Adhesive anastomosis (x31).
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Figure 20. Photomicrographs of the two types of anastomosis at
7 days.
A Sutured anastomosis (x50).
B Adhesive anastomosis (x50).
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Figure 21. Photomicrographs of the two types of anastomosis at
21 days.
A Sutured anastomosis (x50).
B Adhesive anastomosis (x50).
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Sutured anastomoses
One day group. Figure 22 illustrates details of a typical
sutured anastomosis at 1 day.
The lumen was dilated in some of the specimens. At the site
of anastomosis suture material was visible in many of the
specimens, and the vessel walls were slightly bunched. In most
specimens small amounts of clot, consisting of platelets, blood cells
and fibrin, were present at the anastomotic site. Occasionally the
endothelium was broken, but more often it was intact and remained
one to two cells thick. The media thinned out towards sutures, and
tissue in the vicinity of the knot was undergoing hyaline
degeneration with loss of cell structure and no visible cell nuclei.
The media remained intact right up to the sutures, as did the
internal elastic lamina. In cases where the section had been cut
between sutures, media was present and there was no cellular
destruction. The adventitia, similarly, was not damaged except
where it was strangled by a knot. In locations where the adventitia
had been sutured it had lost its cellular appearance and only few
nuclei were present, although elastic and collagen fibres still
remained visible. Outside the anastomosis haematoma was seen,
and this consisted mostly of red cells and the occasional white cell.
At 1 day there was almost no reaction to suture material
(Figure 23).
Seven day group. The lumen was almost free of clot, and its
surface was covered with endothelial cells. At the anastomotic site
there was intimal hyperplasia (Figure 24) and this tapered away
from the anastomosis in a smooth manner. The hyperplastic cells
were arranged longitudinally, and resembled fibroblasts. The
internal elastic lamina was deep to the intimal hyperplasia, and
remained adherent to the media, although in some sections it
appeared to be layered and fragmented. The media and adventitia
were undergoing hyaline degeneration, but the extent of this varied
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Figure 22. Details of sutured anastomosis at 1 day (x50). The
lumen is at the top of the illustration. There is a small
amount of clot (c) at the anastomotic site. Thinned media
and adventitia are entrapped in the knot.
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Figure 23. Reaction to fixation technique at 1 day.
A Adhesive (xl25). The lumen is at the bottom of the
illustration. Adhesive (a) can be seen outside the
vessel wall and, apart from some red blood cells and
a few polymorphonuclear leucocytes, there is very
little tissue reaction.
B Suture (x312). There is some hyaline degeneration




Figure 24. Details of hyperplastic intimal cells (h) at 7 days. The
lumen is labelled (1).
A Sutured anastomosis (xl25).
B Adhesive anastomosis (xl25).
C Details of the cells (x312).
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depending on the plain of histological section. The media
narrowed towards knots, and in areas of hyaline degeneration there
was loss of cell structure with only a few remaining cell nuclei. In
the adventitia overlying sutures there was a fibroblastic reaction,
which appeared to represent organisation of the extra-vascular
haematoma. Sutures were surrounded by a moderate inflammatory
response which contained giant cells (Figure 25).
Twenty-one day group. There was usually no intramural
debris. The endothelial layer was completely reconstituted, and
intimal hyperplasia (Figure 26) was still very visible. The hyaline
necrosis at the knots was still apparent, but the media was normal
up to that point. Folds in the internal elastic lamina were still
present. The inflammatory reaction around suture material was
diminished (Figure 27), although some mononuclear cells were still
to be found in the region of sutures. There was no visible
haematoma outside the anastomoses. This had been replaced by
fibrous tissue.
Fibrinogen adhesive anastomoses
One day group. Figure 28 illustrates details of a typical
adhesive anastomosis at 1 day.
The inner and outer layers of the sleeve could be clearly
identified. The inner vessel wall was separated from the outer
vessel wall by a clot consisting of platelets, fibrin, and some blood
constituents. External to the outside sleeve wall, fibrinogen
adhesive was visible. In some cases, a small amount of this had
found its way between the two layers of the sleeve, but this was
never a large quantity and it did not travel as far as the lumen in any
specimen. In some sections, red blood cells had leaked through
the sleeve, but in almost all cases the fibrinogen adhesive had kept
them within the sleeve and prevented extra-vascular bleeding. On
the lumenal side, the intima was very similar in appearance to the
sutured anastomoses, and tended to remain one to two cells thick.
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Figure 25. Reaction to suture (s) at 7 days. The lumen is labelled
(1). The giant cell reaction is clearly seen.
A Low power (xl25).
B High power (x500).
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Figure 26. Details of hyperplastic intimal cells (h) at 21 days. The
lumen is labelled (1).
A Sutured anastomosis (x50).
B Adhesive anastomosis (xl25).
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Figure 27. Reaction to suture (s) at 21 days. The giant cell reaction
was still present.
A At the knot (x200).
B Single strand (x200).
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Figure 28. Details of adhesive anastomosis at 1 day. The lumen is
labelled (1) and adhesive is labelled (a).
A Free inner margin of the anastomosis (xl25).
B Contents of end-in-end anastomosis (xl25).
C Outer margin of anastomosis demonstrating
containment of haematoma by adhesive (x50).
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The media and adventitia appeared normal in appearance, and
there were no signs of necrosis or hyaline degeneration. In some of
the specimens, stay sutures could be seen near the outer entrance
of the sleeve. There was no inflammatory reaction to the fibrinogen
adhesive (Figure 23), although a few polymorphonuclear leucocytes
were seen in some specimens. Some of the sleeves had come apart
during processing but this was thought to be artifactual.
Seven day group. The sleeves were still easily identified.
There was very little debris in the lumen, although some red and
white cells were still adherent to the endothelium. Intimal
hyperplasia was seen with cells appearing to stream across the
entrance of the sleeve towards the intima of the outer vessel wall.
The hyperplastic cells were similar in appearance to those in the
sutured anastomoses (Figure 24). Some specimens gave the
impression of a superficial layer of streaming overlying a layer of
cells that were orientated as if they had come out of the media.
There was no necrosis in the media or adventitia. The material in
the sleeve itself was organising. Fibrinogen adhesive was present in
much smaller quantities than in the one day specimens, and was
always surrounded by a marked acute inflammatory reaction
(Figure 29), consisting almost exclusively of polymorphonuclear
leucocytes, with a few chronic inflammatory cells. In a number of
places, the inflammatory cells could be seen invading and eroding
the fibrinogen adhesive. Small areas of sequestered adhesive were
present, and these were probably islands not yet destroyed by the
acute inflammatory reaction.
Twenty-one day group. There was almost no intracellular
debris. Intimal hyperplasia had smoothed over the mouths of the
sleeves and was covered by a layer of endothelial cells. The cellular
components of the intimal hyperplasia cells looked similar to that
in the seven day specimens, with cells streaming between the two
vessel wall layers (Figure 26). The contents of the sleeve itself
were becoming well organised into fibrous tissue, although the
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Figure 29. Reaction to adhesive (a) at 7 days. A marked acute
inflammatory reaction surrounded the adhesive.
A Low power (xl25).
B High power (x312).
C Sequestration of adhesive (x312).
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Figure 30. Reaction to adhesive at 21 days. The adhesive was no
longer visible and the acute inflammatory response to it had
completely settled, although a few chronic inflammatory cells
(c) were still visible at the periphery. The lumen is labelled
(1).
A Low power (xl25).
B High power (xl60).
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inner and outer vessel walls were still clearly visible throughout the
sleeve. There was no sign of any fibrinogen adhesive. The outer
margin of the sleeve was sealed by fibrosis. The acute inflammatory
response to the adhesive had completely settled (Figure 30),
although a few chronic inflammatory cells still remained at the
periphery.
Scanning electron microscopy of anastomoses
Scanning electron micrographs of both experimental
adhesive and control sutured anastomoses are illustrated in Figure
31 (1 day), Figure 32 (7 day) and Figure 33 (21 day).
Sutured anastomoses
One day group. Although some of the specimens contained a
lot of intra-lumenal debris, most of the anastomoses could be well
visualised. The intimal endothelial layer was thrown up into
longitudinal folds indicating vessel wall contracture during
processing. Sutures could be seen and, where they perforated the
vessel wall, endothelial cells were torn and there was some mural
thrombus formation. In places, mural thrombus was adherent to
the sutures themselves, but this was not universal. There was de-
endothelialisation at the site of vascular clamp application, and
these locations were covered by a thin layer of leukocytes and
platelets. Mural thrombus was present at the anastomotic site, and
red and white blood cells were adherent to the adjacent
endothelium.
Seven day group. The endothelium had nearly reconstituted
over the surface of the anastomoses, although not all sutures were
covered by endothelial cells. Some breaks in the endothelial lining
were still visible at the anastomotic site, and patches of mural
thrombosis still remained. In some areas, occasional blood
elements were attached to the endothelial surface. Compared to
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Figure 31. Ultrastructure at 1 day. Low power views of the lumenal
surface of experimental and control anastomoses.
A Adhesive anastomosis (x55) showing the inner wall of
the sleeve on the right. Note the small amount of
non-propagating clot at the inner margin of the
end-in-end anastomosis.
B Sutured anastomosis (x70) showing mural thrombus
at the needle puncture sites.
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Figure 32. infrastructure at 7 days. Low power views of the
lumenal surface of experimental and control anastomoses.
A Adhesive anastomosis (x55) showing the appearance
of the hyperplastic intimal cells to the left of the
inner margin of the end-in-end anastomosis (at the
centre of the illustration).
B Sutured anastomosis (x70) showing that the
hyperplastic intimal cells (in the centre of the
illustration) cover the anastomosis and the sutures,
which can no longer be seen).
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Figure 33. Ultrastructure at 21 days. Low power views of the
lumenal surface of experimental and control anastomoses.
A Adhesive anastomosis (x55) showing that the lumen
is re-endothelialised and its contour is much
smoother.
B Sutured anastomosis (x70) which is no longer visible
from the lumenal side.
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one day specimens, there was a tendency towards loss of
thrombosis and regeneration of endothelium.
Twenty-one day group. There was almost no intra-lumenal
debris. The endothelium was completely reconstituted and bridged
the anastomoses. In many specimens it was difficult to identify
where the anastomosis was located. In most cases the sutures were
covered by endothelium, but their location could sometimes be
determined because of contour variation. Mural thrombus was rare,
and the lumenal surface appeared smooth with endothelial cells
orientated longitudinally.
Fibrinogen adhesive anastomoses
One day group. The two layers of the sleeve were seen with
sharp demarcation at the inner margin. Endothelial damage and
desquamation was seen at the site of vascular clamp application,
and blood cells were adherent in that region. The endothelial
lining appeared normal right up to the margin of the sleeve,
although there were a small number of adherent blood cells. Some
specimens demonstrated thrombus at the mouth of the sleeve, but
none showed propagation of this distally.
Seven day group. There was still demarcation at the mouth of
the sleeve although the free margin was becoming smoother as
endothelial cells regenerated. Thrombosis was still visible at the
mouth of the sleeve, but there was never any distal propagation. In
areas where vascular clamps had been applied, regenerating
endothelial cells were seen alongside mural thrombus. In general,
the endothelium was free of debris but adhesion of occasional blood
elements was widespread.
Twenty-one day group. It was possible to identify the inner
layer of the sleeve only by a contour defect. Apart from this, the
inner layer of the vessel was smooth and covered with endothelial
cells which looked fairly normal in appearance and were oriented
in the direction of flow. Clamp injuries were no longer visible, and
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the intima was smooth with almost no adherent debris or blood
elements.
DISCUSSION
This study was no different to any other laboratory
experiment in that it contained strengths and weaknesses.
The study was generally believed to be a strong one in that:
1. There was opportunity to thoroughly research the
initial idea, to develop it in a preliminary study, and
then to test it in an experimental model.
2. The experimental study was designed to be
consecutive, controlled and prospective.
3. It was possible to study anastomotic success or
failure by a variety of different methods.
There were, however, weaknesses. In particular it should be
noted that:
1. The small operative field in the rabbit groin flap
model resulted in a number of minor technical
differences between the adhesive and sutured
anastomoses.
2. The results of this animal experiment, in common
with other animal experiments, might not be
directly applicable to human situations.
The experiment is relevant to contemporary Microvascular
Surgery because:
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1. It adds a new anastomotic technique to the current
armamentarium.
2. It adds information to the basic knowledge
concerning the healing process of microvascular
anastomoses.
Discussion of the results has been divided into three sections:
experimental aspects, technical aspects, and biological aspects.
Experimental aspects
Comparison of anastomotic techniques
According to the Daniel and Terzis86 criteria of an ideal
adhesive substance (see page 72), the fibrinogen adhesive, Tisseel,
would appear to be a very satisfactory material. It has been
demonstrated to be superior to the cyanoaciylics315, and in many
respects is close to the ideal adhesive.
Sully et al364 suggested that it is necessary to demonstrate a
number of specific advantages "if a seemingly easier and more
reliable technique for microvascular repair is to be advocated:
1. Speed of completion of anastomosis.
2. Less intra-lumenal suture exposure.
3. Less vessel trauma owing to fewer sutures and less
manipulation of vessel ends.
4. Prevention of intimal separation.
5. Convenient matching of different sizes of donor and
recipient vessels."
It is true that it is necessary to demonstrate superiority in
these areas, but other factors are also important. According to my
own criteria for suggesting that one type of anastomosis has
advantages over another it would be necessary to:
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1. Carry out a controlled comparative study.
2. Ensure that microvascular patency and flap survival
are, statistically as good as, or better than, the 'gold
standard' conventional suture technique.
3. Demonstrate specific, and worthwhile, areas in
which it excels.
4. Demonstrate that it does not have any detrimental
side effects.
This study is the only consecutive, controlled, prospective
trial that has been undertaken to compare a fibrinogen adhesive
technique with the 'gold standard' conventional suture technique.
The numbers were sufficiently large for statistical analysis.
The rabbit bilateral femoral arteiy/groin flap model was
satisfactory for the experiment. It enabled the two anastomotic
techniques to be compared in a very controlled manner. It also
provided a large number of parameters for comparison. Its main
drawbacks were that:
1. The operative field was small.
2. The presence of numerous branches in the region of
the anastomoses sometimes produced technical
difficulties, which resulted in an unfavourable bias
against the end-in-end technique.
Results indicated that the technique, developed in the
preliminary study, was reliable in its ability to produce satisfactory
microvascular end-in-end anastomoses. The adhesive end-in-end
anastomoses were statistically faster and easier to complete than
sutured end-to-end anastomoses. The overall anastomotic patency
rate compared favourably with previous reports in the literature.
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Interpretation of data
It was necessary to look carefully at the interpretation of the
data. Although there was no statistical difference in the patency
and flap survival rates between the two techniques, the adhesive
technique slightly predominated in the small number of failures. It
may be that this occurred by chance alone, but the possibility that
the adhesive technique was less satisfactory must also be examined.
It is likely that if the technique was basically faulty, the
results would have been poor. At best, there would have been a
spectrum ranging from complete vascular occlusion, through
varying degrees of intra-lumenal thrombus formation, to a small
number of satisfactory results. In addition, it would be reasonable
to expect that a possible cause of failure (e.g. intra-lumenal flow of
adhesive or excessive inflammatory response) might have been
found.
There was no spectrum. The vast majority of anastomoses
were successful, and very comparable to their sutured controls.
There were only a small number of failures, and these were also
comparable to their sutured controls.
Further investigation revealed that it was more likely that the
technique was satisfactory, but problems with the model accounted
for the slightly greater number of adhesive failures. A review of the
detailed operative notes, that were kept on each animal, indicated
that arterial branches located close to the anastomoses may not
have been handled in an ideal manner in some of the procedures,
particularly early in the series (see page 139). Operative notes
indicated that one, and likely two, failures involved branches being
drawn too close to, or actually into, sleeves. This technical error
could explain the statistically insignificant, sporadic predominance
of failures in the adhesive anastomoses. This problem arose
because of the small operative field, the short length of vessel
available for anastomosis, and the inability to avoid the close
proximity of cauterised or clipped side branches. These close side
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branches would have little or no effect on the sutured end-to-end
technique, but would, if unrecognised, be detrimental to the
adhesive end-in-end technique. The problem would be unlikely to
occur in human clinical situations, where the operative field is
larger, and there is usually a much greater length of vessel available
for anastomosis. Later in the series, when the phenomenon had
been recognised, it was found that, in the small number where it
occurred, it was usually possible to make a satisfactory end-in-end
anastomosis. When this was not possible, the procedure was
aborted and the animal replaced.
Anastomotic time
The time taken to complete a fibrinogen adhesive
anastomosis was shown to be significantly less than that necessary
for a sutured anastomosis. The real time saved for a single
anastomosis, however, was only a few minutes. These few minutes
were demonstrated to significantly reduce the total operating time
in the uncomplicated experimental model. It is unlikely, however,
that these few minutes would make a great deal of difference to the
total operating time in a human clinical operation, where most of
the time is spent handling problems related to donor and/or
recipient site preparation.
Subjective observations
The subjective observation, that adhesive anastomoses were
technically much easier to carry out than suturing and required less
expertise and concentration from the surgeon, might, in a clinical
situation, provide the most important indication for using this new




Intra-operative technical failures occurred in both sutured
and adhesive anastomoses in almost equal numbers. According to
the experimental protocol these were revised when they occurred
in end-to-end sutured anastomoses, and animals were replaced
when they occurred in end-in-end adhesive anastomoses.
Clinically, it is mandatory to revise or replace anastomoses that are
judged to be faulty at the time of operation. The small number of
occasions that this was necessary would be fairly typical of that
encountered in standard clinical practice. The nearly equal
distribution between sutured and adhesive intra-operative failures
suggests that the protocol did not impart any bias on the overall
results.
Technical differences between the two types of anastomoses
Despite the attempt to develop the perfect model for a
completely controlled, comparative study, there were still some
differences in the technical aspects of the two types of anastomosis.
In a small number of cases it was felt that these experimental
differences may have had an effect on the results. In other cases
they influenced the way in which decisions were made in problem
solving situations.
In adhesive anastomoses there was inevitable shortening of
the vessel due to the end-in-end technique used. This was not
present in the end-to-end sutured anastomoses. This created a
small difference between the experimental and control sides. In
some animals there was a redundancy in vein length on the
adhesive side. In a human clinical situation this could be corrected
by either shortening the vein or by allowing it to adopt a smooth
curve and 'take up the slack'. The limited space available in the
model did not allow this to be done and it may be that this
increased the risk of kinking with the possibility of developing a
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primary venous and secondary arterial failure. It is thought that
this phenomenon probably accounted for the problems in one
rabbit (R5) and may, possibly, have contributed to problems in two
others (R21; R34). If failures occurred as a result of this problem,
they should be considered to be related to the experimental model
and not to the fibrinogen adhesive anastomotic technique.
Unfortunately there is no way of knowing which anastomoses were
affected in this way, but it should be noted that this complication
was biased, unfavourably, towards the adhesive anastomoses.
The differences between the two types of anastomosis also
influenced the way decisions were made if an anastomosis was
thought to be unsatisfactory intra-operatively. End-to-end sutured
anastomoses could be excised and revised with minimal resection
of vessel. This did not appear to be associated with redundancy in
venous length or other problems. In the case of end-in-end
adhesive anastomoses, however, it was not possible to simply excise
and revise problem anastomoses. The reason for this was related to
the short length of vessels available in this experimental model. If
an end-in-end anastomosis was resected there was not enough
artery left to create another end-in-end anastomosis. Even if it had
been possible, it would have substantially increased the problems
with venous kinking, and, due to the small operative field, might
have been associated with increased risk for entry of adhesive into
the lumen. It was felt that these unfavourable factors could exert an
unfair bias towards the adhesive anastomoses, and that this would
not occur in the human clinical situation. In human free tissue
transfer procedures, there would usually be enough vessel available
to resect and revise a failed end-in-end anastomosis. If this was not
possible, the anastomosis would be replaced with a reversed vein
graft. The large operative fields would allow for removal of excess
adhesive, and re-positioning of vessels to avoid kinking. For these
reasons, when intra-operative failures occurred on the adhesive
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side, it was felt reasonable to abandon the procedure, and start
again with a fresh animal.
Technical factors relating to end-in-end anastomoses
In the preliminary study it was noticed that, when the
microvascular clamps were released, and high pressure blood was
allowed into the lumen of an end-in-end anastomosis, the sleeve
shortened and the cut edge of the inner vessel appeared as a
curved transverse line. It was assumed that this indicated the
effect of intra-lumenal pressure trying to push the components of
the anastomosis apart. Frequently 'unglued' end-in-end
anastomoses did blow apart and this is accounts for most of the
difficulties that microvascular surgeons have had in reproducing
Lauritzen's204"209 success with the sleeve technique. Lauritzen204
did not stipulate how much overlap was ideal or necessary for
satisfactory sleeves, and did not describe any blow-out failures. He
did write that the proximal vessel should be held two millimetres
from the cut end, suggesting that his sleeves were one to one and a
half diameters long. Johnston177 observed microvascular surgeons
using end-in-end anastomoses in China, and commented that the
sleeves were long, and the overlap appeared to be at least two, and
sometimes more, vessel diameters in length.
In the preliminary study it was discovered that when Tisseel
was applied to the surface of end-in-end anastomoses, blow-outs
did not occur. In the experimental series this finding was
confirmed and predictably patent anastomoses resulted. Release of
the arterial microvascular clamps was associated with some sleeve
shortening, but the Tisseel held the anastomoses together and
prevented extra-vascular leakage of blood. Thus the technical
function of Tisseel in the anastomoses appeared to be partly
adhesive and partly sealant.
It is known that if the fibrinogen adhesive had flowed through
the sleeves and into the lumen, there would have been a high
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incidence of anastomotic failure. This did not occur and the
histological specimens demonstrated that only the outer part of the
sleeves contained any fibrinogen adhesive. Adhesive flow towards
the lumen was probably prevented by surface tension between the
two vessels being anastomosed. Two technical factors were
important if separation of the two vessel walls was to be avoided:
1. Stumps of side branches, cauterised or clipped,
should not be pulled into the sleeve.
2. Surgeons should not forget to straighten out folds or
kinks in the wall of the inserted vessel.
Cost of anastomoses
The cost of the two types of anastomoses was similar,
assuming that a single mix of adhesive will provide enough Tisseel
for two anastomoses, and assuming that it takes a minimum of two
microsutures to complete a standard 1.0 millimetre anastomosis.
Compared to the total cost of managing a microvascular patient334,
however, the anastomotic savings would not be important.
Biological aspects
The anastomotic healing process
In Chapter 2 previous descriptions of the healing process of
microvascular anastomoses were discussed. In general,
investigators have agreed about the main events that take place,
although some of the studies varied a little in detail. Differences in
experimental design and, in particular, timing of the post-mortem
studies, accounts for some of the variations. Other differences are
accounted for by the use of different anastomotic techniques,
alternate nomenclature, and varying methods for studying tissue
specimens.
In this experiment, the healing process of both end-to-end
and end-in-end repairs had many features in common and, in
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essence, this did not differ greatly from previous descriptions. It
probably reflects the normal mechanism of anastomotic healing,
which, in summary, consists of:
Immediately after anastomosis there are few biological
changes. Technical features relating to the kind of anastomosis
used are clearly visible. At this stage, the lumen contains only a
small amount of mural thrombus formation at the anastomotic site
and at the site of needle punctures.
Within hours, thrombus formation increases in the region of
the repair and there is endothelial loss, particularly at the
microvascular clamp sites.
By the end of the first week, an inflammatory reaction is
present. Early in this process polymorphonuclear leucocytes
predominate, but, after about two weeks, these decrease in
number, and chronic inflammatory cells became more common.
Intramural thrombus progressively declines during the first week,
although evidence of re-endothelialisation is not seen till the
second or third weeks. During the first week, marked intimal
hyperplasia develops at the anastomotic site, the internal elastic
lamina fragments near the anastomosis, and areas of hyaline
degeneration (with thinning of the vessel wall) occur in the media
and inner adventitia in areas strangulated by sutures. At the same
time, on the outside of the vessel, there is a fibroblastic reaction
which probably represents organisation of haematoma.
By three to four weeks, a smooth layer of endothelial cells
covers the lumenal surface, although the intimal hyperplasia
remains. At this time, the process of fibrosis and scar formation is
well established, although the inflammatory response may not have
completely subsided.
In my experiment, differences between end-to-end and end-
in-end repairs appeared only to reflect the type of approximation or
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method of fixation used to approximate the cut vessel ends. This
finding was in agreement with the findings of previous
investigators18'310'412, who believed that the basic healing process
remained unaltered regardless of the type of anastomosis used.
Wieslander thought that end-in-end and end-to-end anastomoses
did differ in their platelet accumulation, organisation, and re-
endothelialisation406-407. After reviewing his papers, I do not
entirely agree with his interpretation, and I feel that his
histological sections indicate that there was not a great difference
in the two techniques.
Reaction to sutures
The placement of sutures affected the vessel walls in a
number of ways. Needle passage caused endothelial damage with
resulting mural thrombus formation. Suture material stimulated a
foreign body giant cell reaction during the healing phase. Suture
tension produced corrugation and bunching of the vessel wall.
Suture tension also led to strangulation of tissue. In the sutured
anastomoses, the amount of hyaline degeneration observed varied,
depending on the location of the section, and was related to the
proximity of sutures. Sections near or under sutures were severely
affected whilst sections between sutures demonstrated an almost
normal histological appearance.
Reaction to adhesive
In the adhesive anastomoses there were no endothelial
needle perforations, no foreign body reactions, and there was no
evidence of tissue strangulation. There was, however, a response to
the adhesive, and the normal appearance of the healing process
looked a little different because of the end-in-end configuration of
the vascular approximation. The fibrinogen adhesive was clearly
identifiable on the histological sections. By the twenty-first day it
had all disappeared. During the process of resorption, the adhesive
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was surrounded by an intense inflammatory response, although this
was neither as great nor as destructive as the one described around
cyanoacrylic adhesives. The reason for this inflammatory reaction
is not well understood. The fibrin network produced by the
adhesive provides a good substrate for the ingrowth of granulation
tissue and promotion of wound healing. The normal process of
wound healing involves an inflammatory phase and it may be that
this is accelerated in the presence of the fibrinogen adhesive.
Alternately it has been suggested that the inflammatory response
may have been immunological in nature, the fibrinogen adhesive
being recognised as a foreign protein. This seems unlikely in view
of the type of inflammatory cells observed.
Reaction to overlapping vessel walls
In their long term study of microvascular sleeve anastomoses,
Lauritzen et al206 were concerned that stripping adventitia from
the vessels, particularly the inner vessel, might damage the vasa
vasorum and interfere with nourishment of the vessel wall. They
expected to find focal medial sclerotic lesions as a result of vessel
wall ischaemia, but were surprised that the overlapping vessel wall
segments were quite well preserved at six months. The same
finding was noted in this experiment. Presumably nutrition is
obtained either from vasa vasorum that remain intact, or by
diffusion from circulating blood, or from rapid revascularisation of
the vessel wall.
Aneurysm formation
Aneurysm formation was not a problem with either the
sutured or adhesive anastomoses. In 1979, Maxwell et al247
reviewed the subject of aneurysms after microvascular anastomoses
because they had observed a high incidence of aneurysm formation
in the rat femoral artery model. They found that the original
hypothesis, that interrupted suture technique produced leaks at
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the interspace between sutures and subsequent false aneurysm
formation, was wrong. Instead they found that aneurysms were true
aneurysms, and seemed to be related to mechanical trauma of the
vessel walls. The absence of aneurysm formation in this study may
reflect either that rabbits were used instead of rats, or that, with
the passage of time, microsurgical technique has improved to the
extent that vessels are, nowadays, being subjected to less trauma
during preparation and suturing150 of anastomoses.
Mural thrombus
Changes at the cut edge of the inner vessel in the end-in-end
anastomoses were examined carefully, because, at this location, the
full thickness of the vessel wall was directly exposed to circulating
blood. It might be expected that this would stimulate the extrinsic
pathway of the blood clotting mechanism (Figure 1), and result in
rapid and extensive thrombosis. Sully et al364 were particularly
concerned about this and, although they described their mural
thrombi as being non-occlusive, they noted a greater quantity of
mural thrombus in their end-in-end anastomoses, and wondered if
this could have accounted for poorer patency rates.
In my study, mural thrombus was seen at the inner margin of
the end-in-end anastomoses, but this did not result in propagation
of thrombus, and did not produce vascular occlusion. The amount
of mural thrombus did not appear to differ between the two types of
anastomosis compared. The same observation was made by
Lauritzen and Hansson207.
Re-endothelialisation
It is not known how the vascular endothelium regenerates.
There are several theories about how it happens:
1. Endothelial cells may regenerate from adjacent
endothelium95-207.
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2. Penetrating cells from the media may differentiate
into new endothelial cells384.
3. Multipotential cells from the blood stream may
settle and differentiate into endothelial cells114.
The investigations carried out in this experiment were not
aimed at detecting the origin of the new endothelial cells and did
not really throw any new light on this aspect.
Previous investigators have described the timing of
endothelial regeneration (see page 64). Their results have
indicated that re-endothelialisation may take from one to four
weeks. The time variation probably represents interpretation of
experimental results (observations being made at different times,
depending on experimental design) rather than true variation in re-
endothelialisation. Nightingale et al268 made observations at
frequent time intervals, and their description indicates that re-
endothelialisation is virtually complete at two weeks, but it takes
nearly four weeks for correct cellular axial alignment to be
achieved. The observations made in my study concur with
Nightingale's findings.
Re-endothelialisation of end-in-end anastomoses seemed to
be slightly slower than end-to-end anastomoses. It is possible that
this might represent observer variation, but it might also indicate
that it takes longer to re-endothelialise a wider gap. Previous
investigators have demonstrated that it takes longer to re-
endothelialise sutures than the anastomotic margin in end-to-end
anastomoses.
Cellular hyperplasia
Cellular hyperplasia was seen in both end-to-end and end-in-
end anastomoses, although it was greater in the end-in-end
anastomoses, where there was a larger gap to be filled at the inner
margin of the sleeve. The 'flow' of cells appeared to smooth the
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inner lining of the vessel in a way that would again promote laminar
flow. Chen et al64 speculated that the intimal hyperplasia might be
related to changes in the dynamics of the bloodstream, and
Meyermann et al253 also suggested that 'the whirling blood flow' of
end-to-side anastomoses produced more intimal thickening.
The nature and origin of these cells was not elucidated in this
study. Theoretically, because changes at the anastomotic site were
part of a normal healing process, it would not be surprising if these
cells were myofibroblasts. The hyperplastic cells were located
between the intima and the internal elastic lamina. Khodadad184
called the hyperplasia 'intimal' because it was located lumenal to
the internal elastic lamina. Baxter et al26, seeing it in the same
location, called it 'subintimal' because they theorised that the
hyperplasia was the result of smooth muscle cells migrating from
the media. They considered the hyperplasia to be a normal healing
response and stated that the media was the most important mural
component in the repair of small vessels. Chen et al64 did not
agree with Baxter et al. Noting that muscle cells of the media
disappeared in the region of the anastomosis, they felt that the
hyperplastic cells originated from elsewhere, and suggested that
they might represent fibroblasts differentiating into smooth muscle
cells as a result of injury. Lidman and Daniel215 called the
proliferating cells 'myointimal cells' and described them as a
'multipotential mesenchymal repair cell with capability to form
collagen, elastic fibres and also smooth muscle filament, all
depending on the demand of the situation'. This suggests that they
thought the cells were myofibroblasts.
The best way to determine if the cellular hyperplasia was
made up of myofibroblasts would be to use transmission electron
microscopy. The literature contains very little about this method
for studying microvascular anastomoses.
Blair et al, in their histological paper34, briefly mentioned
some transmission electron microscopic observations. They do not
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say that they saw myofibroblasts, but do say that 'smooth muscle
cells were in a state of high intracellular activity in Zone 2b', which
is where the maximal amount of intimal hyperplasia is located.
Meyermann et al254 described two ultrastructural changes in
the intima after microsurgical operations:
1. Widening of the subendothelial space.
2. An increase of specific organelles (tubular bodies,
which are thought to be related to the blood
coagulation system).
Unfortunately, Meyermann's study254 concentrated on
changes in the endothelium, and does not mention whether or not
myofibroblasts were seen in the hyperplastic region.
Ts'ao384, in his study of damaged abdominal aortae, suggested
that the endothelium is replaced by 'myointimal cells', which
migrate from the media to the intima. It is not clear whether these
cells were true myofibroblasts, but from his description it looked as
if they might have been.
Lauritzen and Hansson207 made transmission electron
microscopic observations of the area between the two layers of
sleeve anastomoses. At one week they saw macrophages, cell
debris, and invading cells 'resembling reactive fibroblasts and
smooth muscle cells'.
Taking all this information together, it seems likely that the
hyperplastic cells are myofibroblasts, a conclusion that would fit in
with current theories of wound healing.
CONCLUSIONS
The experimental study has demonstrated that the fibrinogen
adhesive, Tisseel, can be used to make a successful end-in-end
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microvascular anastomosis. Anastomotic patency rates were
comparable to conventional sutured anastomoses, but had
advantages in that they could be completed more easily and in less
time. The disadvantage of the adhesive technique is that it is less
versatile, but it does provide an additional to the anastomotic
armamentarium that may be useful in a number of clinical situations
(see page 187).
The histology and SEM appearances of the two types of
anastomoses have demonstrated the normal process of anastomotic
healing, and differentiated factors that are part of the normal
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INTRODUCTION
The experiment described in Chapter 5 demonstrated that a
series of end-to-end microvascular anastomoses, carried out
experimentally in the rabbit femoral artery, will produce patency
rates and a healing process comparable to conventional suture
anastomoses.
Chapter 6 begins by examining the advantages and
disadvantages of adhesive microvascular anastomotic technique in
order to place its possible clinical application into perspective.
Next, there is a discussion of some other uses that fibrinogen
adhesive may have in Microvascular Surgery. The chapter
concludes with a look at some possible future applications of
Microvascular Surgery.
ADHESIVE MICROVASCULAR ANASTOMOSES
The preceding chapters have reviewed the development and
contemporary role of microvascular surgery and hence the
indications for microvascular anastomoses. A large variety of
techniques for making microvascular anastomoses have been
described. Some of these are commonly used, whilst others are
little more than research curiosities.
Adhesive microvascular anastomoses fall into two general
categories: those made with synthetic adhesives and those made
with biological adhesives.
The synthetic adhesives have some advantages in that they do
not involve the use of human blood products and they do not need
to be mixed at the time of operation. Their main technical
disadvantage is that they are highly inflammatory and cause damage
to adjacent soft tissues. As a result anastomotic patency is
unpredictable, at best and, in general, does not compare favourably
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to the 'gold standard' sutured anastomosis. This disadvantage,
together with the possibility that they may induce soft tissue
sarcomas, has precluded them from clinical use.
A biological fibrinogen adhesive is not locally detrimental to
adjacent tissue and has a number of advantages. In addition to
functioning as an adhesive for the small blood vessels being
anastomosed, it offers other qualities that may be beneficial to the
operative site. It may reduce haemorrhage, and it may promote
healing. Another advantage is that it may be a useful adjunct during
other stages of the operation. For instance it may be used for the
repair of peripheral nerves, for the application of skin grafts or as
an adjunct when packing a cavity with morcellised cancellous bone
graft. The main disadvantage of fibrinogen adhesive is the risk of
disease transmission, but this appears to be more theoretical than
real. Other disadvantages might include the inability to use the
described anastomotic technique for end-to-side and size
discrepancy anastomoses.
In practical terms, the commercially made fibrinogen
adhesive, Tisseel, has been marketed and packaged with a great
deal of care, and close attention has been paid to user education.
This has resulted in a product that is easy to use and that has
minimal waste. Mixing, in theory a complex process, has been
made simple, and the Duploject system has made application a very
straightforward process.
Suturing is still the most common method for securing a
microvascular anastomosis. The technique is versatile and can be
used for all types of anastomoses. Suture technique can be used in
a variety of different ways. The theoretical disadvantage of suture
technique is that inaccurate suturing can damage the intima at the
site of needle entry and introduce irregularity to the intra-lumenal
surface. In practice, contemporary microvascular surgeons are
technically skilled, and modern suture materials are so well made
that these problems are not a major issue. Suture technique does,
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however, require the use of a high degree skill and intense
concentration over a prolonged period of time. This leads to
fatigue.
The experiment described in Chapter 5 demonstrated that
fibrinogen adhesive anastomoses remain patent and can support
cutaneous flaps with results that were comparable to conventional
sutured anastomoses. The fibrinogen adhesive anastomoses can be
secured more rapidly and are, subjectively, less technically
demanding than sutured anastomoses. Fibrinogen adhesive end-in-
end anastomoses are not as versatile as sutured end-to-side
anastomoses. An end-to-side technique has not been developed,
and use of the technique for venous and size discrepancy
anastomoses has not yet been investigated. There may be situations
when a fibrinogen adhesive anastomosis has advantages over a
sutured anastomosis. For instance, fibrinogen adhesive might be
very useful for the awkward anastomosis situated in a deep
intermuscular cleft where the microvascular clamp cannot be
rotated, particularly if blood is pooling in the same location and
causing loss of visibility. The fibrinogen adhesive can be used for
haemostasis by applying it directly to a raw bleeding surface or to
make a temporary dam of fibrin prior to completing the
anastomosis. Another use for a fibrinogen adhesive anastomosis
might be in the difficult 'vertical' anastomosis sometimes
encountered in lower limb reconstructions. It may be easier to
complete an adhesive end-in-end anastomosis than a sutured end-
to-end anastomosis in this circumstance.
Some surgeons may wish to use the fibrinogen adhesive
anastomosis as their standard anastomotic method. In the final
analysis, however, it may be that the main advantage of the
fibrinogen adhesive anastomosis lies in the subjective finding that it
is technically easier to carry out than suturing and demands less
surgical expertise. The technique might be particularly useful for
difficult replantations. For instance in an amputation at the level of
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the distal palm or proximal part of the digits, especially when there
are multiple digits involved, a replantation or revascularisation can
be expected to take many hours to complete. Fatigue can be
minimised by using a team approach, but these operations are
frequently carried out in the middle of the night or on weekends,
when fewer team members are available. Fatigue may become a
serious problem. If fatigue leads to inaccuracy in microsurgical
suture technique, anastomoses may be damaged and/or fail.
Unsatisfactory anastomoses have to be revised, which prolongs the
operation, increases fatigue and ultimately may result a failed
reconstructive procedure. In these circumstances the less
technically demanding adhesive technique might be particularly
useful.
OTHER USES FOR ADHESIVE IN MICROVASCULAR SURGERY
Although experience with the use of fibrinogen adhesive in
Microvascular Surgery is still in its infancy, the results of the
experiment described in Chapter 5 indicate that adhesive would
not enter the vascular lumen even if was applied in quantity directly
onto the anastomosis. This suggests that it would be safe to use
fibrinogen adhesive in the wound during a microsurgical operation.
Thus, in addition to making the microvascular anastomoses,
fibrinogen adhesive could be used for a number of other functions
during a microvascular operation.
Haemostasis
Persistent bleeding may be encountered during microvascular
operations. It can arise from a variety of sources such as dissection
through scar tissue, 'freshened' granulation tissue, anastomotic
leakage, or anticoagulation, which is sometimes used in difficult
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cases. Bleeding can be associated with a number of problems. For
instance:
1. A continuous ooze throughout a long operation will
result in loss of blood volume. If this can be minimised, there will
be maintenance of blood pressure, with better tissue perfusion, and
less need for transfusion, which will reduce likelihood of
transfusion complications.
2. Bleeding from tissue in the area where a
microsurgical anastomosis is being made can be particularly
troublesome. It may produce extreme technical difficulties by
preoccupying the surgeon, or his assistant, and/or obliterating the
field of vision. The result of this situation may be a poor
anastomosis and subsequent flow problems.
3. After the anastomoses have been completed and the
flap has been inset into the wound, unsatisfactory drainage,
associated with persistent bleeding, can result in haematoma
formation in the dead space around the anastomoses. This problem
can cause vascular compression and an extra-lumenal flow
obstruction. In order to salvage the failing flap, the patient must be
returned to the operating room, have the haematoma evacuated,
haemostasis secured, and frequently the anastomoses revised.
Ischaemic reperfusion injury is a serious problem associated with
this situation.
Colen and Mathes76 experimented with the use of
microcrystalline collagen for controlling haemorrhage in the region
of microvascular anastomoses. They reported that it did not
adversely affect patency rates even when applied directly onto the
anastomosis. The results of my study suggest that fibrinogen
adhesive could be used in the same way for the reduction of
haemorrhage in microvascular operations.
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Nerve repair
The use of fibrinogen adhesive for making microneural
anastomoses was discussed in Chapter 3. Fibrinogen adhesive is
commonly used for making microneural anastomoses in some parts
of the world. This technique can be used in conjunction with
microvascular repair, and its use should be considered in
replantations and free tissue transfers using composite tissue
transplants (e.g. functional muscle transplants; neurovascular flaps)
that include nerve244.
Bone replacement
The use of fibrinogen adhesive as an adjunct to morcellised
cancellous bone grafting was discussed in Chapter 3. This
technique might be useful for filling in small bone defects during
replantations244*332.
Pedicle kinking
Kinking of the vascular pedicle can be a troublesome
problem, especially if the length of the vessels is not perfect. This
problem can be minimised by removing retractors and carrying out
a 'dress rehearsal' positioning the flap and pedicle prior to
completing the microsurgical anastomoses. Despite this
precaution, however, vessel length can still be inaccurate and
kinking can result from vascular redundancy. It is important to
place the anastomoses and vessels in a gentle curve and to locate
them away from sharp edges, which may arise in the vicinity of cut
fascia or metallic fixation devices. Cardiovascular surgeons have
used fibrinogen adhesive to fix the position of coronary arteries to
prevent kinking316. This application has not yet been reported in
the microsurgical literature, but there is no reason why this
technique could not be used in Microvascular Surgery. It may be a
better solution than the use of a fixating microsuture, which itself
may lead to kinking.
190
Dead space
As mentioned above, there is always a certain amount of dead
space under a flap, and this is usually located around the vascular
pedicle. It is important to thoroughly drain the wound deep to the
flap so that pools of blood cannot form haematomas that may lead to
pedicle compression. This is particularly important in the
anticoagulated patient. Drainage is the best solution to this
potential problem, but filling the dead space by 'gluing down' the
flap with fibrinogen adhesive would also be a useful preventative
measure.
Skin grafts
The use of fibrinogen adhesive as an adjunct to split thickness
skin grafting was discussed in Chapter 3. This technique has been
used partly because fibrinogen adhesive is believed to promote
wound healing. Rather than using cutaneous or myocutaneous free
flaps for defects in the lower leg, there is now a tendency to use
free muscle transfers covered with split thickness skin grafts. The
use of fibrinogen adhesive to attach the skin grafts would save time
at the end of the operation.
FUTURE DEVELOPMENTS IN MICROVASCULAR SURGERY
Future developments in Microvascular Surgery cannot be
separated from a discussion of microvascular anastomoses because
the two are mutually inseparable.
It is likely that microvascular technique will become used
more frequently as free tissue transplantation increases in scope
and sophistication. Surgeons will continue to strive to find faster,
simpler and better ways to anastomose small blood vessels in order
to facilitate the ease with which operations can be carried out. It is
likely that investigators will continue to examine many different
191
techniques, and it is probable that adhesive microvascular
anastomoses will find a niche in the overall armamentarium of
techniques available for the microsurgical repair of small blood
vessels.
In 1965, Fisher104 first reported on the use of microvascular
surgical techniques in experimental organ transplantation. Since
that time, the possibilities for both experimental and clinical tissue
transplantation have increased immensely, largely because of major
advances in the field of immunology.
The development of cyclosporin A has been associated with
increasing success in the transplantation of vital organs such as
kidney, liver, bone marrow and heart. It has even facilitated
transplantation of the lung, which is highly antigenic. The
improved results and relative safety of this drug have encouraged
reconstructive microvascular surgeons to look further into the
possibility of allograft transplantation of non life-maintaining
tissues.
The possibility of using allograft transplantation procedures
for reconstructive hand surgery is particularly attractive. Despite
the spectacular success of replantation, there are still many
patients whose injuries are so devastating that their final outcome
is less than satisfactory. The ultimate dream would be to have a
tissue bank containing numerous tissues, varying in size, shape and
cosmetic appearance, which could be used for all kinds of free
tissue transfer operations.
There are many differences between the vital parenchymal
tissues, whose transplantation has now become common, and the
type of tissues used for extremity reconstruction. At the present
time there appear to be two major differences, and these have been
the focus of academic discussion and laboratory research:
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1. The variety of different tissues in the limbs and the
considerable variation in their degree of antigenicity
(unfortunately, skin presents the immune system
with a particularly great challenge).
2. The absolute need for re-innervation that is required
if satisfactory functional results are to be obtained in
the extremities (it seems that visceral transplants
can function adequately without direct neural
regulation).
There are a number of reports describing experimental limb
transplantation91.
Some whole limb transplants have been carried out using
methods that would not be possible in humans. Lapchinsky250 used
a technique involving an exchange transfusion from donor to
recipient dogs, several months prior to transplantation, to achieve
immunological tolerance. The method of parabiosis, by the surgical
union of two very young individuals, was examined by Schwind333.
Poole et al308 were able to induce tolerance, prior to
transplantation in adults, by first carrying out an antiserum-
enhanced renal allograft transplant.
Other investigators have examined the effect of different drug
induced immunosuppression regimens. In the days prior to the use
of cyclosporin A results were far from ideal. In a canine
experiment122 the use of 6-mercaptopurine and azothioprine were
shown to slightly prolong graft survival although they did not
prevent rejection. Results were not very different in a similar
experiment carried out by Doi96 using rat limb transplantations. In
both these studies, side effects of the drug regimen proved to be
fatal on numerous occasions. One study200 did obtain prolonged
survival of canine limb transplantations, but this was only achieved
with the use of a very potent combination of multiple
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immunosuppressive therapies, and severe side effects were
encountered.
In the 1980s experiments with limb transplantation have
used cyclosporin A for immunosuppression. A number of
publications concerning adult rat limb transplantation31-109'154 have
demonstrated that cyclosporin A can dramatically improve
transplant survival. In many of the experimental animals there was
no histological evidence of rejection, a finding that differed
markedly from the histological observations made in the non
immunosuppressed controls. Kim et al186 compared adult rat hind
limb allograft transplantations with a replantation control. Their
results indicated that transplantations in rats treated with
cyclosporin A behaved similarly to replantations.
Following these reports, demonstrating the striking
improvement in the survival of composite tissue transplantation
when cyclosporin A was used for immunosuppression, investigators
have gone on to examine the results of similar experiments in
primate species. Particular emphasis has been placed on the
return of nerve function, partly because this is so important if
satisfactory limb function is to be achieved and partly to ensure that
cyclosporin A does not in some way (its mode of action is not yet
clearly defined) inhibit functional re-innervation.
In 1986, Daniel et al91 described an experiment in which
four hand transplantations and seven neurovascular free flap
transplantations were carried out in baboons immunosuppressed
with a combination of cyclosporin A and methylprednisolone. Stark
et al359-360 have subsequently reported the results of similar
experiments in which baboon hand transplantations were carried
out using cyclosporin A and prednisolone. The results of both
groups of investigators clearly indicated that limb transplantation
can be achieved in primates, and that recovery of motor and
sensory function will occur in hand transplantation in a manner
that is comparable to replantation.
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The reason that limb allografts are still not carried out
clinically is that, even with cyclosporin A, the toxicity of the
required immunosuppression is too high for elective reconstructive
surgery. Cyclosporin A is nephrotoxic at high levels and
hepatotoxic when combined with other immunosuppressants. In
the primate experiments91.359,360 ^ was necessary to obtain high
serum levels of cyclosporin A to ensure survival of the limb
allografts. The dominant target of rejection appeared to be the
skin, whilst the skeleton and other soft tissues were better
tolerated. It has been suggested that hands could be transplanted
denuded of skin and then covered with recipient skin grafts. The
best solution, however, will be the development of more selective,




1. Acland RD. Prevention of thrombosis in microvascular
surgery by the use of magnesium sulfate. Br J Plast Surg
25:292-299, 1972.
2. Acland RD. New instruments for microvascular surgery.
Br J Surg 59:181-184, 1972.
3. Acland RD. A new needle for microvascular surgery. Surgery
71:130-131, 1972.
4. Acland RD. Signs of patency in small vessel anastomosis.
Surgery 72:744-748, 1972.
5. Acland RD. Thrombus formation in microvascular surgeiy:
An experimental study of the effects of surgical trauma.
Surgery 73:766-771, 1973.
6. Acland RD. Microvascular anastomosis: A device for holding
stay sutures and a new vascular clamp. Surgery 75:185-187,
1974.
7. Acland RD. Notes on the handling of ultrafine suture material.
Surgery 77:505-511, 1975.
8. Acland RD. Instrumentation for microsurgery. Orth Clin
North Am 8:281-294, 1977.
9. Acland RD and Trachtenberg L. The histopathology of small
arteries following experimental microvascular anastomosis.
Plast Reconstr Surg 60:868-875, 1977.
197
10. Acland RD, Lubbers LL, Grafton RB and Bensimon R.
Irrigating solutions for small blood vessel surgery - a
histologic comparison. Plast Reconstr Surg 65:460-465,
1980.
11. Acland RD. Microsurgery Practice Manual. St Louis:
CV Mosby Co, 1980.
12. Acland RD, Schusterman M, Godina M, Eder E, Taylor GI and
Carlisle I. The saphenous neurovascular free flap. Plast
Reconstr Surg 67:763-774, 1981.
13. Aksik IA, Kikut RP and Apshkalne DL. Extraintracranial
anastomosis performed by means of biological gluing
materials: experimental and clinical study. Microsurgery
7:2-8, 1986.
14. Androsov PI. New method of surgical treatment of blood
vessel lesions. Arch Surg 73:902-910, 1956.
15. Antia NH and Buch VI. Transfer of an abdominal dermo-fat
graft by direct anastomosis of blood vessels. Br J Plast Surg
24:15-19, 1971.
16. Auer L, Gratzl O, Waltinger P, Sixl G and Tritthart H.
Endothelial changes after vascular surgery: a scanning
electron microscopic study. Chapter 13, 119-122. In
Schmiedek P (Ed), Microsurgery for Stroke. New York,
Heidelberg, Berlin: Springer-Verlag, 1977.
17. Awe WC, Roberts W and Braunwald NS. Rapidly polymerizing
adhesive as a hemostatic agent: study of tissue response and
bacteriological properties. Surgery 54:322-328, 1963.
198
18. Bailes JE, Quigley MR, Kwaan HC, Cerullo LJ and Brown JT.
Fibrinolytic activity following laser-assisted vascular
anastomosis. Microsurgery 6:163-168, 1985.
19. Bailes JE, Quigley MR, Cerullo LJ and Kwaan HC. Review of
tissue welding applications in neurosurgery. Microsurgery
8:242-244, 1987.
20. Bakamjian VY. A two-stage method for phaiyngoesophageal
reconstruction with a primary pectoral skin flap. Plast
Reconstr Surg 36:173-184, 1965.
21. Bakamjian VY, Long M and Rigg B. Experience with the
medially based deltopectoral flap in reconstructive surgery of
the head and neck. Br J Plast Surg 24:174-183, 1971.
22. Barone R, Pavaux C, Blin PC and Cuq P. Atlas d'Anatomie du
Lapin. Paris: Masson et Cie, 1973.
23. Barwick WJ, Goodkind DJ and Serafin B. The free scapular
flap. Plast Reconstr Surg 69:779-785, 1982.
24. Bass LS, Treat MR, Dzakonski C and Trokel SL. Sutureless
microvascular anastomosis using the THC:YAG laser: a
preliminary report. Microsurgery 10:189-193, 1989.
25. Baudet J, Guimberteau JC and Nascimento E. Successful
clinical transfer of two free thoraco-dorsal axillary flaps. Plast
Reconstr Surg 58:680-688, 1976.
26. Baxter TJ, O'Brien BM, Henderson PN and Bennett RC. The
histopathology of small blood vessels following microvascular
repair. Br J Surg 59:617-622, 1972.
199
27. Bell LD, Blair WF, Pedersen DR and Gabel RH. A
haemodynamic evaluation of cuffed microarteriorrhaphy.
Microsurgery 6:106-112, 1985.
28. Berger A and Millesi H. Functional results from replantation
surgery: a five-year report from the Viennese replantation
team. Aust NZ J Surg 50:244-247, 1980.
29. Berggren A, Ostrup LT and Lidman D. Mechanical
anastomosis of small arteries and veins with the Unilink
apparatus: A histologic and scanning electron microscopic
study. Plast Reconstr Surg 80:274-283, 1987.
30. Bemhard WF, Cummin AS, Vawter GF and Carr JG. Closure of
vascular incisions utilizing a new flexible adhesive. Surg
Forum 13:231-233, 1962.
31. Black KS, Hewitt CW, Fraser LA, Osborne JG, Achauer BM,
Martin DC and Furnas DW. Cosmas and Damian in the
laboratory. N Engl J Med 306:368-369, 1982.
32. Blair WF, Pedersen DR, Joos K and Bondi D. Interrupted and
continuous microarteriorraphy techniques: A hemodynamic
comparison. J Orth Res 2:419-424, 1984.
33. Blair WF, Steyers CM, Brown TD and Gable RH. A
microvascular anastomotic device: Part I. A hemodynamic
evaluation in rabbit femoral arteries and veins. Microsurgery
10:21-28, 1989.
34. Blair WF, Morecraft RJ, Steyers CM and Maynard JA. A
microvascular anastomotic device: Part II. A histologic study
in arteries and veins. Microsurgery 10:29-39, 1989.
200
35. Boeckx WD, DeConinck A and Vanderlinden E. Ten free flap
transfers: use of intra-arterial dye injections to outline a flap
exactly. Plast Reconstr Surg 57:716-721, 1976.
36. Bowen CVA. Microsurgical growth plate transfers. Pp 55-59.
In Uhthoff HK, Wiley JJ (Eds), Behaviour of the Growth Plate.
New York: Raven press, 1988.
37. Bowen CVA and Chang P. An operating table for hand surgery.
Plast Reconstr Surg 81:270-273, 1988.
38. Bowen CVA, Beveridge J, Milliken RG and Johnston GHF.
Rotating shaft avulsion amputations of the thumb. J Hand
Surg (In press).
39. Boyd JB, Taylor GI and Corlett R. The vascular territories of
the superior epigastric and the deep inferior epigastric
systems. Plast Reconstr Surg 73:1-14, 1984.
40. Brennen MD and O'Brien BMcC. Patency rates in end to side
anastomoses in the rabbit. Br J Plast Surg 32:24-30, 1979.
41. Brent B, Upton J, Acland RD, Shaw WW, Finseth FJ, Rogers C,
Pearl RM and Hentz VR. Experience with the
temporoparietal fascial free flap. Plast Reconstr Surg
76:177-188, 1985.
42. Brown RG, Vasconez LO and Jurkiewicz MJ. Transverse
abdominal flaps and the deep epigastric arcade. Plast
Reconstr Surg 55:416-421, 1975.
201
43. Brunner FX. Histological findings in sutured and fibrin-glued
microvascular anastomosis. Arch Otorhinolaryngol
240:311-318, 1984.
44. Buchler U, Phelps DB, Winspur I and Boswick JA. The
irrigation jet: An aid in microvascular surgery. J Hand Surg
2:24-28, 1977.
45. Buncke HJ and Schulz WP. Experimental digital amputation
and reimplantation. Plast Reconstr Surg 36:62-70, 1965.
46. Buncke HJ and Schulz WP. Total ear reimplantation in the
rabbit utilising microminiature vascular anastomoses.
Br J Plast Surg 19:15-22, 1966.
47. Buncke HJ, Buncke CM and Schulz WP. Immediate
Nicoladani procedure in the Rhesus monkey, or
hallux-to-hand transplantation, utilizing microminiature
vascular anastomoses. Br J Plast Surg 19:332-337, 1966.
48. Buncke HJ. The suture repair of 1 millimeter vessels. In
Donaghy RMP and Yasargil MG (Eds.), Micro-vascular Surgery.
Stuttgart: Thieme, 1967.
49. Buncke HJ and McLean DH. The advantage of a straight
needle in microsurgery. Plast Reconstr Surg 47:602-603,
1971.
50. Buncke HJ, Chater NL and Szabo Z. Manual of Microvascular
Surgery. Davis and Geek, 1975.
202
51. Bunkis J, Walton RL and Mathes SJ. The rectus abdominis
free flap for lower extremity reconstruction. Ann Plast Surg
11:373-380, 1983.
52. Carrel A. The operative technique of vascular anastomoses
and the transplantation of viscera. Med Lyon 98:859, 1902.
(English translation in Clin Orthop 29:3-6, 1963).
53. Carter EL and Roth EXT. Direct nonsuture coronary artery
anastomosis in the dog. Ann Surg 148:212-218, 1958.
54. Carton CA, Kessler LA, Seidenberg B and Hurwitt ES.
Experimental studies in the surgery of small blood vessels.
IV. Nonsuture anastomosis of arteries and veins, using
flanged ring prostheses and plastic adhesive. Surg Forum
11:238-239, 1960
55. Carton CA, Kessler LA, Seidenberg B and Hurwitt ES.
Experimental studies in the surgery of small blood vessels.
II. Patching of arteriotomy using a plastic adhesive.
J Neurosurg 18:188-194, 1961.
56. Casanova R, Herrera GA, Engels BV, Valasquez C and Grotting
JC. Microarterial sutureless anastomosis using a polymeric
adhesive: an experimental study. J Reconstr Microsurg
3:201-207, 1987.
57. Cassel J, Alpert BS, Buncke HJ and Gordon L. The Tweener
maneuver. J Reconstr Microsurg 1:287-289, 1985.
58. Chang TS. Shanghai symposium. Editorial. Report from the
second French-Chinese microsurgical mission. J Reconstr
Microsurg 1:53-54, 1984.
203
59. Chen CW, Chien YC and Bao YS. Salvage of the forearm
following complete traumatic amputation; report of a case.
Chin Med J 82:632, 1963.
60. Chen CW, Chien YC, Bao YS and Lin CT. Further experience
in the restoration of amputated limbs. Chin Med J
84:225-231, 1965.
61. Chen ZW, Yang DY and Chang DS. Microsurgery. Berlin,
Heidelberg and New York: Springer-Verlag, 1982.
62. Chen ZW, Yang DY and Chang DS. The instruments and
sutures of microsurgery. Chapter 3, 37-51. In Microsurgery.
Berlin, Heidelberg and New York: Springer-Verlag, 1982.
63. Chen ZW, Yang DY and Chang DS. Microsurgical suturing
technique. Chapter 5, 68-92. In Microsurgery. Berlin,
Heidelberg and New York: Springer-Verlag, 1982.
64. Chen ZW, Yang DY and Chang DS. Microsurgery and
pathology. Chapter 6, 93-104. In Microsurgery. Berlin,
Heidelberg and New York: Springer-Verlag, 1982.
65. Chen ZW and Zhang GJ. Epiphyseal transplantation.
Pp 121-127. In Pho RWH (Ed), Microsurgical Technique in
Orthopaedics. London: Butterworths, 1988.
66. Choi HK, Stowe N, and Novick A. Comparison of end-to-end
and telescoped arterial anastomoses in renal transplantation
in rats. J Microsurg 3:85-88, 1981.
67. Chow SP. The significance of the retrograde patency test in
microarterial anastomoses. Hand 14:153-158, 1982.
204
68. Chow SP, Huang CD and Chan CW. Microvascular anastomosis
of arteries under tension. Br J Plast Surg 35:82-87, 1982.
69. Chow SP. The histopathology of microvascular anastomosis:
A study of the incidence of various tissue changes.
Microsurgery 4:5-9, 1983.
70. Chow SP, Zhu JK and So YC. Effect of bipolar coagulation and
occlusion clamping on the patency rate in microvascular
anastomosis. J Reconstr Microsurg 2:111-115, 1986.
71. Cobbett JR. Diameter changes in small vessel anastomoses.
In Donaghy RMP and Yasargil MG (Eds.), Micro-Vascular
Surgery. Stuttgart: Thieme, 1967.
72. Cobbett JR. Small vessel anastomosis. A comparison of
suture techniques. Br J Plast Surg 20:16-20, 1967.
73. Cobbett JR. Microvascular surgery. Surg Clin N Am
47:521-542, 1967.
74. Cobbett JR. Free digital transfer. Report of a case of transfer
of a great toe to replace an amputated thumb. J Bone Joint
Surg 51-B:677-679, 1969.
75. Colen LB, Gonzales FP and Buncke HJ. The relationship
between the number of sutures and the strength of
microvascular anastomoses. Plast Reconstr Surg 64:325-329,
1979.
76. Colen LB and Mathes SJ. The use of microciystalline collagen
in microsurgery and its effect on anastomotic patency. Ann
Plast Surg 9:471-474, 1982.
205
77. Cook AF, Grossman JAI, Herpy ES and Dinner MI. The
correlation of histology to needle type in microvascular
anastomoses: a quantitative analysis. Br J Plast Surg
35:156-157, 1982.
78. Cooley BC, Ruas EJ and Shaw Wilgis EF. Scanning electron
microscopy of crush/avulsion arterial trauma: effect of
heparin and aspirin administration. Microsurgery 8:11-16,
1987.
79. Cooley B. Invited discussion of "Re-endothelialization stages
at the microvascular anastomosis" by Isogai N, Kamiishi H,
and Chichibu S. Microsurgery 9:93-94, 1988.
80. Cooney WP. Microsurgery in China and the development of
western reconstructive microsurgery. Microsurgery 9:75-77,
1988.
81. Curtis LM, Lottis WJ and Wissinger AH. Objective signs of
patency following microvascular arterial anastomoses: A
controlled study. J Hand Surg 2:22-23, 1977.
82. Daniel RK and Williams HB. The free transfer of skin flaps by
microvascular anastomoses. An experimental study and a
reappraisal. Plast Reconstr Surg 52:16-31, 1973.
83. Daniel RK and Taylor GI. Distant transfer of an island flap by
microvascular anastomoses. Plast Reconstr Surg 52:111-117,
1973.
84. Daniel RK and Terzis JK. Reconstructive Microsurgery.
Boston: Little, Brown and Co, 1977.
206
85. Daniel RK and Terzis JK. Microsurgical instruments.
Chapter 2, 25-41. In Reconstructive Microsurgery. Boston:
Little, Brown and Company, 1977.
86. Daniel RK and Terzis JK. Microsutures: their evolution and
role in microvascular surgery. Chapter 3, 43-55. In
Reconstructive Microsurgery. Boston: Little, Brown and
Company, 1977.
87. Daniel RK and Terzis JK. Microvascular surgical techniques.
Chapter 4, 61-124. In Reconstructive Microsurgery. Boston:
Little, Brown and Company, 1977.
88. Daniel RK, Lidman D, Olding M, Williams JA and Matlaga BF.
An anastomotic device for microvascular surgery: Evolution.
Ann Plast Surg 13:402-411, 1984.
89. Daniel RK and Olding M. An absorbable anastomotic device
for microvascular surgery: Experimental studies. Plast
Reconstr Surg 74:329-336, 1984.
90. Daniel RK and Olding M. An absorbable anastomotic device
for microvascular surgery: Clinical applications. Plast
Reconstr Surg 74:337-342, 1984.
91. Daniel RK, Egerszegi EP, Samulack DD, Skanes SE, Dykes RW
and Rennie WRJ. Tissue transplants in primates for upper
extremity reconstruction: a preliminary report. J Hand Surg
11-A: 1-8, 1986.
92. Davis CB, Smith BM, Haggen P and Urbaniak JR. The
strength of microvascular anastomoses - an experimental
evaluation in rats. J Microsurg 3:156-161, 1982.
207
93. DeBakey ME and Simeone FA. Battle injuries of the arteries
in World War II. An analysis of 2,471 cases. Ann Surg
123:534-579, 1946.
94. Dinges HP, Matras H, Kletter G and Chiari F.
Histopathologishe Untersuchengen zum Heilungsverlauf von
Mikrogefassasastomosen bei Anwendung der kombinierten
Naht- und Klebetechnik. VASA 7:161-166, 1978.
95. Dirrenberger RA and Sundt TM. Carotid endarterectomy.
Temporal profile of the healing process and effects of
anticoagulation therapy. J Neurosurg 48:201-219, 1978.
96. Doi K. Homotransplantation of limbs in rats: a preliminary
report on an experimental study with nonspecific
immunosuppressive drugs. Plast Reconstr Surg 64:613-621,
1979.
97. Donaghy RMP and Yasargil MG (Eds). Micro-vascular Surgery:
Conference on Micro-vascular Surgery, 1st, Burlington,
Vermont, 1966. Stuttgart: Thieme, 1967.
98. dos Santos LF. The vascular anatomy and dissection of the
free scapular flap. Plast Reconstr Surg 73:599-603, 1984.
99. Duarte A, Valauri FA and Buncke HJ. Importance of vessel
tension in end-to-end and end-in-end anastomoses.
J Reconstr Microsurg 3:327-331, 1987.
100. Duarte A, Valauri FA and Buncke HJ. Microvascular thermic
sleeve anastomosis: a sutureless technique. J Reconstr
Microsurg 4:53-60, 1987.
208
101. Eder G, Neumann M, Cerwenka R and Baumgarten K.
Preliminary results of a randomized controlled study on the
risk of hepatitis transmission of a two-component fibrin
sealant (Tissucol/Tisseel). Pp 51-59. In Schlag G and Redl H
(Eds), Fibrin Sealant in Operative Medicine. Vol 7. Berlin,
Heidelberg and New York: Springer-Verlag, 1986.
102. Euler E, Wilker D, Eital F and Mager S. Nonsuture
microsurgical vessel anastomosis. J Reconstr Microsurg
4:49-52, 1987.
103. Euler E, Lechleuthner A, Stephan F and Kenn R-W.
Nonsuture microsurgical vessel anastomosis using an
absorbable cuff. J Reconstr Microsurg 5:323-326, 1989.
104. Fisher B and Lee S. Microvascular surgical techniques in
research, with special reference to renal transplantation in
the rat. Surgery 58:904-914, 1965.
105. Foucher G and Schuind F. A new trick for end-to-end
anastomosis in microvascular surgery. Modified Harashina
procedure. J Reconstr Microsurg 1:49-51, 1984.
106. Frazier OH, Painvin GA, Morris JR, Thomsen S and
Neblett CR. Laser-assisted microvascular anastomoses:
Angiographic and anatomopathologic studies on growing
microvascular anastomoses: Preliminary report. Surgery
97:585-590, 1985.
107. Freeman BS. Adhesive anastomosis technique for fine nerves
- experimental and clinical. Am J Surg 108:529-532, 1964.
209
108. Freeman BS. Adhesive neural anastomosis. Plast Reconstr
Surg 35:167-176, 1965.
109. Fritz WD, Swartz W, Rose S, Futrell JW and Klein E. Limb
allografts in rats immunosuppressed with Cyclosporin A. Ann
Surg 199:211, 1984.
110. Fujimaki A, O'Brien BMcC, Kurata T and Threlfall GN.
Experimental micro-anastomosis of 0.4-0.5 mm vessels. Br J
Plast Surg 30:269-272, 1977.
111. Fujino T, Harashina T and Aoyagi F. Reconstruction for
aplasia of the breast and pectoral region by microvascular
transfer of a free flap from the buttock. Plast Reconstr Surg
56:178-181, 1975.
112. Fujino T and Saito S. Repair of pharyngoesophageal fistula by
microvascular transfer of a free skin flap. Plast Reconstr Surg
56:549-553, 1975.
113. Fukui A and Tamai S. Factors influencing the failure of
microsurgical composite tissue transplantation. J Reconstr
Microsurg 4:285-290, 1988.
114. Gelderman PW and Berendsen W. Re-endothelialization of
microvascular end-to-side anastomosis in the rat. A scanning
electron microscopic study. J Neurosurg 51:785-795, 1979.
115. Gestring GF, Lerner R and Requena R. The sutureless
microanastomosis. Vase Surg 17:364-367, 1983.
116. Gilbert A and Teot L. The free scapular flap. Plast Reconstr
Surg 69:601-604, 1982.
210
117. Gilbert RW, Ragnarsson R, Berggren A and Ostrup L.
Strength of microvascular anastomoses: comparison between
the Unilink anastomotic system and sutures. Microsurgery
10:40-46, 1989.
118. Glover MG, Seaber AV and Urbaniak JR. Arterial intimal
damage in avulsion and crush injuries in rat limbs.
J Reconstr Microsurg 1:247-251, 1985.
119. Godina M. Preferential use of end-to-side arterial
anastomoses in free flap transfers. Plast Reconstr Surg
64:673-682, 1979.
120. Godina M. Discussion. The free scapular flap. Plast Reconstr
Surg 69:786-787, 1982.
121. Goetz RH, Rohman M, Haller JD, Dee R and Rosenak SS.
Internal mammary-coronary artery anastomosis: A nonsuture
method employing tantalum rings. J Thorac Cardiovasc Surg
41:378-386, 1961.
122. Goldwyn RM, Beach PM, Feldman D and Wilson RE. Canine
limb homotransplantation. Plast Reconstr Surg 37:184-195,
1966.
123. Gomes OM, Macruz R, Armelin E, Ribeiro MP, Brum JM,
Bittencourt D, Verginelli G and Zerbini EJ. Vascular
anastomosis by argon laser beam. Tex Heart Inst J
10:145-149, 1983.
124. Goossens DP, Gruel SM and Rao VK. A survey of microsurgery
training in the United States. Microsurgery 11:2-4, 1990.
21 1
125. Gottlob R and Bltimel G. Anastomoses of small arteries and
veins by means of bushings and adhesive. J Cardiovasc Surg
9:337-341, 1968.
126. Grabb WC. Basic techniques of plastic surgery. Chapter 1,
3-74. In Grabb WC and Smith JW (Eds.), Plastic surgery,
3rd Ed. Boston: Little, Brown, and Co, 1979.
127. Green AR, Milling MAP and Green ART. Butylcyanoacrylate
adhesives in microvascular surgery: an experimental pilot
study. J Reconstr Microsurg 2:103-105, 1986.
128. Green GE, Som ML and Wolff WI. Experimental
microvascular suture anastomosis. Circulation 33
suppl 1:199-203, 1966.
129. Gu Y, Li J, Jiang J, Zhong C and Tang P. Scanning electron
microscopic observations on the endothelial healing
mechanism of vessels. J Reconstr Microsurg 5:327-330,
1989.
130. Guity A and Young PH. "Window technique" for approximation
during end-to-end vascular anastomosis. Microsurgery
10:315-316, 1989.
131. Guity A, Young PH and Fischer VW. In search of the "perfect"
anastomosis. Microsurgery 11:5-11, 1990.
132. Hafner CD, Fogarty TJ and Cranley JJ. Nonsuture anastomosis
of small arteries using a tissue adhesive. Surg Gynae Obstet
116:417-421, 1963.
212
133. Haller JD. Kripke DC, Rosenak SS, Dee R, Roberts T,
Rohman M and Goetz RH. Long-term results of small vessel
anastomoses with a ring technic. Ann Surg 161:67-72, 1965.
134. Hamilton RB and O'Brien BMcC. An experimental study of
microvascular patency using a continuous suture technique.
Br J Plast Surg 32:153-154, 1979.
135. Hamilton SGL and Morrison WA. The scapular free flap.
Br J Plast Surg 35:2-7, 1982.
136. Harashina T, Fujino T and Watanabe S. The intimal healing of
microvascular anastomoses. Plast Reconstr Surg 58:608-613,
1976.
137. Harashina T. The site of reapplication of microvascular
clamps. Plast Reconstr Surg 58:719-720, 1976.
138. Harashina T. Use of the untied suture in microvascular
anastomoses. Plast Reconstr Surg 59:134-135, 1977.
139. Harashina T and Fujino T. Experimental microvascular
procedures. Chapter 12, 164-174. In Serafin D and Buncke
HJ (Eds), Microsurgical Composite Tissue Transplantation.
St Louis: CV Mosby Co, 1979.
140. Harashina T. Use of continuous suture for back wall. Repair
of end-to-end or end-to-side anastomosis. Plast Reconstr
Surg 69:139-144, 1982.
141. Harashina T, Kuwako Y, Kiyoizumi T and Tsuchiya Y.
Usefulness of the Y-shaped anastomotic technique in free flap
surgery. J Reconstr Microsurg 3:95-98, 1987.
213
142. Harii K, Ohmori K and Ohmori S. Successful clinical transfer
of ten free flaps by microvascular anastomoses. Plast
Reconstr Surg 53:259-270, 1974.
143. Harii K, Ohmori K and Ohmori S. Free deltopectoral skin
flaps. Br J Plast Surg 27:231-239, 1974.
144. Harii K and Ohmori K. Free skin flap transfer. Clin Plast Surg
3:111-127, 1976.
145. Harii K, Ohmori K and Sekiguchi J. The free
musculocutaneous flap. Plast Reconstr Surg 57:294-303,
1976.
146. Harris GD, Finseth F and Buncke HJ. Posterior-wall-first
microvascular anastomotic technique. Br J Plast Surg
34:47-49, 1981.
147. Harris GD, Finseth F and Buncke HJ. The microvascular
anastomotic autogenous cuff. Br J Plast Surg 34:50-52, 1981.
148. Hart NB. The effect of absorbable gelatin sponge on
experimental microvascular anastomoses. Br J Plast Surg
40:300-304, 1987.
149. Havranek P, Hajkova H, Motl V and Povysil C. Fibrin glue
osteosynthesis of epiphyseal injuries. Int Surg 70:257-261,
1985.
150. Hayhurst JW and O'Brien BMcC. An experimental study of
microvascular technique, patency rates and related factors.
Br J Plast Surg 28:128-132, 1975.
214
151. Healey JE. Clark RL, Gallager HS, O'NeiU P and Sheena KS.
Nonsuture repair of blood vessels. Ann Surg 155:817-826,
1962.
152. Henderson PN, O'Brien BMcC and Parel JM. An adjustable
double microvascular clamp. Med J Aust 1:715-717, 1970.
153. Henderson PN, Pericic L and O'Brien. Mobile arm rests. Med
J Aust 1:720-721, 1971.
154. Hewitt CW, Black KS, Fraser LA, Osborne JG, Sayles TJ,
Achauer BM, Martin DC and Furnas DW. Cyclosporin-A (CyA)
is superior to prior donor-specific blood (DSB) transfusion for
the extensive prolongation of rat limb allograft survival.
Transplant Proc 15:514-517, 1983.
155. Holt GP and Lewis FJ. A new technique for end-to-end
anastomosis of small arteries. Surg Forum 11:242-243, 1960.
156. Horn JS. Successful reattachment of a completely severed
forearm. Lancet 1:1152-1154, 1964.
157. Hosbein DJ and Blumenstock DA. Anastomosis of small
arteries using a tissue adhesive. Surg Gynaec Obst
118:112-114, 1964.
158. Hou S-M, Seaber AV and Urbaniak JR. An alternative
technique of microvascular anastomosis. Microsurgery
8:22-24, 1987.
159. Huang CT, Li PH and Kong GT. Successful restoration of a
traumatic amputated leg. Chin Med J 84:641-645, 1965.
215
160. Hurwitt ES, Altman S, Borow M and Rosenblatt M. Intra¬
abdominal arterial anastomoses. An experimental study.
Surgery 34:1043 -1060, 1953.
161. Hurwitz PJ. Experimental transplantation of small joints by
microvascular anastomoses. Plast Reconstr Surg 64:221-231,
1979.
162. Inokuchi K. A new type of vessel-suturing apparatus. Arch
Surg 77:954-957, 1958.
163. Inokuchi K. Stapling device for end-to-side anastomosis of
blood vessels. Arch Surg 82:337-341, 1961.
164. Ikuta Y. Studies on small vessel anastomosis. Hiroshima J
Med Sci 17:285-311, 1968.
165. Ikuta Y, Watari S, Kawamura K, Shima R, Matsuishi Y,
Miyoshi K and Tsuge K. Free flap transfers by end-to-side
arterial anastomosis. Br J Plast Surg 28:1-7, 1975.
166. Ismail TLA. The free fascial forearm flap. Microsurgery
10:155-160, 1989.
167. Isogai N, Kamiishi H and Chichibu S. Re-endothelialization
stages at the microvascular anastomosis. Microsurgery
9:87-92, 1988.
168. Jacobson JH and Suarez EL. Microsurgery in anastomosis of
small vessels. Surg Forum 11:243-245, 1960.
169. Jacobson JH. Microsurgical technic in repair of the
traumatized extremity. Clin Orthop 29:132-145, 1963.
216
170. Jacobson JH, Moody RA, Kusserow BK, Reich T and
Wang MCH. The tissue response to a plastic adhesive used in
combination with microsurgical technique in reconstruction
of small arteries. Surgery 60:379-385, 1966.
171. Jacobson JH. Microsurgery, Curr Prob Surg 3-56, 1971.
172. Jahnke EJ and Seeley SF. Acute vascular injuries in the
Korean War: An analysis of 77 consecutive cases. Ann Surg
138:158-177, 1953.
173. Jain KK and Gorisch W. Repair of small blood vessels with
Neodymium-YAG laser. Surgery 85:684-688, 1979.
174. Jain KK. Sutureless microvascular anastomosis using a
Neodymium YAG laser. J Microsurg 1:436-439, 1980.
175. Jain KK. Sutureless end-to-side microvascular anastomosis
using Neodymium-YAG laser. Vase Surg 17:240-243, 1983.
176. Jain KK. Sutureless extra-intracranial anastomosis by laser.
Lancet 2:816-817, 1984.
177. Johnston GHF. Personal communication.
178. Kanaujia RR, Miyamoto Y, Hatano E and Ikuta Y. Resin
corrosion cast (Mercox) in experimental evaluation of small
vessel anastomosis. J Reconstr Microsurg 2:213-220, 1986.
179. Karl P, Tilgner A and Heiner H. A new adhesive technique for
microvascular anastomoses: A preliminary report. Br J Plast
Surg 34:61-63, 1981.
217
180. Katsaros J, Schusterman M, Beppu M, Banis JC and Acland
RD. The lateral arm flap: anatomy and clinical applications.
Ann Plast Surg 12:489-500, 1984.
181. Kerrigan C. Personnal communication.
182. Khodadad G and Lougheed WM. Repair and replacement of
small arteries, microsuture technique. J Neurosurg
24:61-69, 1966.
183. Khodadad G and Lougheed WM. Stapling technique in
segmental vein autografts and end-to-end anastomosis of
small vessels in dogs. Utilization of the operating
microscope. J Neurosurg 24:855-864, 1966.
184. Khodadad G. Histological evaluation of long-term
microvascular repair and replacement. Arch Surg
101:503-507, 1970.
185. Khodadad G. Long-term results of microvascular repair and
replacement. Surgery 69:397-403, 1971.
186. Kim SK, Aziz S, Oyer P and Hentz VR. Use of Cyclosporin A in
allotransplantation of rat limbs. Ann Plast Surg 12:249-255,
1984.
187. Kleinert HE and Kasdan ML. Salvage of devascularized upper
extremities including studies on small vessel anastomosis.
Clin Orthop 29:29-38, 1963.
188. Kleinert HE, Kasdan ML and Romero JL. Small blood-vessel
anastomosis for salvage of severely injured upper extremity.
J Bone Joint Surg 45-A:788-796, 1963.
218
189. Kleinert HE, Serafin D and Daniel RK. The place of
microsurgery in hand surgery. Orth Clin North Am
4:929-944, 1973.
190. Kletter G, Matras H, Chiari H, Dinges N and Witzmann A.
Comparative evaluation of conventionally sutured and clot-
sutured microsurgical anastomoses. Chapter 19, 149-153. In
Microsurgery for Stroke. Schmiedek P (Ed). Berlin,
Heidelberg and New York, Springer-Verlag, 1977.
191. Kletter G, Matras H and Dinges HP. Zur partiellen kleburg
von mikrogefabanastomosen im intrakraniellen bereich. Wien
Klin Wochenschr 90:415, 1978.
192. Kletter G. Fibrin adhesives in intracranial microvascular
surgery. In Schlag G and Redl H (Eds), Fibrin Sealant in
Operative Medicine. Vol. 2. Berlin, Heidelberg and New
York: Springer-Verlag, 1986.
193. Klitzman B. Microvascular determinants of blood flow.
J Reconstr Microsurg 4:77-80, 1987.
194. Kolb S, Wray C and Weeks PM. Bursting strength of
microarterial repairs. Surg Forum 30:531-533, 1979.
195. Komatsu S and Tamai S. Successful replantation of a
completely cut-off thumb. Plast Reconstr Surg 42:374-377,
1968.
196. Krag C and Hoick S. Microvascular anastomoses: A
comparison of the end-to-end and the telescope techniques
in rats. J Microsurg 2:3-10, 1980.
219
197. Rrag C and Hoick S. The value of the patency test in
microvascular anastomosis: correlation between observed
patency and size of intraluminal thrombus: an experimental
study in rats. Br J Plast Surg 34:64-66, 1981.
198. Krag C, Hoick S, DeRose G, Lyczakowski T and Freeman CR.
Healing of microvascular anastomoses. A comparative study
using normal and irradiated recipient vessels for
experimental free flaps in rabbits. Scand J Plast Reconstr
Surg 16:267-274, 1982.
199. Krizek TJ, Tani T, DesPrez JD and Kiehn CL. Experimental
transplantation of composite grafts by microsurgical vascular
anastomoses. Plast Reconstr Surg 36:538-546, 1965.
200. Lance EM, Inglis AE, Figarola F and Veith FJ. Transplantation
of the canine hind limb. J Bone Joint Surg 53-A: 1137-1149,
1971.
201. Lang WH. Handbook of Zeiss Microscopes for Microsurgery,
their Technical Principle and Operation. Oberkochen, West
Germany: Carl Zeiss, 1981.
202. Lang WH and Muchel F. Zeiss Microscopes for Microsurgery.
Berlin, Heidelberg and New York: Springer-Verlag, 1981.
203. Lapchinsky AG. Recent results of experimental
transplantation of preserved limbs and kidneys and possible
use of this technique in clinical practice. Ann NY Acad Sci
87:539-571, 1960.
220
204. Lauritzen C. A new and easier way to anastomose
microvessels. Scand J Plast Reconstr Surg 12:291-294,
1978.
205. Lauritzen C and Bagge U. A technical and biomechanical
comparison between two types of microvascular anastomoses.
An experimental study in rats. Scand J Plast Reconstr Surg
13:417-421, 1979.
206. Lauritzen C, Johansson BR and Eriksson E. Long-term study
of the microvascular sleeve anastomosis. An experimental
study in the rabbit renal artery. Scand J Plast Reconstr Surg
14:165-169, 1980.
207. Lauritzen C and Hansson HA. Microvascular repair after the
sleeve anastomosis. An ultrastructural study in the rat
femoral vessels. Scand J Plast Reconstr Surg 14:65-70, 1980.
208. Lauritzen C. A presentation of the sleeve anastomosis. Scand
J Plast Reconstr Surg Suppl 19:49-51, 1982.
209. Lauritzen C. The sleeve anastomosis revisited. Ann Plast Surg
13:145-149, 1984.
210. Lauro JS. The use of pericranial flap in scalp wounds with
exposed bone. Plast Reconstr Surg 72:786-791, 1983.
211. Lee S, Frank DH and Choi SY. Historical review of small and
microvascular vessel surgery. Ann Plast Surg 11:53-62, 1983.
212. Lee S, Hweidi SA and Skivolocki WP. An open-loop technique
to facilitate microtubal anastomoses in the rat. J Reconstr
Microsurg 1:45-48, 1984.
221
213. Lehman RAW and Hayes GJ. The toxicity of alkyl 2-
cyanoacrylate tissue adhesives: Brain and blood vessels.
Surgery 61:915-922, 1967.
214. Leonard EF. The role of flow in thrombogenesis. Bull New
York Acad Med 48:273-280, 1972.
215. Lidman D and Daniel RK. The normal healing process of
microvascular anastomoses. Scand J Plast Reconstr Surg
15:103-110, 1981.
216. Lidman D and Ostrup LT. Blood flow and scanning electron
microscope study on venous microvascular anastomoses with
Nakayama's apparatus and manual suture. Scand J Plast
Reconstr Surg 15:97-101, 1981.
217. Lindstrom BL and de Takats G. Bifurcational anastomosis of
small arteries with pedicled grafts. Surgery 53:340-343,
1963.
218. Longa EZ, Weinstein PR and Chater G. Scanning electron
microscopy studies of needle and suture damage in rat
carotid and femoral arteries. Microsurgery 5:169-174, 1984.
219. Lourie GM, Seaber AV and Urbaniak JR. Microanastomotic
response to needle and suture size. J Reconstr Microsurg
1:135-138, 1984.
220. McCabe M, Cunningham GJ, Wyatt AP, Rothnie NG and Taylor
GW. A histological and histochemical examination of
autogenous vein grafts. Br J Surg 54:147-155, 1967.
222
221. McCraw JB and Furlow LT Jr. The dorsalis pedis arterialized
flap. A clinical study. Plast Reconstr Surg 55:177-185, 1975.
222. McCraw JB and Dibbell DG. Experimental definition of
independent myocutaneous vascular territories. Plast
Reconstr Surg 60:212-220, 1977.
223. McCraw JB, Dibbell DG and Carraway JH. Clinical definition
of independent myocutaneous vascular territories. Plast
Reconstr Surg 60:341-352, 1977.
224. McCraw JB, Penix JO and Baker JW. Repair of major defects
of the chest wall and spine with the latissimus dorsi
myocutaneous flap. Plast Reconstr Surg 62:197-206, 1978.
225. McGregor LA and Jackson IT. The groin flap. Br J Plast Surg
25:3-16, 1972.
226. McGregor LA and Morgan G. Axial and random pattern flaps.
Br J Plast Surg 26:202-213, 1973.
227. McGrouther DA. The operating microscope: a necessity or a
luxury? Br J Plast Surg 33:453-460, 1980.
228. MacKinnon SE, Kelly L and Hunter DA. Comparison of
regeneration across a vascularized versus conventional nerve
graft: case report. Microsurgery 9:226-233,1988.
229. MacKinnon SE and Dellon AL. Surgery of the Peripheral
Nerve. New York: Thieme, 1988.
223
230. McLean DH and Buncke HJ. Autotransplant of omentum to a
large scalp defect with microsurgical revascularisation. Plast
Reconstr Surg 49:268-274, 1972.
231. McLean DH and Buncke HJ. Use of the saran wrap cuff in
microsurgical arterial repairs. Plast Reconstr Surg
51:624-627, 1973.
232. MacLeod AM. Personal communication.
233. MacLeod AM and Robinson DW. Reconstruction of defects
involving the mandible and floor of mouth by free osteo¬
cutaneous flaps derived from the foot. Br J Plast Surg
35:239-246, 1982.
234. McNamara MJ, Seaber AV and Urbaniak JR. Effect of
irrigation fluids on arterial and venous endothelium after
ischemia. J Reconstr Microsurg 4:27-32, 1987.
235. Mallon WJ, Seaber AV and Urbaniak JR. A comparison of
absorbable and non absorbable sutures to vascular response in
immature arteries. J Reconstr Microsurg 2:87-92, 1986.
236. Malt RA and McKhann CF. Replantation of severed arms.
JAMA 189:716-722, 1964.
237. Man D and Acland RD. The microarterial anatomy of the
dorsalis pedis flap and its clinical applications. Plast
Reconstr Surg 65:419-423, 1980.
238. Manktelow RT and McKee NH. Free muscle transplantation
to provide active finger flexion. J Hand Surg 3:416-426,
1978.
224
239. Manktelow RT. Microvascular Reconstruction. Anatomy,
Applications and Surgical Technique. Berlin, Heidelberg and
New York: Springer-Verlag, 1986.
240. Manax WG, Bloch JH, Longerbeam JK and Lillehei R. Plastic
adhesive as an adjunct in suture anastomoses of small blood
vessels. Surgery 54:663-666, 1963.
241. Marty FM, Montandon D, Gumener R and Brodowski AZ. The
use of subcutaneous tissue flap in the repair of soft tissue
defects of the forearm and hand - an experimental and
clinical study of a new technique. Br J Plast Surg 37:95-102,
1984.
242. Mathes SJ and Nahai F. Classification of the vascular anatomy
of muscles: experimental and clinical correlation. Plast
Reconstr Surg 67:177-187, 1981.
243. Matras H, Chiari FM, Kletter G and Dinges HP. Zur klebung
von mikrogefabanastomosen (Eine experimentelle studie).
Pp 357. In Schmid E, Widmaier W, Reichert H (Eds).
Weiderherstellung von Form und Funktion Organischer
Einheiten. der Verschiedenen Korperregionen Stuttgart:
Georg Thieme Verlag, 1977.
244. Matras H. Fibrin seal: the state of the art. J Oral Maxillofacial
Surg 43:605-611, 1985.
245. Matsumoto T, Wolferth C and Jones N. Cyanoacrylate
monomers as adhesive. Int Surg 57:703-706,1972.
225
246. Maxwell GP, Stueber K and Hoopes JE. A free latissimus
dorsi myocutaneous flap. Case report. Plast Reconstr Surg
62:462-466, 1978.
247. Maxwell GP, Szabo Z and Buncke JH. Aneurysms after
microvascular anastomoses. Incidence and pathogenesis in
experimental animals. Plast Reconstr Surg 63:824-829,
1979.
248. May JW, Chait LA, Cohen BE and O'Brien BMcC. Free
neurovascular flap from the first web of the foot in hand
reconstruction. J Hand Surg 2:387-393, 1977.
249. Mayou BJ, Whitby D and Jones BM. The scapular flap-an
anatomical and clinical study. Br J Plast Surg 35:8-13, 1982.
250. Medical News-International Roundup. Tissue imbalance
overcome in transplant of dog's leg. Med Tribune 5:2, 1964.
251. Merrell JC, Zook EG and Russell RC. Cuffing techniques in
microarterial surgery. J Hand Surg 9-A:76-82, 1984.
252. Meyer VE, Smahel J and Donski P. Microvascular
anastomosis using the telescope principle: experimental
study. Int J Microsurg 2:81, 1980.
253. Meyermann R, Kletter G and Koos W Th. Morphologic
changes after vascular microanastomoses as a function of the
technique used. Chapter 14, 123-127. In Schmiedek P (Ed),
Microsurgery for Stroke. Berlin, Heidelberg and New York:
Springer-Verlag, 1977.
226
254. Meyermann R, Wismann H and Kletter G. Morphometric
approach to fine structural changes in the intima of the
common carotid artery of the rat following microsurgery.
Chapter 15, 128-134. In Schmiedek P (Ed), Microsurgery
for Stroke. Berlin, Heidelberg and New York: Springer-
Verlag, 1977.
255. Mii Y, Tamai S, Hori Y, Shimizu T and Fakui A. Microvascular
anastomosis with absorbable and nonabsorbable sutures - a
comparable study. J Microsurg 2:42-52, 1980.
256. Milliken RG. Personal communication.
257. Mtihlbauer W, Herndl E and Stock W. The forearm flap. Plast
Reconstr Surg 70:336-342, 1982.
258. Muller GH. Improved techniques in microvascular surgery.
Pp 201-208. In Reidiger D and Ehrenfeld M (Eds),
Microsurgical Tissue Transplantation. Chicago: Quintessence
Publishing, 1989.
259. Nakayama K, Tamiya T, Yamamoto K and Akimoto S. A simple
new apparatus for small vessel anastomosis (free autograft of
the sigmoid included). Surgery 52:918-931, 1962.
260. Nakayama K, Yamamoto K and Makino H. A new vascular
anastomosing instrument and its clinical application. Clin
Orthop 29:123-131, 1963.
261. Nakayama K, Yamamoto K, Tamiya T, Makino H, Odaka M,
Ohwada M and Takahashi H. Experience with free autografts
of the bowel with a new venous anastomosis apparatus.
Surgery 55:796-802, 1964.
227
262. Nakayama Y, Soeda S, lino T and Uchida A. Is the sleeve
anastomosis a risky technique? Br J Plast Surg 40:288-294,
1987.
263. Nakayama Y, Soeda S and Kiyosawa T. Vessel anastomosis
using a venous cuff and two sutures: an experimental study in
rat femoral and epigastric vessels. J Reconstr Microsurg
4:335-339, 1988.
264. Nassif TM, Vidal L, Bovet JL and Baudet J. The parascapular
flap; a new cutaneous microsurgical free flap. Plast Reconstr
Surg 69:591-600, 1982.
265. Nathan HS, Nachlas MM, Solomon RD, Halpern BD and
Seligman AM. Nonsuture closure of arterial incisions using a
rapidly-polymerizing adhesive. Ann Surg 152:648-659, 1960.
266. Nathan PA and Rose MC. An alternative technique for
microvascular suture. Plast Reconstr Surg 58:635-637, 1976.
267. Nieuborgh L. Assessing the patency of microvascular
anastomoses. Br J Plast Surg 32:151-152, 1979.
268. Nightingale G, Fogdestam I and O'Brien BMcC. Scanning
electron microscope study of experimental microvascular
anastomoses in the rabbit. Br J Plast Surg 33:283-298, 1980.
269. Nomoto H, Buncke HJ and Chater NL. Improved patency
rates in microvascular surgery when using magnesium sulfate
and a silicone rubber vascular cuff. Plast Reconstr Surg
54:157-160, 1974.
228
270. Nylander G, Ragnarsson R, Berggren A and Ostrup LT. The
UNILINK system for mechanical microvascular anastomosis in
hand surgery. J Hand Surg 14-A:44-48, 1989.
271. Nylen CO. The microscope in aural surgery, its first use and
later development. Acta Otolaryngol Suppl 116:226-240,
1954.
272. Nylen CO. The otomicroscope and microsurgery 1921-1971.
Acta Otolaryngol 73:453-454, 1972.
273. Obora Y, Tamaki N and Matsumoto S. Nonsuture
microvascular anastomosis using magnetic rings: Preliminary
report. Surg Neurol 9:117-120, 1978.
274. O'Brien BMcC. Personal communication.
275. O'Brien BMcC Crock GW, Bennett RC, Henderson PN and
Galbraith JEK. Experimental and clinical microsurgery. Med
J Aust 1:708-709, 1970.
276. O'Brien BMcC, Henderson PN and Crock GW. Metallized
microsutures. Med J Aust 1:717-719, 1970.
277. O'Brien BMcC, Henderson PN, Bennett RC and Crock GW.
Microvascular surgical technique. Med J Aust 1:722-725,
1970.
278. O'Brien BMcC, MacLeod AM, Hayhurst JW and Morrison WA.
Successful transfer of a large island flap from the groin to the
foot by microvascular anastomoses. Plast Reconstr Surg
52:271-278, 1973.
229
279. O'Brien BMcC, MacLeod AM, Miller GDH, Newing RK,
Hayhurst JW and Morrison WA. Clinical replantation of digits.
Plast Reconstr Surg 52:490-502, 1973.
280. O'Brien BMcC and Hayhurst JW. Metallized microsutures and
a new microneedle holder. Plast Reconstr Surg 52:673-676,
1973.
281. O'Brien BMcC. Microvascular Reconstructive Surgery.
Edinburgh, London And New York: Churchill Livingstone,
1977.
282. O'Brien BMcC. Micro-instruments and microsutures.
Chapter 2, 11-28. In Microvascular Reconstructive Surgeiy.
Edinburgh, London And New York: Churchill Livingstone,
1977.
283. O'Brien BMcC. Basic microvascular technique. Chapter 5,
50-78. In Microvascular Reconstructive Surgery. Edinburgh,
London And New York: Churchill Livingstone, 1977.
284. O'Brien BMcC, Gould JS, Morrison WA, Russell RC,
MacLeod AM. Free vascularized small joint transfer to the
hand. J Hand Surg 9:634-641, 1984.
285. O'Brien BMcC. Reconstructive microsurgery of the upper
extremity. J Hand Surg 15-A:316-321, 1990.
286. Ohmori K and Harii K. Free dorsalis pedis sensory flap to the
hand, with microneurovascular anastomoses. Plast Reconstr
Surg 58:546-554, 1976.
230
287. Olivari N. The latissimus flap. Br J Plast Surg 29:126-128,
1976.
288. Onishi K. Experimental studies in new method for nonsuture
anastomoses of small blood vessels. Jap J Surg 76:592-601,
1975.
289. Orticochea M. The musculo-cutaneous flap method: an
immediate and heroic substitute for the method of delay.
Br J Plast Surg 25:106-110, 1972.
290. dstrup LT. Anastomosis of small veins with suture or
Nakayama's apparatus: A comparative study. Scand J Plast
Reconstr Surg 10:9-17, 1976.
291. Ostrup LT. Mechanical "non-suture" anastomosis. Scand J
Plast Reconstr Surg (Suppl) 19:52-54, 1982.
292. Ostrup LT and Berggren A. The UNILINK instrument system
for fast and safe microvascular anastomosis. Ann Plast Surg
17:521-525, 1986.
293. Oxley J. Reference Handbook of Operation Microscopes.
Toronto: C Zeiss Canada Ltd, 1984.
294. Pagnanelli DM, Pait TG, Rizzoli HV and Kobrine AI. Scanning
electron micrographic study of vascular lesions caused by
microvascular needles and suture. J Neurosurg 53:32-36,
1980.
23 1
295. Pagnanelli DM, Maradzay JFX, Pait TG, Rizzoli HV and
Kobrine AI. The cutting-edged microvascular needle. A
scanning electron microscopy study. J Neurosurg
59:510-513, 1983.
296. Pan Y-C and Lee WPA. Recent microsurgical advances in
China. Microsurgery 9:65-74, 1988.
297. Pang CY and Forrest CR. Discussion. Beneficial effects of
Ibuprofen on experimental microvascular free flaps:
pharmacologic alteration of the no-reflow phenomenon. Plast
Reconstr Surg 79:372-374, 1987
298. Parel J-M, Crock GW, O'Brien BMcC, Henderson PN and
Galbraith JEK. Prototypal electro-microsurgical instruments.
Med J Aust 1:709-714, 1970.
299. Parenti G and Lenzi B. Clinical and angiographic results in 47
anastomoses for cerebral revascularization. In Schlag G and
Redl H (Eds), Fibrin Sealant in Operative Medicine. Vol. 2.
Springer-Verlag: Berlin, Heidelberg and New York, 1986.
300. Parsa FD and Spira M. Experimental evaluation of two-layer
anastomosis in microarterial surgery. Br J Plast Surg
32:325-328, 1979.
301. Pederson WC and Barwick WJ. Use of the vascular punch in
microsurgery. J Reconstr Microsurg 5:115-118, 1989.
302. Pempinello C, Haghighi P, Lee S and Curtis GP. Efficacy of
dexon microsutures in rat major abdominal vessel
anastomosis. I: application to heterotopic heart transplant.
Microsurgery 7:161-165, 1986.
232
303. Pennington DG, Lai MF and Pelly AD. The rectus abdominis
myocutaneous free flap. Br J Plast Surg 33:277-282, 1980.
304. Phelan JT, Young WP and Gale JW. The effect of suture
material on small artery anastomoses. Surg Gynecol Obstet
107:79-83, 1958.
305. Pho RWH, Patterson MH, Kour AK and Kumar VP. Free
vascularized epiphyseal transplantation in upper extremity
reconstruction. J Hand Surg 13-B:440-447, 1988.
306. Pitt TTE and Humphries NLM. Microarterial anastomoses in
the rat: The influence of different suture materials on the
patency, strength and electron microscopic appearance of
the vessels. Br J Plast Surg 35:150-155, 1982.
307. Polack FM, Sanchez J and Eve FR. Microsurgical sutures.
I. Evaluation of various types of needles and sutures for
anterior segment surgery. Can J Ophthal 9:42-47, 1974.
308. Poole M, Bowen JE and Batchelor JR. Prolonged survival of
rat leg allografts due to immunological enhancement.
Transplantation 22:108-111, 1976.
309. Pribil S and Powers SK. Carotid artery end-to-end
anastomosis in the rat using the argon laser. J Neurosurg
63:771-775, 1985.
310. Quigley MR, Bailes JE, Kwaan HC and Cerullo LJ. Laser-
assisted vascular anastomosis. Lancet 1:334, 1985.
233
311. Quigley MR, Bailes JE, Kwaan HC, Cerullo LJ, Brown JT and
Fitzsimmons J. Comparison of bursting strength between
suture- and laser-anastomosed vessels. Microsurgery
6:229-232, 1985.
312. Quigley MR, Bailes JE, Kwaan HC, Vidovich D, Nora P and
Cerullo LJ. Laser-assisted end-to-side anastomosis.
J Reconstr Microsurg 3:277-279, 1987.
313. Ragnarsson R, Berggren A and Ostrup LT. Microvenous end-
to-side anastomosis: an experimental study comparing the
unilink system and sutures. J Reconstr Microsurg 5:217-224,
1989.
314. Redl H, Schlag G and Dinges HP. The use and
biocompatability of a human fibrin sealant for hemostasis and
tissue sealing. In Schlag G and Redl H (Eds), Fibrin Sealant
in Operative Medicine. Vol 1, 135-157. Berlin, Heidelberg
and New York: Springer-Verlag, 1986.
315. Redl H and Schlag G. Properties of different tissue sealants
with special emphasis on fibrinogen-based preparations. In
Schlag G and Redl H (Eds), Fibrin Sealant in Operative
Medicine. Vol 4, 27-38. Berlin, Heidelberg and New York:
Springer-Verlag, 1986.
316. Redl H and Schlag G. Fibrin sealant and its mode of
application. In Schlag G and Redl H (Eds), Fibrin Sealant in
Operative Medicine. Vol 7, 13-26. Berlin, Heidelberg and
New York: Springer-Verlag, 1986.
234
317. Reidiger D and Ehrenfeld M (Eds). Microsurgical Tissue
Transplantation. Chicago: Quintessence Publishing Co Inc,
1989.
318. Report of the American Replantation Mission to China.
Replantation Surgery in China. Plast Reconstr Surg
52:476-489, 1973.
319. Richards RR and Mercer N. Effect of hydrostatic dilation on
the structure and patency of small arteries. J Reconstr
Microsurg 2:97-102, 1986.
320. Robertson JH and Robertson JT. The relationship between
suture number and quality of anastomoses in microvascular
procedures. Surg Neurol 10:241-245, 1978.
321. Robinson DW. Microsurgical transfer of the dorsalis pedis
neurovascular island flap. Br J Plast Surg 29:209-213, 1976.
322. Rosenbaum TJ and Sundt TM Jr. Thrombus formation and
endothelial alterations in microarterial anastomoses.
J Neurosurg 47:430-441, 1977.
323. Rousou J, Levitsky S, Gonzalez-Lavin L, Cosgrove D, Magilligan
D, Weldon C, Hiebert C, Hess P, Joyce L, Bergsland J and
Gazzaniga A. Randomized clinical trial of fibrin sealant in
patients undergoing resternotomy or reoperation after
cardiac operations. J Thorac Cardiovasc Surg 97:194-203,
1989.
324. Ruiz-Razura A, Lan M and Cohen BE. The laser-assisted end-
to-side microvascular anastomosis. Plast Reconstr Surg
83:511-517, 1989.
235
325. Russel RC, O'Brien BMcC, Morrison WA, Pamamull G and
MacLeod AM. The late functional results of upper limb
revascularization and replantation. J Hand Surg 9-A:623-633,
1984.
326. Sagi A, Han-Liang Yu, Ferder M, Gordon MJ and Strauch B.
"No suture" microanastomosis using vicryl rings and fibrin
adhesive system: an unsuccessful attempt. Plast Reconstr
Surg 79:776-777, 1987.
327. Sagi A. Invited discussion of "Casanova R, Herrera GA, Engels
BV, Valasquez C and Grotting JC. Microarterial sutureless
anastomosis using a polymeric adhesive: an experimental
study." J Reconstr Microsurg 3:209-210, 1987.
328. Salmon PA and Assimacopoulos CA. A pneumatic needle
holder suitable for microsurgical procedures. Surgery
55:446-450, 1964.
329. Sanders R, Green CJ and Tan WTL. The "wrap-around" end-
to-side anastomosis for micro-vessels. Br J Plast Surg
34:178-180, 1981.
330. Sartorius CJ, Shapiro SA, Campbell RL, Klatte EC and
Clark SA. Experimental laser-assisted end-to-side
microvascular anastomosis. Microsurgery 7:79-83, 1986.
331. Schlag G, Redl H, Turnher M and Dinges HP. The
importance of fibrin in wound repair. In Schlag G and Redl H
(Eds), Fibrin Sealant in Operative Medicine. Vol 4, 3-12.
Berlin, Heidelberg and New York: Springer-Verlag, 1986.
236
332. Schlag G and Redl H. Fibrin sealant in orthopaedic surgery.
Clin Orthop 227:269-285, 1988.
333. Schwind JV. Homotransplantation of extremities of rats.
Radiology 78:806-809, 1962.
334. Serafin D, Georgiade NG and Smith DH. Comparison of free
flaps with pedicled flaps for coverage of defects of the leg or
foot. Plast Reconstr Surg 59:492-499, 1977.
335. Serafin D, Georgiade NG, Morris RL and Mullen YM. A
Laboratory Manual of Microvascular Surgery. Ethicon, 1978.
336. Serafin D and Buncke HJ. Microsurgical Composite Tissue
Transplantation. St Louis: CV Mosby Co, 1979.
337. Serafin D and Buncke HJ. Versatility of composite tissue
transplantation in soft tissue reconstruction of the head and
neck. Chapter 35, 496-517. In Microsurgical Composite
Tissue Transplantation. St Louis: CV Mosby Co, 1979.
338. Serure A, Withers EH, Thomsen S and Morris J. Comparison
of carbon dioxide laser-assisted anastomosis and conventional
microvascular sutured anastomosis. Surg Forum 34:634-636,
1983.
339. Servant J, Ikuta Y and Harada Y. A scanning electron
microscope study of microvascular anastomoses. Plast
Reconstr Surg 57:329-334, 1976.
340. Seung HP. A new microvascular anastomosis using a sleeve
method and tissue adhesive (Abstract). Plast Reconstr Surg
80:878, 1986.
237
341. Shuhmacker HB and Lowenberg RI. Experimental studies in
vascular repair. I. Comparison of reliability of various methods
of end-to-end arterial sutures. Surgery 24:79-89, 1948.
342. Siemionow M. Evaluation of different microsurgical
techniques for arterial anastomosis of vessels of diameter less
than one millimeter. J Reconstr Microsurg 3:333-340, 1987.
343. Siemionow M. Evaluation of long-term patency rates of
different techniques of arterial anastomosis in rabbits.
Microsurgery 8:25-29, 1987.
344. Sigel B and Acevedo FJ. Vein anastomosis by electrocoaptive
union. Surg Forum 13:233-235, 1962.
345. Sigel B and Acevedo FJ. Electrocoaptive union of blood
vessels. A preliminary experimental study. J Surg Res
3:90-96, 1963.
346. Sigel B and Dunn MR. The mechanism of blood vessel closure
by high frequency electrocoagulation. Surg Gynecol Obstet
121:823-831, 1965.
347. Smahel J, Meyer VE and Bachem U. Glueing of peripheral
nerves with fibrin: experimental studies. J Reconstr
Microsurg 3:211-218, 1987.
348. Smith JW. Microsurgery of peripheral nerves. Plast Reconstr
Surg 33:317-329, 1964.
349. Smith JW. Microsurgery: review of the literature and
discussion of microtechniques. Plast Reconstr Surg
37:227-245, 1966.
238
350. Smith PJ, Foley B, McGregor IA and Jackson IT. The
anatomical basis of the groin flap. Plast Reconstr Surg
49:41-47, 1972.
351. Smith PJ. The vascular basis of axial pattern flaps. Br J Plast
Surg 26:150 -157, 1973.
352. Snyder CC. On the history of the suture. Plast Reconstr Surg
58:401-406, 1976.
353. Song R, Gao Y, Song Y, Yu Y and Song Y. The forearm flap.
Clin Plast Surg 9:21-26, 1982.
354. Song YG, Chen GZ and Song YL. The free thigh flap: a new
free flap concept based on the septocutaneous artery.
Br J Plast Surg 37:149-159, 1984.
355. Soutar DS, Scheker LR, Tanner NSB and McGregor IA. The
radial forearm flap: a versatile method for intra-oral
reconstruction. Br J Plast Surg 36:1-8, 1983.
356. Souther SG, Levitsky S and Roberts WC. Bucrylate tissue
adhesive for microvascular anastomosis. Technique, results
and histologic evaluation. Arch Surg 103:496-499, 1971.
357. Staindl O. The healing of wounds and scar formation under
the influence of a tissue adhesion system with fibrinogen,
thrombin, and coagulation factor XIII. Arch Otorhinolaryngol
222:241-245, 1979.
358. Staindl O. Indications of the fibrin sealant in facial plastic
surgery. Facial Plastic Surgery 2(4):323, 1985.
239
359. Stark GB, Swartz WM, Narayanan K and Moller AR. Hand
transplantation in baboons. Transplant Proc 19:3968-3971,
1987.
360. Stark GB, Swartz WM, Narayanan K, Moller AR, Jaeger K and
Hong C. Allograft composite tissue transplantation:
experimental hand transplantation in primates. Pp 209-216
In Reidiger D and Ehrenfeld M (Eds). Microsurgical Tissue
Transplantation. Chicago: Quintessence Publishing Co Inc,
1989.
361. Strauch B and Murray DE. Transfer of composite graft with
immediate suture anastomosis of its vascular pedicle
measuring less than 1 mm in external diameter using
microsurgical techniques. Plast Reconstr Surg 40:325-329,
1967.
362. Strecker WB, Wood MB and Schroeder AR. Stasis-induced
thrombosis of rat microvascular anastomosis. J Reconstr
Microsurg 4:69-73, 1987.
363. Sugiura K, Nakatsuchi Y, Yagi R and Sugimoto Y. A new
method for venous interposition grafts using fibrin glue.
Microsurgery 6:125-128, 1985.
364. Sully L, Nightingale MG, O'Brien BMcC and Hurley JV. An
experimental study of the sleeve technique in microarterial
anastomoses. Plast Reconstr Surg 70:186-192, 1982.
365. Swenson O and Gross RE. Absorbable fibrin tubes for vein
anastomoses. Surgery 22:137-143, 1947.
240
366. Sykes PJ and Bryson JR. How valuable are free flaps? An
early look at their results compared with those of standard
pedicled flaps. Br J Plast Surg 32:1-2, 1979.
367. Szilagyi DE, Whitcomb JG, Schenker W and Waibel P. The
laws of fluid flow and arterial grafting. Surgery 47:55-73,
1960.
368. Tamai S, Komatsu S, Sakamoto H, Sano S, Sasauchi N, Hori Y,
Tatsumi Y and Okuda H. Free muscle transplants in dogs,
with microsurgical neurovascular anastomoses. Plast
Reconstr Surg 46:219-225, 1970.
369. Tamai S, Sasauchi N, Hori Y, Tatsumi Y and Okuda H.
Microvascular surgery in orthopaedics and traumatology.
J Bone Joint Surg 54-B:637-647, 1972.
370. Tarlov IM and Benjamin B. Plasma clot and silk suture of
nerves. I. An experimental study of comparative tissue
reaction. Surg Gynaecol Obstet 76:366-374, 1943.
371. Taylor GI, Miller GDH and Ham FJ. The free vascularized
bone graft. A clinical extension of microvascular techniques.
Plast Reconstr Surg 55:533-544, 1975.
372. Taylor GI and Daniel RK. The anatomy of several free flap
donor sites. Plast Reconstr Surg 56:243-253, 1975.
373. Taylor GI and Ham FJ. The free vascularized nerve graft: a
further experimental and clinical application of microvascular
techniques. Plast Reconstr Surg 57:413-426, 1976.
241
374. Taylor GI, Townsend P and Corlett R. Superiority of the deep
circumflex iliac vessels as the supply for free groin flaps:
experimental work. Plast Reconstr Surg 64:595-604, 1979.
375. Taylor GI, Townsend P and Corlett R. Superiority of the deep
circumflex iliac vessels as the supply for free groin flaps:
clinical work. Plast Reconstr Surg 64:745-759, 1979.
376. Taylor GI, Corlett R and Boyd JB. The extended deep inferior
epigastric flap: a clinical technique. Plast Reconstr Surg
72:751-764, 1983.
377. Tegtmeier RE and Gooding RA. The use of a fascial flap in ear
reconstruction. Plast Reconstr Surg 60:406-411, 1977.
378. Thiede A, Lutjohann K, Beck C and Blunck F. Absorbable and
nonabsorbable sutures in microsurgery: standardized
comparable studies in rats. J Microsurg 1:216-222, 1979.
379. Thurston JB, Buncke HJ, Chater NL and Weinstein RW. A
scanning electron microscopy study of micro-arterial damage
and repair. Plast Reconstr Surg 57:197-203, 1976.
380. Tidrick PT, Seegers WH and Warner ED. Clinical experience
with thrombin as a hemostatic agent. Surgery 14:191-196,
1943.
381. Tidrick RT and Warner ED. Fibrin fixation of skin
transplants. Surgery 15:90-95, 1944.
242
382. Tomasello F, Spadaro A, Albanese V and Conforti. SEM
evaluation of endothelial changes following end-to-side
microvascular anastomoses in rats. J Neurosurg 54:525-531,
1981.
383. Travers V, Kanaujia RR, Ochi M and Ikuta Y. Microvascular
anastomosis using carbon dioxide (CO2) laser: evaluation by
SEM after corrosion cast. J Reconstr Microsurg 4:61-67,
1987.
384. Ts'ao C-H. Myointimal cells as a possible source of
replacement for endothelial cells in the rabbit. Circ Res
23:671-682, 1968.
385. Tsitsopoulos P, Malbouisson ANB and Harrison MJG. End-to-
side vascular anastomosis: a study of technical considerations
in the rat. J Neurosurg 56:642-645, 1982.
386. Tsui CY, Shih YF, Tang LY and Wang WH. Successful
restoration of a completely amputated arm. Chin Med J
85:536-541, 1966.
387. Tsui CY, Feng YH, Tang CY, U CM, Yu YC, Chen CC, Shih YF,
Wang WH, Chiang LP, Chui HP, Ma SC, Lin TL and Chen C.
Microvascular anastomosis and transplantation. Experimental
studies and clinical application. Chin Med J 85:610-617,
1966.
388. Upton J. Leeches. Plast Reconstr Surg 79:311, 1987.
389. Urbaniak JR, Soucacos PN and Adelaar RS. Experimental
evaluation of microsurgical techniques in small artery
anastomoses. Orth Clin North Am 8:249-263, 1977.
243
390. Urbaniak JR, Koman LA, Goldner RD, Armstrong NB and
Nunley JA. The vascularized cutaneous scapular flap. Plast
Reconstr Surg 69:772-778, 1982.
391. Urbaniak JR. Discussion. The vascular anatomy and
dissection of the free scapular flap. Plast Reconstr Surg
73:604, 1984.
392. Urschel HC and Roth E. Small arterial anastomoses.
I. Nonsuture. Ann Surg 153:599-610, 1961.
393. Urschel HC and Roth E. Small arterial anastomoses:
II. Suture. Ann Surg 153:611-616, 1961.
394. Vale BH, Frenkel A, Trenka-Benthin S and Matlaga BF.
Microsurgical anastomosis of rat carotid arteries with the CO2
laser. Plast Reconstr Surg 77:759-766, 1986.
395. Vilkki SK. Microvascular sleeve anastomosis in clinical
replantation. Scand J Plast Reconstr Surg (Suppl) 19:71-74,
1981.
396. Vogelfanger IJ and Beattie WG. A concept of automation in
vascular surgery: A preliminary report on a mechanical
instrument for arterial anastomosis. Can J Surg 1:262-265,
1958.
397. Wang S, Grubbs PE, Basu S, Robertazzi RR, Thomsen S,
Rose DM, Jacobowitz IJ and Cunningham JN. Effect of blood
bonding on bursting strength of laser-assisted microvascular
anastomoses. Microsurgery 9:2-9, 1988.
244
398. Weiland AJ, Villarreal-Rios A, Kleinert HE, Kutz J, Atasoy E
and Lister G. Replantation of digits and hands; analysis of
surgical techniques and functional results in 71 patients with
86 replantations. J Hand Surg 2:1-12, 1977.
399. Weinstein PR, Chater NL and Maglio MT. Scanning electron
microscope studies of endothelial injury in microsurgical
anastomosis. Chapter 16, 135-138. In Schmiedek P (Ed),
Microsurgery for Stroke. Berlin, Heidelberg and New York:
Springer-Verlag, 1977.
400. Weinstein PR, Mehdom HM and Szabo Z. Microsurgical
anastomosis: vessel injury, regeneration and repair. Chapter
9, 111-144. In Serafin D and Buncke HJ (Eds), Microsurgical
Composite Transplantation. St. Louis: CV Mosby Co, 1979.
401. Weiss EW and Lam CR. Tantalum tubes in the non-suture
method of blood vessel anastomosis. Am J Surg 80:452-454,
1950.
402. Weissberg D and Goetz RH. Necrosis of arterial wall following
application of methyl 2-cyanoacrylate. Surg Gynecol Obstet
119:1248-1252, 1964.
403. Wheatley MJ, Mathes SJ and Hassett C. Comparison of
continuous and interrupted suture techniques in
microvascular end-to-side anastomosis. J Reconstr Microsurg
2:93-96, 1986.
404. Wieslander JB and Aberg M. Blood flow in small arteries after
end-to-end and end-in-end anastomoses: An experimental
quantitative comparison. J Microsurg 2:121-125, 1980.
245
405. Wieslander JB and Aberg M. Stenosis following end-in-end
microarterial anastomoses: an angiographic comparison with
the end-to-end technique. J Microsurg 3:151, 1982 .
406. Wieslander JB, Aberg M and Dougan P. Accumulation of
isotope labelled platelets in small arteries after end-to-end
and end-in-end anastomoses in the rabbit. Br J Plast Surg
35:158-162, 1982.
407. Wieslander JB and Rausing A. A histologic comparison of
experimental microarterial end-in-end (sleeve) and end-to-
end anastomoses. Plast Reconstr Surg 73:279-285, 1984.
408. Wieslander JB. The appearance of normal vascular walls and
endothelium in small arteries. Microsurgery 8:173-179,
1987.
409. Wieslander JB. What is the appearance of vascular walls and
endothelium in small arteries? Pp 227-231. In Reidiger D
and Ehrenfeld M (Eds): Microsurgical Tissue
Transplantation. Chicago: Quintessence Publishing, 1989.
410. Wiman D, Ostrup LT and Enestrom S. The effect of dextran
on the incidence of thrombosis in microvenous Nakayama
ring pin anastomoses: Including further studies on the
histopathology of Nakayama anastomoses. Scand J Plast
Reconstr Surg 13:263-268, 1979.
411. Wintermantel E. The thermic vascular anastomosis (TVA). A
new nonsuture method. 1 History, instruments and
microsurgical technique. Acta Neurochirurgica 56:5-24,
1981.
246
412. Wintermantel E. The thermic vascular anastomosis (TVA).
III. Analysis of histology. Acta Neurochirurgica 66:221-232,
1982.
413. Woodward SC, Herrmann JB, Cameron JL, Brandes G,
Pulaski EJ and Leonard F. Histotoxicity of cyanoacrylate
tissue adhesive in the rat. Ann Surg 162:113-122, 1965.
414. Wray RC, Mathes SM, Young VL, Weeks PM. Free vascularized
whole-joint transplants with ununited epiphyses. Plast
Reconstr Surg 67:519-525, 1981.
415. Wu YK. Progress of surgery in China. Chin Med J
84:351-361, 1965.
416. Wyatt AT, Rothnie NG and Taylor GW. The vascularization of
vein-grafts. Br J Surg 51:378-381, 1964.
417. Yasargil MG. Microsurgery: As Applied to Neurosurgery.
Stuttgart: Thieme, 1969.
418. Yasargil MG. Experimental microsurgical operations in
animals. Chapter 3, 60-81. In Microsurgery: As Applied to
Neurosurgery. Stuttgart: Thieme, 1969.
419. Yasargil MG. Reconstructive and constructive surgery of the
cerebral arteries in man. Chapter 4, 82-150. In
Microsurgery: As Applied to Neurosurgery. Stuttgart:
Thieme, 1969.
420. Young JZ and Medawar PB. Fibrin suture of peripheral
nerves. Measurement of the rate of regeneration. Lancet
239:126-128, 1940.
247
421. Yu H-L, Sagi A, Ferder M and Strauch B. A simplified
technique for end-to-end microanastomosis. J Reconstr
Microsurg 2:191-194, 1986.
422. Zingg W and Khodadadeh M. Vascular anastomosis - sutures,




APPENDIX. Papers written and directly related to this thesis.
Papers published:
1. Bowen CVA. Reconstructive microsurgery: Historical
background, application and techniques for small blood vessel
repair. Transplantation Implantation Today 5:37-43, 1988.
Papers submitted for publication:
1. Bowen CVA, Leach DH, Crosby NL and Reynolds R.
Microvascular anastomoses. A comparative study of fibrinogen
adhesive and interrupted suture techniques. (Plast Reconstr
Surg).
2. Bowen CVA, Leach DH and Crosby NL. A comparison of the
healing process in two techniques of microvascular
anastomosis. (J Reconstr Micro).
Papers commissioned for publication:
1. Bowen CVA. History of microvascular anastomotic technique.
I. A review of suture techniques. (Microsurgery).
2. Bowen CVA. History of microvascular anastomotic technique.
II. A review of non-suture techniques. (Microsurgery).
250
